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Abstract	
	 Documentation	 of	 patterns	 in	 traditional	 knowledge	 is	 of	 paramount	
importance	 if	we	 are	 to	 fully	 understand	 the	 relationship	 between	people	 and	 their	
local	environment.	Investigations	of	medicinal	plant	use	also	contribute	to	discoveries	
of	 new	 drugs,	 by	 highlighting	 taxa	 which	 might	 have	 bioactivity	 of	 interest,	 and	
preservation	 of	 traditional	 knowledge,	 by	 identifying	 species	 important	 to	 local	
communities	 and	 describing	 how	 traditional	 knowledge	 is	 transmitted	 to	 future	
generations.	 Increasingly	 methods	 borrowed	 from	 ecology	 and	 community	
phylogenetics	 are	 used	 to	 understand	 patterns	 in	 medicinal	 plant	 use	 and	 inform	
bioprospecting.	 These	methods	 are	best	 applied	 to	 information-rich,	 large	data	 sets,	
yet	 despite	 the	 growth	 in	 ethnobotanical	 research,	 data	 are	 scattered.	 This	 thesis	
exploits	 traditional	 knowledge	 documented	 in	 literature	 and	 herbaria,	 using	 newly	
compiled	data	for	Brazil	to	explore	patterns	in	medicinal	plant	use,	in	documentation	
of	ethnomedicinal	species,	pharmacological	investigation	and	distribution	of	plant	use.	
Comparison	of	data	from	literature	and	herbarium	sources,	based	on	1400	use	reports	
of	 medicinal	 use	 of	 species	 of	 the	 family	 Leguminosae,	 showed	 herbaria	 to	 be	 a	
valuable	source	of	data	for	ethnobotanical	research.	Despite	the	 lower	proportion	of	
herbarium	 records	 (compared	 to	 literature	 records)	with	 information	on	 therapeutic	
application,	 modes	 of	 use	 and	 parts	 used,	 herbarium	 records	 validated	 data	 in	 the	
literature	 and	 added	 new	 information.	 These	 and	 additional	 data	 were	 used	 to	
demonstrate	 Ewé,	 a	 web-based	 database	 developed	 here,	 with	 tools	 to	 store	 and	
visualise	 ethnobotanical	 data.	 Research	 questions	 relating	 to	 pharmacological	
investigation	 of	 Brazilian	 plants	 used	 in	 traditional	 medicine,	 and	 to	 the	 spatial	
		 v	
distribution	of	traditional	knowledge	were	addressed	using	these	and	other	data	sets	
compiled	 for	 this	 study.	Phylogenetic	methods	were	used	 to	explore	 the	diversity	of	
Leguminosae	 species	 with	medicinal	 use,	 revealing	 phylogenetic	 diversity	 of	 species	
used	despite	of	lineages	rich	in	species	with	medicinal	use	(hot	nodes)	accounting	for	
45%	 of	 the	 species	 used	 in	 local	 medicine.	 Hot	 nodes	 are	 better	 characterized	
pharmacologically.	 Finally,	 the	 spatial	 distribution	 of	 traditional	 knowledge	 in	 Brazil	
was	 investigated,	 using	 a	 novel	 generic-level	 phylogeny	 for	 the	 Brazilian	 flora	 and	
species-level	herbarium	data	for	Angiosperms	in	Brazil	with	medicinal	uses.	According	
to	 taxonomic	 and	 phylogenetic	 measures	 of	 beta	 diversity,	 spatial	 heterogeneity	 in	
medicinal	 plant	 use	 was	 identified,	 highlighting	 local	 adaptation	 of	 medicinal	 floras	
despite	the	preference	for	some	plant	groups	revealed	by	clustering	in	deep	nodes.		
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Chapter	1 	Introduction	
	
“Cosi	Ewé,	Ewé	Orixá,	Ewé-ô,	Ewé-ô	Orixá	
Sem	folha	não	tem	sonho	
Sem	folha	não	tem	festa	
Sem	folha	não	tem	vida	
Sem	folha	não	tem	nada…”	
(Gerônimo	/	Ildásio	Tavares)	
	
1.1 Medicinal	plant	use-	history	and	perspectives	
	
Gerônimo	 and	 Ilsádio	 Tavares’	 song	 expresses	 the	 relationship	 between	
followers	of	the	Candomblé,	an	Afro-Brazilian	religion,	and	plant	species.	The	song	says	
that	without	 leaves	or	plants	 there	 is	no	dream,	 there	 is	no	 joy,	and	there	 is	no	 life.	
Candomblé	 is	one	of	many	 religions	where	plants	play	a	 central	 role	 in	worship	and	
wider	 culture.	 Throughout	human	history	plants	have	been	 sources	of	 food,	 shelter,	
tools,	 and	 medicine	 (Gurib-Fakim,	 2006).	 As	 in	 Candomblé,	 the	 relationship	 has	
sometimes	 encompassed	 supernatural	 beliefs	 of	 ritual	 use	 (Bussmann	 and	 Sharon,	
2006;	 Dafni,	 2006;	 Dhiman,	 2003;	 Merlin,	 2003;	 Naranjo,	 1979;	 Prance,	 1970).	 The	
medicinal	 properties	 of	 plant	 species	 have	 been	 the	 subject	 of	 empirical	 tests	 since	
ancient	 times	 (Gurib-Fakim,	 2006;	 Halberstein,	 2005;	 Leonti	 et	 al.	 2013).	 Whether	
plant	use	 is	magic-symbolic,	 founded	 in	 relevant	bioactivity,	or	both,	 is	unknown	 for	
most	 plants	 species	 used	 medicinally	 (Fabricant	 and	 Farnsworth,	 2001;	 Saslis-
Lagoudakis	 et	 al.	 2012a).	 Throughout	 history,	 medicinal	 plant	 knowledge	 has	 been	
transmitted	 mainly	 orally,	 either	 from	 older	 to	 younger	 generations	 (vertical	
transmission),	 or	 between	 non-parental	 pairs	 in	 the	 same	 generation	 (horizontal	
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transmission)	 (Hewlett	 and	 Cavalli-Sforza,	 1986).	 Nevertheless,	 written	
pharmacopoeias	and	guides	to	medicinal	plant	use	and	the	formulas	and	preparations	
can	also	be	found	from	ancient	times,	for	example	in	Sumerian	or	Chinese	texts,	and	
more	recently	in	the	form	of	many	modern	pharmacopoeias	(Petrovska,	2012).	
	
Medicinal	plants	are	of	great	importance	to	human	life,	being	used	by	almost	
80%	of	 the	population	of	developing	countries	 (Farnsworth	et	al.	1985;	WHO,	2007),	
acting	as	a	primary	 source	of	medicine	 for	different	 societies	 (Alves	and	Rosa,	2007;	
Vandebroek	 et	 al.	 2004).	 This	 relation	 of	 dependency	 on	 traditional	 medicine	 for	
healthcare	 is	 so	 strong	 that	 it	 is	 speculated	 that	 even	 when	 western	 medicine	 is	
available	 some	 traditional	 plant	 use	 will	 continue	 (Jäger,	 2015).	 The	 significance	 of	
medicinal	 plant	 use	 raises	 concerns	 about	 conservation	 of	 both	 plant	 species	 and	
traditional	 knowledge	 (TK),	 since	 habitat	 and	 species	 loss	 together	 with	 erosion	 of	
traditional	 knowledge	 is	 reported	 (Alves	 and	Rosa,	 2007;	Gupta	 et	 al.	 2005;	 Shanley	
and	Luz,	2003;	Voeks	and	Leony,	2004).		
	
Alongside	 their	 social	 and	 cultural	 importance,	 medicinal	 plants	 are	 an	
important	 source	 of	 drugs,	 and	 bioprospecting	 methods	 based	 on	 traditional	
knowledge	 are	 reported	 to	 contributed	 to	discovery	 and	development	of	 new	drugs	
(Cragg	and	Newman,	2013;	Fabricant	and	Farnsworth,	2001;	McChesney	et	al.	2007).	
Nevertheless,	the	number	of	plant	species	still	to	be	investigated	in	bioprospecting	is	
huge,	and	less	than	20%	of	plant	species	have	been	accessed	for	bioactivity	(Soejarto	
et	 al.	 2005).	 The	 number	 of	medicinal	 plant	 species	 globally	 is	 estimated	 at	 50	 000	
species	worldwide	 (Schippmann	 et	 al.	 2002);	 exploiting	 these	 using	 and	methods	 of	
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bioprospecting	 focusing	on	 traditional	 knowledge	might	be	expected	 to	 increase	 the	
number	of	 commercial	 plant-based	medicines.	Although	 the	 rate	of	 discovery	 is	 low	
(Firn,	2003),	methodologies	encompassing	phylogenetic,	ecological	and	meta-analytic	
methods	 to	 investigate	 traditional	 plant	 use	 may	 enhance	 drug	 discovery	
(Albuquerque	and	de	Medeiros,	2012;	de	Albuquerque,	2010;	Saslis-Lagoudakis	et	al.	
2012a).	 The	 topic	 of	 this	 thesis	 “Patterns	 amongst	medicinally-used	 plants	 in	 Brazil”	
combines	a	diversity	of	approaches	to	document	and	investigate	medicinal	plant	use	in	
Brazil	in	order	to	contribute	to	a	better	understanding	of	human-plant	relationships.	
	
1.2 Medicinal	plant	use	in	Brazil	
	
With	a	high	diversity	of	plant	species,	estimated	at	more	than	40	000	species	
(Forzza	 et	 al.	 2012),	 and	 rich	 in	 cultural	 manifestations,	 Brazil	 is	 a	 good	 source	 of	
traditional	 knowledge	 of	 plant	 species	 (Nogueira	 et	 al.	 2010).	 Hotspots	 for	 plant	
communities,	 for	 example	 the	 Cerrado	 and	 the	 Atlantic	 Forest	 might	 become	
important	 for	 new	medicinal	 plant	 discovery.	 Of	 the	 10	 000	 species	 of	 the	 Cerrado	
(Mendonça	et	al.	2008)	about	500	species	have	documented	medicinal	use	 (Guarim-
Neto	and	Morais,	2003).	With	a	wide	variety	of	vegetation	formations,	Cerrado	species	
have	different	adaptive	strategies	 to	biotic	or	abiotic	 stresses,	 resulting	 in	 secondary	
compounds	 that	 may	 be	 of	 great	 interest	 to	 bioprospecting	 for	 new	 drugs	 (Benko-
Iseppon	 and	 Crovella,	 2010).	 Surveys	 of	 Brazilian	 medicinal	 plants	 have	 been	made	
throughout	the	country,	but	there	are	understudied	regions	remaining	(de	Medeiros	et	
al.	 2013).	Brazilian	 traditional	medicine	 incorporates	not	only	 its	 local	 flora,	but	 also	
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many	 introduced	 species,	 as	 a	 result	of	human	migration	 to	 the	American	 continent	
(Bennett	and	Prance,	2000).	Nevertheless,	similarities	between	the	Brazilian	flora	and	
others,	 such	 as	 the	West-African	 flora,	 from	where	many	 Africans	 were	 brought	 to	
Brazil,	 facilitated	 the	 adaptation	 to	 the	 new	 environment	 and	 contributed	 to	 the	
increase	in	the	diversity	of	traditionally	used	species	(Voeks,	2013).	
	
Although	practiced	in	Brazil	before	the	arrival	of	Europeans,	traditional	uses	of	
Brazilian	 flora	only	 started	 to	be	documented	by	naturalists	 that	 visited	Brazil	 in	 the	
19th	 century,	 such	 as	 Auguste	 P.	 Saint-Hilaire,	 Karl	 F.P	 von	Martius,	 Johann	 E.	 Pohl,	
Gregory	 Langsdorffii	 (Brandão	 et	 al.	 2008).	 The	 book	 “Systema	 Materiae	 Medicae	
Vegetabilis	 Brasiliensis”	 published	 by	 Karl	 Friedrich	 von	Martius	 is	 one	 of	 the	 most	
important	historical	accounts	of	the	Brazilian	flora,	documenting	medicinal	plants	and	
their	 uses.	 Another	 important	 naturalist,	 Manuel	 Freire	 Allemāo	 de	 Cyneiros,	
published	 several	 papers	 known	 as	 “Materia	 Medica	 Brasileira”	 between	 1862	 and	
1864	(Lorenzi	and	Abreu	Matos,	2002).	Missionaries	and	priests	also	had	an	important	
role	 in	 documenting	 the	 Brazilian	 “Materia	medicas”,	while	 spreading	 knowledge	 of	
edible	 and	 medicinal	 species,	 in	 particular	 the	 priests	 from	 the	 Jesuits	 Order	
(Anagnostou,	2007).	Many	of	 these	“Materia	Medicas”	were	compiled	 together	with	
herbarium	vouchers	that	can	now	be	examined	and	used	to	investigate	historical	uses	
of	medicinal	plants	 in	Brazil.	Compilations	of	historical	use	data	reported	203	species	
with	past	medicinal	use	in	the	Brazilian	flora	(Brandão	et	al.	2008)	and	since	then,	the	
number	 of	 reports	 has	 increased	 to	 753	 species	 with	 medicinal	 use	 from	 literature	
survey	reported	by	de	Medeiros	et	al.	 (2013).	Despite	this	extensive	 list	of	medicinal	
plant	 species,	 only	 57	 plant	 species	 are	 present	 in	 the	 latest	 version	 of	 the	 official	
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Brazilian	Pharmacopoeia	(Anvisa,	2010).	Although	the	number	of	plant	species	 in	the	
Brazilian	Pharmacopoeia	has	fluctuated	(Alkin	et	al.	2017),	it	has	always	represented	a	
small	proportion	of	the	number	of	medicinal	plants	in	use.		
	
How	 plants	 are	 selected	 for	 medicinal	 use,	 and	 whether	 there	 are	 general	
patterns	underpinning	traditional	use	is	a	research	area	of	 interest	(Ankli	et	al.	1999;	
Geck	 et	 al.	 2017;	 Ladio	 et	 al.	 2007;	 Leonti	 et	 al.	 2002;	 Lucena	 et	 al.	 2007;	 Saslis-
Lagoudakis	 et	 al.	 2014).	 Several	 studies	 have	 been	 directed	 towards	 a	 better	
understanding	of	the	selection	of	Brazilian	medicinal	plants.	Voeks	(1996)	showed	that	
plant	resources	obtained	from	secondary	forest	were	more	important	for	local	healers	
than	the	ones	 from	primary	 forest	 in	a	study	 in	the	northeast	of	Brazil	 (Bahia	State).	
Primary	 forest	was	 preferred	 for	 timber	 gathering	while	 secondary	 forest	 had	more	
medicinal	 species.	 de	 Medeiros	 et	 al.	 (2013)	 showed	 that	 there	 is	 no	 difference	
between	woody	and	non-woody	habits	in	the	Brazilian	Traditional	Medicine,	but	exotic	
(or	introduced)	plants	have	a	higher	relative	importance	than	native	species	(which	are	
more	 important	considering	only	the	number	of	species).	 Indigenous	people,	such	as	
the	Krahô	 tribe,	would	 rather	make	use	of	only	native	plants	 (Rodrigues	and	Carlini,	
2006),	perhaps	because	of	the	isolation	of	their	society.	Despite	increasing	numbers	of	
studies,	 many	 are	 focused	 on	 local	 communities.	 Studies	 using	 large	 data	 sets	 to	
identify	 patterns	 of	medicinal	 plant	 use	 across	 Brazil	 are	 rare	 (Albuquerque	 and	 de	
Medeiros,	2012;	de	Medeiros	et	al.	2013).	
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1.3 Thesis	organization	
	
This	 thesis	 has	 three	 themes,	 the	documentation	of	 traditional	 knowledge	of	
medicinal	 plants,	 the	 phylogenetic	 distribution	 of	 knowledge	 and	 the	 spatial	
distribution	of	knowledge.	I	aim	to	identify	patterns	relating	to	medicinal	plant	use	in	
Brazil	across	all	three	themes.		
1.3.1 The	documentation	of	traditional	knowledge	
	
The	perception	that	erosion	of	traditional	knowledge	was	at	an	unprecedented	
rate,	and	the	view	that	traditional	knowledge	of	medicinal	plants	presents	solutions	to	
global	health	problems,	has	focussed	ethnobotanical	research	on	recording	knowledge	
before	it	 is	 lost	(Cox,	2000).	 In	light	of	this	urgency,	documentation	of	traditional	use	
has	often	been	entirely	descriptive.	Ethnographic	research,	taking	in	traditional	use	of	
plants,	is	traditionally	focussed	on	definable	groups	of	people.	Many	hold	the	view	that	
each	culture	has	its	own	unique	relationship	with	natural	resources	(Albuquerque	et	al.	
2007).	 This	 approach	 to	documentation	of	 TK	has	 furnished	a	huge	amount	of	 data,	
and	 increasingly	 ethnobotanists	 are	 questioning	whether	 these	 data	 can	 be	 used	 to	
test	 hypotheses	 (de	 Medeiros	 et	 al.	 2013).	 Examples	 of	 questions	 addressed	 using	
published	data	describing	medicinal	plant	use	include	whether	“core”	medicinal	floras	
can	be	identified	(Ellen	and	Puri,	2016),	whether	there	are	taxonomic	or	phylogenetic	
patterns	in	medicinal	plant	use	(Saslis-Lagoudakis	et	al.	2012a;	Saslis-Lagoudakis	et	al.	
2011a;	Weckerle	et	al.	2011),	whether	urbanisation	influences	plant	use	(de	Medeiros	
et	al.	2013)	and	whether	socioeconomic	and	environmental	factors	influence	plant	use	
(de	 la	 Torre	 et	 al.	 2012).	 Despite	 the	 potential	 of	 this	 research	 to	 contribute	 to	 the	
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understanding	 of	 relationship	 between	 humans	 and	 plants,	 the	 data	 that	 could	 be	
used	 are	 often	 very	 dispersed	 (Albuquerque	 and	 Medeiros,	 2012).	 Compilation	 of	
existing	data	is	 important	to	determine	the	extent	to	which	large-scale	questions	can	
be	addressed,	and	to	highlight	where	different	information	can	be	found.		
	
In	 chapter	 2	 I	 present	 ethnobotanical	 data	 from	 different	 sources,	 namely	
literature	and	herbarium	specimens,	 in	order	to	quantify	and	qualify	the	 information	
present	for	the	medicinal	uses	of	the	Leguminosae	in	Brazil.	Meta-analyses	have	used	
data	 published	 in	 the	 literature,	 but	 the	 documentation	 of	 traditional	 knowledge	 in	
herbaria	 is	 also	 noteworthy	 in	 providing	 data	 for	 ethnobotanical	 studies	 (Bedigian,	
2004;	de	 la	Torre	et	al.	2012;	Fantz,	1991;	van	Andel	et	al.	2014).	The	comparison	of	
literature	and	herbarium	data	is	in	order	to	determine	the	extent	to	which	herbarium	
and	published	sources	are	comparable.	I	also	ask	whether	herbaria	can	fill	gaps	in	our	
knowledge	of	plant	use.	Much	of	 the	exploration	of	 the	data	described	 in	 chapter	2	
depended	on	tools	I	developed	and	embedded	in	an	online	database.	The	primary	data	
compiled	for	chapter	2	provide	a	core	dataset	to	demonstrate	the	archiving,	curation,	
efficient	 analysis	 and	 interpretation	 of	 ethnobotanical	 data	 using	 the	 new	database.	
The	new	database,	which	I	call	Ewé,	is	described	in	chapter	3.	
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1.3.2 The	phylogenetic	distribution	of	knowledge		
	
The	 potential	 of	medicinal	 plant	 use	 in	 drug	 discovery	 and	 bioprospecting	 is	
reported	in	many	studies	(Cragg	and	Newman,	2013;	Fabricant	and	Farnsworth,	2001;	
McChesney	 et	 al.	 2007),	 and	 lately	 the	 use	 of	 phylogenetic	 methods	 together	 with	
ethnobotanical	data	is	increasing	in	order	to	improve	bioprospecting	(Ernst	et	al.	2016;	
Halse-Gramkow	et	al.	2016;	Lukhoba	et	al.	2006;	Saslis-Lagoudakis	et	al.	2012a,	2015).	
Based	on	reports	of	overuse	in	some	plant	lineages	(Amiguet	et	al.	2006;	Bennett	and	
Husby,	2008;	Moerman	et	al.	1999)	 implying	a	phylogenetic	signal	 in	plant	selection,	
phylogenetic	 investigation	 of	 medicinal	 plant	 use	 also	 relies	 on	 the	 presence	 of	
phylogenetic	 signal	 in	 the	 distribution	 of	 chemical	 constituents	 and	 shared	
biochemistry	between	closely	 related	species	 (Agrawal	et	al.	2009;	Champagne	et	al.	
1993;	 Muellner	 et	 al.	 2005;	 Rønsted	 et	 al.	 2008;	 Wink,	 2003,	 2013;	 Wink	 and	
Mohamed,	2003).	Despite	the	increase	in	number	of	studies	targeting	plant	species	for	
bioprospecting,	 the	 number	 of	 species	 that	 yield	 natural	 products	 that	 have	 been	
screened	was	reported	to	be	of	 less	than	10%	(Fabricant	and	Farnsworth,	2001),	and	
more	recent	estimates	are	needed.		
	
In	chapter	4	I	make	further	use	of	the	data	compiled	for	chapter	2.	Chapter	4	
describes	 the	 investigation	 of	 phylogenetic	 structure	 amongst	 Leguminosae	 species	
used	medicinally	in	Brazil.	As	well	as	describing	the	phylogenetic	structure	of	use	and	
for	different	therapeutic	applications,	the	findings	are	reviewed	relative	to	intensity	of	
pharmcological	 investigation.	 Pharmacological	 data	 were	 sought	 and	 reported	 here,	
and	 I	 report	 the	 proportion	 of	 Brazilian	 plants	 screened.	 Whether	 the	 screening	 is	
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related	 to	 the	 phylogenetic	 distribution	 of	 the	 species	 used	medicinally	 is	 explored,	
specifically	with	relations	to	lineages	rich	in	traditional	medicinal	use.	
	
1.3.3 The	spatial	distribution	of	knowledge		
	
Several	studies	have	sought	to	understand	the	effect	of	the	composition	of	the	
local	 flora	 on	 species	 selection	 for	medicinal	 purposes.	 Abundance	 is	well	 known	 to	
influence	 plant	 selection,	 and	 weedy	 plants	 from	 disturbed	 environments	 are	 often	
preferred	 (Albuquerque	 &	 de	 Oliveira,	 2007;	 Stepp	 and	 Moerman,	 2001).	 Looking	
beyond	 ecology	 to	 floristic	 composition	 overall,	 there	 are	 few	 comparative	 studies	
which	 aim	 to	 tease	 out	 the	 extent	 to	 which	 the	 same	 plants	 are	 used	 in	 different	
cultural	 and	 floristic	 backgrounds.	 One	 such	 study	 (Saslis-Lagoudakis	 et	 al.	 2014)	
considered	all	medicinal	plant	use	of	12	people-groups	in	Nepal	across	three	regions	of	
Nepal.	This	study	suggested	the	floristic	environment	was	a	more	important	influence	
on	medicinal	 plant	 selection	 than	 cultural	 relatedness	 or	 proximity	 to	 other	 cultural	
groups.	Another	study	(Cámara-Leret	et	al.	2017)	showed	a	preference	for	widespread	
palm	species	in	the	Amazon,	suggesting	that	TK	transmission	plays	an	important	role	in	
homogenising	 plant	 use	 across	 floristic	 environments.	 This	 view	 is	 supported	 by	 the	
study	 of	migrations,	which	 often	 highlight	 continuity	 in	 use	 of	medicinal	 plants	 (van	
Andel	 and	van’t	Klooster,	 2007;	Vandebroek	et	 al.	 2007;	Volpato	et	 al.	 2008).	 Saslis-
Lagoudakis	 et	 al.	 (2014)	 considered	 three	 regions	 of	 Nepal,	 but	 these	 did	 not	
correspond	 to	 natural	 floristic	 regions,	 whilst	 Cámara-Leret	 et	 al.	 (2017)	 compared	
communities	 considering	 the	 distribution	 of	 the	 study	 species	 but	 not	 the	 floristic	
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composition	overall.	More	studies	of	spatial	distribution	of	TK	are	needed	to	document	
and	begin	to	understand	complexity	in	traditional	knowledge	patterns.	
	
In	chapter	5	I	set	out	to	characterise	spatial	patterns	in	medicinal	plant	use	in	
Brazil.	Using	data	from	herbaria	for	all	Angiosperm	species,	I	applied	a	set	of	methods	
borrowed	 from	 biogeography	 and	 ecology.	 This	 study	 used	 taxonomic	 and	
phylogenetic	 beta	 diversity	 to	 investigate	 the	 composition	 of	 species	 and	medicinal	
floras	between	biomes,	and	Principal	Components	of	Phylogenetic	Structure	(PCPS)	to	
identify	lineages	contributing	to	biome	differences.	Brazil	 is	an	interesting	contrast	to	
Nepal,	since	it	is	relatively	linguistically	uniform,	but	floristically	highly	diverse	yet	well	
characterised.	In	Saslis-Lagoudakis	et	al.	(2014)		study	the	cultural	identities	were	well-
known,	 but	 floristic	 ones	 were	 not.	 In	 this	 study	 we	 expected	 to	 find	 relatively	
homogeneous	plant	use	because	of	a	 lack	of	 linguistic	boundaries	to	TK	transmission	
and	a	history	of	migration.		
	
1.4 A	synthesis		
	
Each	of	 the	 four	 chapters	outlined	above	are	presented	as	 if	 for	 submission	 to	a	
peer-reviewed	 scientific	 journal.	 Chapter	 2	 has	 been	 published	 at	 the	 time	 of	
submission	 of	 this	 thesis	 (Appendix	 1),	 in	 the	 journal	 Economic	 Botany	 (Souza	 and	
Hawkins,	 2017).	Whilst	 each	 chapter	 is	 written	 to	 stand	 alone,	 there	 is	 clear	 cross-
fertilisation	 between	 chapters.	 Chapters	 2	 and	 3	 depend	 on	 the	 same	 data	 set	
describing	medicinal	use	of	species	of	family	Leguminosae	in	Brazil.	Chapter	2	critically	
Chapter	1	Introduction	
	 11	
evaluates	 the	 ethnobotanical	 data	 describing	 medicinal	 use	 of	 plants	 found	 on	
herbarium	labels	and	makes	comparison	to	data	from	written	sources,	whilst	chapter	3	
uses	the	data	to	populate	and	demonstrate	the	use	of	a	new	database.	Chapter	4	also	
uses	 the	same	data	set	describing	medicinal	use	of	 species	of	 family	Leguminosae	 in	
Brazil.	In	this	chapter	additional	data	to	capture	pharmacological	research	activity	are	
collected.	The	novelty	 in	 this	 chapter	 lies	 in	 the	comparison	between	 traditional	use	
and	 scientific	 screening,	 using	 a	 phylogenetic	 framework	 for	 comparison.	 Chapter	 5	
extends	 the	 data	 on	medicinal	 plant	 use,	 compiling	 data	 from	 all	 Angiosperms.	 The	
compilation	of	these	data	from	herbarium	specimens	is	justified	based	on	the	findings	
presented	in	chapter	2.	Phylogenetic	methods	are	also	applied	 in	this	chapter,	but	 in	
this	 case	 they	 are	methods	 from	biogeography	 and	ecology,	 rather	 than	 “hot	node”	
analyses	 applied	 to	 the	 data	 in	 chapter	 4.	 Thus	 the	 applications	 of	 plant	 phylogeny,	
emerging	as	 tool	 to	better	understand	how	plants	are	used	by	people,	are	extended	
here.	
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Chapter	2 Comparison	 of	 herbarium	 label	 data	 and	 published	
medicinal	 use:	 herbaria	 as	 an	 underutilized	 source	 of	
ethnobotanical	information	
	
2.1 	Introduction	
	 Ethnobotanical	 research	 is	 crucial	 to	 understanding	 relationships	 between	
people	 and	 their	 biological	 environment	 (Thomas,	 2003).	 Global	 or	 regional	 studies	
which	compile	and	analyze	data	from	multiple	literature	sources	can	lead	to	a	general	
understanding	about	plant	use	(de	la	Torre	et	al.	2012;	de	Medeiros	et	al.	2013;	Saslis-
Lagoudakis	et	al.	2012a;	Weckerle	et	al.	2011),	but	the	availability	of	appropriate	data	
is	a	limitation	to	broad-scale	research	(Albuquerque	and	de	Medeiros,	2012).	Herbaria	
are	 repositories	 of	 information	 in	 the	 form	 of	 vouchers,	 originally	 serving	 economic	
botany,	and	increasingly	seen	primarily	as	resources	for	plant	taxonomy	(Bebber	et	al.	
2010;	Van	Andel	et	al.	2012).	Today	the	wider	value	of	herbaria	is	appreciated	(Lavoie	
et	 al.	 2013);	 herbaria	 worldwide	 house	 more	 than	 300	 million	 specimens	 collected	
over	 400	 years,	 and	 as	 such	 are	 a	 rich	 repository	 of	 specimen	 collection	 dates	 and	
localities	(Thiers,	2014).	Nevertheless,	the	extent	to	which	herbarium	specimens	may	
contribute	 ethnobotanical	 data	 not	 captured	 in	 publications,	 filling	 gaps	 in	 our	
knowledge	and	providing	data	for	analyses,	remains	only	partially	explored.		
Ethnobotanists	frequently	and	routinely	collect	and	cite	herbarium	specimens;	
indeed,	 journals	 such	 as	 Economic	 Botany	 require	 voucher	 specimens	 to	 be	 cited	
alongside	use	 reports.	However,	 specimens	which	were	not	 collected	as	vouchers	 to	
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support	published	studies	may	include	use	data.	The	most	complete	survey	to	assess	
the	frequency	of	ethnobotanical	information	in	herbarium	collections	was	that	of	von	
Reis	(1962;	1968).	She	reported	almost	6,800	specimens	citing	medicinal	uses	amongst	
the	2,500,000	specimens	of	Harvard	Herbarium,	despite	excluding	those	published	or	
likely	 to	 be	 known	 already.	 Since	 von	 Reis	 enumerated	 the	 advantages	 of	 searching	
herbaria	 for	 novel	 reports	 of	 use,	 herbarium	 surveys	 have	 become	 a	 minor	 but	
established	 source	 of	 ethnobotanical	 data	 (Bedigian	 2004;	 de	 la	 Torre	 et	 al.	 2012;	
Fantz	1991;	Jenks	&	Kim	2013;	Krishna	et	al.	2014;	Lampe	1986;	Lira	&	Caballero	2002;	
Lukhoba	et	al.	2006;	McKenna	et	al.	2011;	Prakash	2011;	Van	Andel	et	al.	2014;	Vickery	
1990;	Shinde	and	Prakash	2015).	Since	herbaria	are	 rich	 in	historical	data,	 they	have	
found	particular	use	 in	documenting	change	 (Nesbitt,	2014).	 For	example,	 studies	of	
historic	 herbaria	 have	 used	 the	 annotation	 on	 specimens	 to	 reveal	 changes	 in	 local	
names	and	uses	(van	Andel	et	al.	2012	-	Hermann	herbarium),	or	the	changing	species	
composition	of	pharmacopeia	(Birch	2009	-	Gideon	Lincecum	Herbarium;	De	Natale	&	
Pollio	2012	-	Trotter	collection	).		
	 The	 Leguminosae	 (legumes)	 is	 one	 of	 the	 largest	 plants	 families	 (Lewis	 et	 al.	
2005),	 over-utilized	 for	 medicine	 in	 some	 regions	 (Korea	 and	 Ecuador),	 and	 under-
utilized	 in	 others	 (North	 America),	 and	 with	 many	 documented	 uses	 (Moerman	 et	
al.1999).	In	Brazil,	the	family	comprises	c.	2,800	species	in	more	than	200	genera	(Flora	
of	Brazil	2020	 in	construction).	The	 legumes	of	Brazil	are	distributed	amongst	the	six	
biomes	 described	 for	 Brazil,	 Amazon	 Forest	 (1147	 sp.),	 Atlantic	 Rainforest	 (997	 sp.),	
Caatinga	 (620	 sp.),	 Cerrado	 (1237	 sp.),	 Pampas	 (138	 sp.)	 and	 Pantanal	 (161	 sp.).	
Ethnobotanical	work	in	Brazil	is	increasing,	particularly	in	the	Northeast	and	Southeast	
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regions	 of	 Brazil,	 where	 there	 are	 active	 research	 groups.	 However,	 in	 the	 Amazon,	
Cerrado,	Pantanal	and	Pampas	there	is	a	relative	deficit	of	ethnobotanical	data	in	the	
literature	(Ritter	et	al.	2015).		
The	complementarity	of	herbarium	and	published	data	on	medicinal	use	is	yet	
to	 be	 formally	 assessed,	 and	 the	proportion	of	 herbarium	 specimens	with	medicinal	
use	 information	 is	uncertain,	 since	 the	von	Reis	 study	did	not	 record	 the	number	of	
excluded	specimens	(von	Reis	1962,	1968;	Nesbitt	2014).	Here	we	compare	literature	
and	 herbaria	 as	 sources	 of	 ethnobotanical	 data,	 taking	 medicinal	 use	 of	 Brazilian	
legumes	as	a	case	study.	We	ask	how	often	herbaria	provide	data	on	plant	use	that	is	
not	present	in	the	literature,	whether	the	data	provided	in	the	two	sources	is	broadly	
comparable	and	 if	so,	whether	the	data	from	herbarium	specimens	could	be	used	to	
validate	 or	 augment	 poorly	 substantiated	 literature	 records.	 By	 addressing	 these	
questions,	we	seek	to	outline	a	role	for	herbarium	data	in	ethnobotanical	research.	
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2.2 Methods	
2.2.1 	Data	collection	
	 Published	 medicinal	 use	 data,	 and	 data	 from	 Brazilian	 herbarium	 specimens	
were	compiled	for	the	legumes	of	Brazil.	Data	were	organized	in	a	database	with	the	
following	fields:	genus	and	species	as	recorded	 in	the	publication	or	 in	the	specimen	
database,	 currently	 accepted	 name,	 therapeutic	 application	 as	 recorded	 in	 the	
publication	or	in	the	specimen	database,	therapeutic	application	categorized	according	
to	WHO	International	Classification	of	Diseases	10	(World	Health	Organization	2016),	
parts	used,	mode	of	application	and	 locality.	Where	necessary,	Google	maps	and	the	
Brazilian	 Geographic	 and	 Statistical	 Institute	 online	 data	 (IBGE)	 were	 used	 to	 get	
geographical	 coordinates	 for	 the	 localities	 cited	 on	 papers	 but	 with	 no	 cited	
coordinates.	Generic	and	species	names	followed	The	Plant	List	 (The	Plant	List	2013)	
and	 Missouri	 Botanical	 Garden's	 Tropicos	 database	 (Tropicos.org	 2016),	 and	 were	
corrected	to	a	currently	accepted	name	using	the	Plantminer	R	script	(Carvalho	et	al.	
2010)	
	 Publications	citing	medicinal	uses	of	 legumes	species	 in	Brazil	were	 identified	
using	Google	 Scholar	 and	 searches	of	 the	 following	 journals:	Acta	Botanica	Brasilica,	
Economic	Botany,	Fitoterapia,	Flovet,	Journal	of	Ethnobiology,	Journal	of	Ethnobiology	
and	 Ethnomedicine,	 Journal	 of	 Ethnopharmacology,	 Journal	 of	 Medicinal	 Plants	
Research,	 Revista	 Brasileira	 de	 Biociencias,	 Revista	 Brasileira	 de	 Farmacognosia,	
Revista	 Brasileira	 de	 Plantas	Medicinais	 and	 Rodriguesia.	 Search	 terms,	 which	 were	
used	both	 in	English	and	Portuguese,	are	presented	 in	Table	2-1.	From	the	subset	of	
papers	 found	 which	 record	 medicinal	 plant	 use,	 a	 dataset	 was	 compiled	 to	 record	
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fields	 as	 above.	 The	 frequency	 of	 voucher	 specimens	 being	 cited	 on	 the	 selected	
publications	was	calculated.		
Table	 2-1.Combinations	 of	 words	 and	 terms	 used	 as	 search	 terms	 in	 the	 literature	
review.	 Each	word	or	 term	 in	 column	1	was	 combined	with	 each	 in	 column	2.	 *The	
term	“Brazilian	Ethnobotany”	was	also	searched	alone.	
Column	1	 Column	2	
Brazilian	ethnobotany*	 Cerrado	
Ethnobotany	 Atlantic	rainforest	
Ethnopharmacology	 Caatinga	
Medicinal	Plants	 Pantanal/	Wetlands	
Medicinal	Flora	 Pampas/	Grasslands	
Ethnobiology	 Amazon	forest	
	 	
Herbarium	data	were	extracted	from	the	online	list	of	herbarium	and	biological	
collections	 from	Brazil,	 Species	 Link	 (http://splink.cria.org.br/).	 The	 file	was	exported	
to	excel	format	and	a	search	using	the	keywords	“medicinal”	and	“uses”	(in	Portuguese)	
was	 conducted	 in	 order	 to	 filter	 only	 the	 specimens	 with	 medicinal	 information.	
Although	search	was	 limited	 to	 these	 two	 terms,	a	 test	 search	 that	 included	specific	
diseases	 or	medical	 conditions,	 such	 as	 cold,	 influenza,	 migraines,	 heart	 conditions,	
abortifacients	stomach-ache	and	diarrhea,	rarely	resulted	in	even	one	more	use	report	
that	could	be	included	in	the	analysis.	Therefore,	only	the	two	previously	cited	terms	
were	used	to	obtain	the	final	list.	Specimens	were	sourced	from	15	herbaria,	FEMACT,	
INPA,	 IPA,	 JBRJ,	MBML,	 UEL,	 UEM,	 UEM,	 UFERSA,	 UFG,	 UFMS,	 UFPB,	 UFPE,	 UFRPE,	
UNESPSJRP,	UNICAMP.	 	
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2.2.2 Data	analysis	
The	data	from	the	surveys	were	explored	in	several	ways	to	draw	out,	for	the	
different	 sources,	 how	 much	 data	 there	 were,	 whether	 they	 were	 comparable	 or	
complementary	and	their	spatial	and	temporal	characteristics.		
Number	 of	 reports	 and	 presence/absence	 of	 ethnobotanical	 data:	Numbers	 of	 use	
reports	 from	 the	 literature	 and	 from	 the	 herbarium	 were	 calculated,	 where	 a	 use	
report	is	the	accepted	species	name	plus	all	the	associated	data	originating	from	one	
publication	 or	 one	 voucher	 specimen	 (i.e.	 entries	 or	 rows	 in	 Appendix	 2).	 How	
frequently	use	reports,	whether	from	publications	or	herbarium	labels,	include	data	on	
therapeutic	application,	plant	part	used	or	mode	of	application	was	also	calculated	as	
percentages.		
Number	of	species	described	and	comparison	of	species	lists:	The	number	of	species	
reported	 from	 literature	 and	 from	 the	 herbarium	 sources	 was	 determined.	 By	
comparing	species	lists,	species	unique	to	either	literature	or	herbarium	sources	were	
identified,	and	their	proportions	calculated	based	on	the	total	number	of	species	 for	
each	 source.	 Similarly,	 the	 species	with	 associated	 therapeutic	 indications/modes	 of	
application/plant	 part	 data	 were	 compared	 between	 the	 literature	 lists	 and	 the	
herbarium	lists,	and	the	proportions	of	species	with	these	data	were	also	calculated.	
To	account	for	the	possibility	that	the	same	study	contributed	both	the	herbarium	and	
publication	data,	we	scored	the	number	of	times	authors	and	collectors	were	the	same	
person,	for	records	of	the	same	content.		
Comparison	of	 information	content:	To	test	whether	the	 information	content	of	the	
data	from	the	two	sources	was	similar	we	compared	numbers	of	reports	by	genus,	for	
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each	 therapeutic	 application	 and	 in	 total.	 To	 compare	 therapeutic	 applications,	 we	
classified	 literature	 and	 herbarium	 reports	 following	 the	 WHO	 ICD-10	
(http://www.who.int/classifications/icd/en/).	 Although	 data	 standardization	 is	
reported	to	be	challenging,	as	researchers’	(etic)	classification	does	not	always	reflect	
properly	on	local	communities’	(emic)	classification	and	understanding	of	diseases,	for	
reasons	 of	 comparison	 and	meta-analysis	 such	 standards	 are	 reported	 (Staub	 et	 al.,	
2015).	 This	 is	 discussed	 further	 in	 Chapter	 3.	 Total	 numbers	 of	 each	 therapeutic	
application,	plant	part	used	and	mode	of	application	were	recorded	for	both	sources,	
so	 that	 the	 broad	 comparability	 of	 the	 data	 content	 could	 be	 assessed	 visually	 and	
using	Spearman	Rank-Order	Correlation	tests.		
Spatial	 and	 temporal	distribution	of	data:	The	number	of	 reports	and	species,	 from	
both	 literature	 and	 herbaria,	 were	 calculated	 for	 each	 biome	 in	 Brazil.	 Their	
coordinates	were	plotted	to	compare	spatial	distribution	of	studies	and	collections.	To	
investigate	 whether	 the	 number	 of	 reports	 in	 each	 biome	 from	 each	 source	 were	
correlated,	 Spearman	 Rank-Order	 Correlation	 was	 used.	 Dates	 of	 collection	 and	
publication	 between	 the	 two	 sources	 were	 also	 compared,	 and	 the	 changing	
proportions	 of	 specimens	 through	 time	 which	 report	 any	 information	 about	
therapeutic	application,	plant	part	used	or	mode	of	application	was	assessed.		
Validation	and	augmentation	of	data	sets:	We	searched	for	the	species	only	reported	
once	 in	 the	 literature	 (whether	 data-rich,	 i.e.	 including	 mode	 of	 use,	 plant	 part	 or	
therapeutic	application,	or	not)	in	the	herbarium	reports.	We	considered	the	literature	
report	 “validated”	 if	 there	 was	 an	 independently	 collected	 herbarium	 report	 of	
medicinal	use	for	that	species	(not	a	voucher	specimen	collected	by	the	authors	of	the	
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study).	We	also	listed	the	species	that	were	reported	as	medicinal	in	the	literature,	but	
where	there	were	no	literature	reports	of	the	mode	of	use,	plant	part	or	therapeutic	
application,	 and	 searched	 for	 these	 in	 the	 herbarium	 data.	 For	 these	 species	 we	
identified	 the	 number	 of	 herbarium	 reports	 of	 mode	 of	 use,	 plant	 part	 used	 or	
therapeutic	application	that	were	not	in	the	literature;	these	reports	we	considered	to	
augment	the	literature	reports.	Finally,	considering	only	the	species	with	reports	from	
both	literature	and	herbarium,	we	counted	the	total	number	of	new	use	reports	from	
each	source.		
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2.3 Results	
Number	of	reports	and	presence	or	absence	of	associated	data	describing	use:	
Considering	the	data	sourced	from	publications,	excluding	reports	where	identification	
was	only	to	genus	level	and	uses	that	were	not	medicinal,	there	were	938	reports	from	
104	publications.	Of	these	a	subset	of	69%	record	therapeutic	application,	49%	provide	
information	about	mode	of	application	and	61%	provided	information	about	plant	part	
used	 (Table	 2-2).	 91%	 of	 publications	 cited	 voucher	 specimens.	 	 Considering	 the	
herbarium	data,	 of	 the	 240,000	 specimens	 from	15	Brazilian	 herbaria	 searched,	 462	
(0.2%)	 indicated	 whether	 the	 plant	 was	 used	 medicinally.	 These	 represented	 154	
species	 in	62	genera.	Of	these	specimens,	16%	described	therapeutic	application,	4%	
provided	 information	about	mode	of	application	and	6%	provided	 information	about	
plant	part	used	(Table	2-2).		
Number	 of	 species	 described	 and	 comparison	 of	 species	 lists:	 In	 total	 264	
species	in	97	genera	were	reported	as	medicinal	in	the	literature,	of	which	165	species	
(62%)	were	uniquely	from	literature.	Of	the	154	species	in	62	genera	known	from	the	
herbarium,	55	 (36%)	were	 known	only	 from	 that	 source.	 The	percentages	of	 unique	
species	from	literature	where	therapeutic	applications,	plant	parts	used	and	modes	of	
application	were	known	were	much	higher,	from	82	to	92%.	Nevertheless,	in	the	fewer	
cases	from	herbaria	we	found	14%	of	unique	species	with	 indicated	plant	parts	used	
and	25%	of	unique	species	with	therapeutic	indications.	(Table	2).			
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Table	 2-2.	 Summary	 of	 data	 from	 literature	 and	 from	 herbarium	 specimens.	 The	
number	 of	 reports	 from	 literature	 or	 herbarium	 sources	 are	 indicated,	 and	whether	
they	 include	 any	 further	 information	 about	 use	 (therapeutic	 indication,	 mode	 of	
application,	plant	parts).	 Species	data	 is	 also	presented.	 The	 total	number	of	 species	
with	recorded	medicinal	use	is	given,	also	the	numbers	and	proportions	of	species	that	
are	either	unique	to	literature	or	unique	to	herbarium	(those	included	in	one	data	set	
but	not	the	other).	Species	with	uses	are	those	where	use	for	a	species	is	described	in	
that	 source;	 unique	 species	 are	 species	 for	 which	 information	 about	 that	 use	
(therapeutic	 indication,	 mode	 of	 application,	 plant	 parts)	 is	 derived	 only	 from	 that	
source.	
	
Literature	 Herbaria	
Number	of	use	reports	 938	 462	
	
Number	of	reports	with	therapeutic	indications	 654	 76	
	
Number	of	reports	with	modes	of	application	 462	 19	
	
Number	of	reports	with	plant	parts	used	 579	 30	
	
Number	of	reports	without	further	information	 284	 385	
	
Number	 of	 species	 (number/percentage	 of	 unique	
species)		
264	(165/62%)	 154	(55/36%)	
Number	 of	 species	 with	 therapeutic	 indications	
(number/percentage	of	unique	species)	 203	(167/82%)	 48	(12/25%)	
	
Number	 of	 species	 with	 modes	 of	 application	
((number/percentage	of	unique	species)	
162	(149/92%)	 16	(3/19%)	
	
Number	 of	 species	 with	 plant	 parts	 used	
(number/percentage	of	unique	species)		
184	(165/90%)	 22	(3/14%)	
	
Number	 of	 species	 without	 further	 information	
(number/percentage	of	unique	species)	
146(78/33%)	 141(73/52%)	
	
Comparison	of	information	content:	For	publications,	descriptions	of	use	could	
be	translated	to	16	of	the	19	WHO	ICD-10	categories	of	use.	For	herbaria,	therapeutic	
uses	were	allocated	 to	13	of	 the	19	WHO	 ICD-10	 categories.	Herbaria	 and	 literature	
reports	showed	a	statistically	significant	association	between	the	sets	of	ranks,	when	
the	most	 cited	 genera	 (p=<0,0001,	 rho=0.88),	 therapeutic	 applications	 (p=1.901e-07,	
rho=0.91),	 modes	 of	 application	 (p=0.002,	 rho	 0.86)	 and	 plant	 parts	 (p=0.0003,	
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rho=0.94)	 were	 ranked	 and	 compared	 (Tables	 2-3	 and	 2-4).	 The	 number	 of	 records	
which	had	 the	 same	 information	 and	 for	which	 collector	 and	 author	were	 the	 same	
person	was	35	(3.6%	of	records).		
Table	2-3.	Most	cited	genera	 in	 literature	and	herbarium.	Counts	 represent	 the	 total	
number	of	reports	for	each	genus,	in	the	literature	and	in	the	herbarium.	
Literature	 Herbarium	
Genus	 Count	 Genus	 Count	
Senna	 116	 Bauhinia	 77	
Bauhinia	 97	 Senna	 64	
Hymenaea	 66	 Mimosa	 27	
Caesalpinia	 65	 Caesalpinia	 23	
Mimosa	 50	 Hymenaea	 16	
Anadenanthera	 34	 Stryphnodendron	 15	
Stryphnodendron	 30	 Copaifera	 14	
Copaifera	 29	 Anadenanthera	 11	
Amburana	 26	 Amburana	 8	
Bowdichia	 23	 Bowdichia	 5	
Desmodium	 14	 Desmodium	 9	
Libidibia	 1	 Libidibia	 9	
	
Table	2-4.	Comparison	of	uses	between	 literature	and	herbaria,	showing	the	number	
of	reports	per	therapeutic	application,	plant	part	used,	and	mode	of	application.	
Use	
Literature	
reports	
	
Herbarium	
reports	
Therapeutic	Application	 	 	
Diseases	of	the	respiratory	system	
	 193	 21	
Diseases	of	the	digestive	system	
	 156	 10	
Diseases	of	the	blood	and	blood-forming	organs	and	certain	
disorders	involving	the	immune	mechanism	
	 151	 13	
Endocrine,	nutritional	and	metabolic	diseases	
	 151	 13	
Diseases	of	the	genitourinary	system	
	 64	 4	
Diseases	of	the	femalegenito	system	
	 62	 7	
Diseases	 of	 the	 musculoskeletal	 system	 and	 connective	
tissue	
	 56	 5	
Diseases	of	the	circulatory	system	 48	 5	
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Table	2.4	Comparison	of	uses	between	literature	and	herbaria,	showing	the	number	of	
reports	 per	 therapeutic	 application,	 plant	 part	 used,	 and	 mode	 of	 application	
(continuation).	
Diseases	of	the	nervous	system	
	 43	 3	
Certain	infectious	and	parasitic	diseases	
	 41	 5	
Diseases	of	the	skin	and	subcutaneous	tissue	
	 24	 5	
Neoplasms	
	 14	 1	
Diseases	of	the	eye	and	adnexa	
	 6	 0	
Diseases	of	the	ear	and	mastoid	process	
	 5	 0	
Pregnancy,	childbirth	and	the	puerperium	
	 4	 0	
OTHERS	 2	 0	
Mental	and	behavioural	disorders	
	 0	 0	
Plant	Part	Used	 	 	
Bark	 288	 14	
Leaves	 199	 7	
Root	 74	 12	
Fruit	 44	 1	
Seeds	 38	 1	
Flowers	 29	 0	
Whole	Plant	 16	 0	
Stem	 8	 0	
Mode	Of	Application	 	 	
Decoction	 153	 3	
Tea	 131	 11	
Infusion	 113	 2	
Syrup	 50	 2	
Alcoholic	Infusion	 44	 0	
Bath	 32	 2	
Powder	 3	 0	
Oil	 3	 0	
Wine	 2	 0	
		
Spatial	 and	 temporal	 distribution	 of	 data:	 Figure	 2-1	 shows	 the	 spatial	
distribution	 of	 data.	 Considering	 the	 geographic	 origin	 of	 literature	 and	 herbarium	
reports	combined,	the	Cerrado	and	Caatinga	biomes	were	best	represented,	with	418	
and	 361	 reports	 respectively,	 and	 the	 Pampas	 the	most	 under-represented,	with	 12	
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reports	(Table	2-5).		
	
Figure	 2-1.	Geographic	 origin	 of	 data	 extracted	 from	papers	 (triangles)	 and	 herbaria	
(circles).	 	 Triangles	and	circles	 shows	 the	 location	of	 studied	 sites	and	can	 represent	
more	than	1	record.	
	
Table	2-5.	Spatial	comparison	of	data	from	literature	and	the	herbaria.	The	distribution	
of	reports	and	species	from	each	source	 in	the	six	Brazilian	biomes	is	presented.	The	
percentages	 of	 total	 reports	 and	 total	 species	 that	 each	 source	 contributes	 to	 each	
biome	are	shown.	
		 Herbarium	 Literature	 Total	
Biomes	 Reports	 Species	 Reports	 Species	 Reports	 Species	
Amazon	forest	 32	(39%)	 22	(39%)	 50	(60%)	 39	(68%)	 82	 57	
Atlantic	forest	 74	(43%)	 51	(56%)	 96	(56%)	 56	(61%)	 170	 91	
Caatinga	 159	(44%)	 54	(55%)	 202	(56%)	 80	(82%)	 361	 97	
Cerrado	 96	(22%)	 49	(34%)	 322	(77%)	 126	(88%)	 418	 142	
Pampas	 2	(16%)	 2	(18%)	 10	(83%)	 8	(72%)	 12	 11	
Pantanal	 32	(58%)	 22	(62%)	 23	(41%)	 18	(51%)	 55	 35	
	
Biomes	with	more	herbarium	records	also	had	more	literature	records	(p=0.007,	
rho=0.92).	 Dates	 of	 collection	 and	 publication	 comparison	 revealed	 herbaria	 as	 a	
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unique	source	of	ethnobotanical	data	until	1980,	and	 the	2000’s	as	 the	decade	with	
most	 reports	 (Table	 2-6).	 The	 proportion	 of	 herbarium	 reports	 with	 medicinal	
information	 increased	 through	 time,	 (0.12%-0.36%	 from	 1900-1910	 to	 2000-2009)	
(Figure	2-2).	Data	for	2010	to	2014	are	not	plotted:	in	this	period,	of	19910	specimens	
23	(0.11%)	included	information	about	the	medicinal	use	of	the	specimen.	
	
Figure	2-2.	Temporal	patterns	in	the	recording	of	medicinal	data	in	herbaria.	The	graph	
shows	 the	 total	 number	 of	 herbarium	 specimens	 collected	 in	 each	 period	 and	 now	
deposited	in	the	herbaria	surveyed	(line),	and	the	proportion	of	those	specimens	with	
any	 associated	 information	 indicating	 whether	 or	 how	 the	 plant	 is	 used	 medicinal	
(bars).	
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Table	2-6.	Temporal	comparison	of	data	from	literature	and	the	herbaria.	The	total	
number	of	reports	in	each	decade,	and	in	the	last	four	years,	is	reported.	
Time	period	 Literature	reports	 Herbarium	reports	
1900-09	 0	 2	
1910-19	 0	 0	
1920-29	 0	 3	
1930-39	 0	 2	
1940-49	 0	 14	
1950-59	 0	 7	
1960-69	 0	 27	
1970-79	 0	 51	
1980-89	 3	 54	
1990-99	 20	 70	
2000-09	 591	 203	
2010-2014	 324	 23	
Validation	 and	 augmentation	 of	 data	 sets:	 From	 the	 literature,	 123	 species	 were	
reported	 once	 (hereafter	 “singletons”),	 excluding	 five	 species	 re-reported	 in	 later	
literature	 based	 on	 earlier	 original	 publication.	 Twenty-one	 (17%)	 of	 these	 species	
were	 validated	 by	 an	 independent	 herbarium	 report.	 Eighty-four	 singleton	 species	
were	reported	 in	the	herbarium	data	(including	eight	species	whose	multiple	reports	
originated	from	plant	collections	made	in	the	same	proximity	by	the	same	collector	in	
the	same	year,	since	this	is	considered	resulting	from	one	observation).	Of	these	84,	39	
(46%)	 were	 validated	 by	 a	 literature	 report.	 From	 the	 literature,	 there	 were	 53	
singleton	species	for	which	there	was	no	information	about	how	the	species	was	used;	
use	 reports	 were	 available	 from	 the	 herbarium	 for	 6	 of	 these	 (1	 for	 therapeutic	
application).	From	the	herbarium	there	were	73	singleton	species	without	use	record;	
use	 reports	 were	 available	 from	 the	 literature	 for	 27	 of	 these	 (27	 for	 therapeutic	
application,	24	for	mode	of	use	and	25	for	plant	part	used).	Considering	the	94	shared	
species,	 herbarium	 data	 added	 58	 new	 therapeutic	 indications,	 25	 new	 plant	 parts	
used	 and	 16	 new	modes	 of	 application,	 a	 total	 of	 99	 new	 uses	 when	 compared	 to	
literature.		 	
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2.4 Discussion	
	
Our	 study	 shows	 that	 the	 modern	 (1900-2010)	 herbarium	 specimens	 we	
surveyed	 comprise	 a	 significant	 source	 of	 data.	 They	 are	 information-rich,	 often	
describe	 how	 the	 plant	 is	 used,	 and	 overall	 the	 information	 they	 contain	 appears	
broadly	 similar	 to	 the	 information	 recorded	 in	 the	 literature.	We	were	 surprised	 at	
how	frequently	specimens	contained	information	about	the	specific	applications	of	the	
plants	used;	we	expected	many	specimens	might	simply	report	that	a	species	was	used	
medicinally.	 However,	 of	 those	 specimens	 citing	 any	 medicinal	 use	 at	 all,	 69%	 also	
reported	the	therapeutic	application	of	the	species,	49%	the	mode	of	application	and	
61%	the	plant	part	used.	Overall,	the	number	of	specimens	with	medicinal	information	
is	 low,	 however.	 We	 show	 here	 that	 just	 0.2%	 of	 the	 herbarium	 specimens	 we	
examined	for	this	study	contain	some	information	about	medicinal	application	of	the	
species	represented	by	the	voucher.		
Until	critical	studies	of	other	herbaria	are	made	it	is	not	possible	to	determine	
whether	 our	 findings	 about	 the	 proportion	 of	 specimens	 recording	 ethnomedicinal	
data	apply	more	generally.	Our	survey	 included	all	 specimens,	 regardless	of	whether	
the	 species	were	 previously	 known	 to	 have	 use,	 yet	 this	 proportion	 is	 less	 than	 the	
0.27%	 reported	 in	 von	 Reis’	 studies	 even	 after	 she	 excluded	 species	 already	 known	
(von	Reis	1962,	1968;	Harvard	Herbarium),	and	much	less	than	another	study	reporting	
3%	 of	 specimens	 with	 information	 about	 medicinal	 use	 (Shinde	 and	 Prakash	 2015;	
Mumbai’s	109	year	old	Blatter	herbarium).	Why	this	might	be	 is	unclear.	Few	of	our	
herbarium	specimens	are	as	old	as	those	in	the	Blatter	herbarium	and	we	also	expect	
the	 age	 profile	 of	 the	 specimens	 we	 examine	 to	 be	 younger	 than	 the	 Harvard	
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specimens	examined	by	von	Reis.	Her	survey	was	carried	out	in	the	1960s;	fewer	than	
2%	of	 the	specimens	we	examined	pre-dated	1900	 (no	pre-1900	specimens	 included	
medicinal	 information),	 and	we	don’t	 include	 specimens	collected	before	1900.	Very	
early	collections	were	often	made	by	botanists	who	were	trained	physicians	or	made	
in	the	context	of	colonial	expansion	through	exploitation	of	plant	resources,	and	thus	
were	made	 to	 record	plant	use	 (Schiebinger	 2004,	Van	Andel	 et	 al.	 2012).	Historical	
herbaria,	 and	 the	 significant	 national	 and	 institutional	 herbaria	 they	 have	 been	
bequeathed	 to	 and	 incorporated	 into,	 might	 therefore	 be	 richer	 in	 ethnobotanical	
information	that	the	more	modern	herbaria	we	surveyed.	Yet	we	also	show	that	later	
herbarium	 specimens	 in	 our	 study	 are	more	 likely	 to	 include	medicinal	 information	
(Figure	 2-2),	 suggesting	 a	 renaissance	 in	 Brazil	 in	 recording	plant	 uses	 on	herbarium	
labels.	 This	 might	 reflect	 the	 exponential	 growth	 in	 the	 number	 of	 individuals	 and	
institutions	 involved	 in	 ethnobotanical	 studies	 and	 the	 recent	 formal	 inclusion	 of	
ethnobotany	 in	 undergraduate	 and	 graduate	 courses	 in	 Brazil	 (Fonseca-Kruel	 et	 al.	
2005).	 Outside	 of	 Brazil,	 we	 might	 also	 expect	 different	 herbaria,	 emphasizing	
specimens	 from	 different	 geographical	 regions,	 to	 include	 different	 proportions	 of	
specimens	with	 label	data	 reporting	medicinal	use.	 This	might	be	because	 the	 label-
making	practices	of	 collectors	 lodging	 their	 specimens	 in	different	herbaria	differ,	or	
because	 documentation	 of	 ethnobotanical	 uses	 is	 more	 incomplete	 in	 some	 areas	
(Cámara-Leret	et	al.	2014).		
There	are	caveats	about	the	quality	of	medicinal	plant	use	data	from	herbarium	
specimens.	Unlike	 publications,	which	 report	 how	 the	data	were	 collected	 and	 from	
whom,	the	herbarium	labels	are	silent	about	how	the	information	was	gathered.	There	
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are	no	data	about	the	ethnobotanical	indices,	such	as	informant	consensus,	recording	
the	 relative	 importance	 of	 the	 plants	 used	 or	 the	 distribution	 of	 knowledge	 in	 a	
community	 (Andrade-Cetto	 and	 Heinrich,	 2011).	 It	 is	 even	 possible	 that	 the	
information	about	plant	use	is	drawn	from	someone	from	outside	of	the	community,	
such	 as	 a	 field	 assistant.	 Nevertheless,	 our	 tests	 to	 determine	 whether	 the	 overall	
content	of	herbarium	 labels	 shows	that	statistically	 the	same	plant	parts	are	used	 in	
the	 same	ways	 for	 the	 same	 therapeutic	 applications,	whether	data	 is	 sourced	 from	
herbarium	or	published	sources.	Specifically,	the	rank	order	of	genera	used,	plant	parts	
used	 and	modes	 of	 application	 are	 not	 significantly	 different	 between	 sources.	 This	
statistical	significance	of	the	ranks	of	parts,	modes	and	applications	might	hide	more	
subtle	 differences	between	 the	ways	 in	which	 ethnobotanists	 and	 general	 collectors	
report	 plant	 use.	 For	 example,	 the	 use	 of	 teas	 (extracts	 infused	 by	 pouring	 boiling	
water	over	them)	is	more	commonly	reported	for	the	herbarium	data	than	in	literature	
reports,	where	decoctions	(extracts	concentrated	by	boiling)	are	more	important.	This	
might	 reflect	 a	 failure	 of	 more	 general	 collectors	 to	 distinguish	 between	 teas	 and	
decoctions.	Similarly,	the	use	of	leaves	may	be	under-reported	in	the	herbarium	labels,	
since	 leaves	could	be	considered	the	“default”	plant	part,	whereas	 in	ethnobotanical	
literature	 that	 reports	 the	 plant	 parts	 used,	 use	 of	 leaves	would	 be	 expected	 to	 be	
reported.	 Similar	 data	 content	 between	 publications	 and	 literature	 could	 be	 due	 to	
double-recording,	 if	 the	 authors	 of	 the	 publications	 have	 deposited	 specimens	
describing	the	uses	they	also	document	in	their	paper.	We,	as	far	as	possible,	rule	out	
this	 explanation	 for	 shared	 patterns	 by	 showing	 that	 the	 collectors	 names	 on	 the	
specimens	were	 the	 same	as	 the	author	names	of	 the	publications	only	3.6%	of	 the	
time.		
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Whereas	 the	 genera	 recorded,	 and	 the	 way	 plants	 in	 general	 are	 used,	 are	
comparable	between	herbaria	and	literature,	the	geographical	distribution	of	data	are	
less	similar.	Ritter	et	al.	(2015)	reported	in	their	survey	of	ethnobotanical	research	in	
Brazil,	 that	 the	 Atlantic	 Forest	 and	 Caatinga	 biomes	 are	most	 studied,	 and	 that	 the	
Amazon,	 Pampa	 and	 Pantanal	 less	 frequently	 so.	 Our	 data	 from	 literature	 are	 not	
directly	comparable,	since	we	record	numbers	of	reports,	not	articles,	and	the	details	
of	 our	 research	 strategies	 differ.	 Nevertheless,	we	 also	 find	 fewer	 literature	 reports	
from	 the	 Amazon,	 Pampa	 and	 Pantanal.	 Considering	 data	 from	 the	 herbarium,	 the	
same	 three	 biomes,	 Caatinga,	 Cerrado	 and	 Atlantic	 Forest,	 are	 also	 best	 known.	
However,	 the	 proportions	 of	 data	 from	 each	 source	 differ.	 For	 the	 less	 studied	
Pantanal,	58%	of	reports	and	62%	of	the	species	known	are	known	from	the	herbarium.	
Thus	the	herbarium	goes	some	way	towards	meeting	the	deficit	of	 information	from	
this	biome.	This	 is	not	 so	 for	 the	Pampas,	which	 lacks	herbarium	reports	even	more	
than	literature	reports	(just	16%	of	reports	and	18%	of	species	from	herbaria),	nor	for	
the	Amazon	biome	(39%	of	reports	and	39%	of	species	from	herbaria).	For	the	Amazon,	
this	might	be	because	as	Ritter	et	al.	(2015)	note,	most	Amazonian	studies	have	been	
carried	 out	 by	workers	 from	outside	 of	 Brazil,	 and	 possibly	 related	 to	 governmental	
constraints	 on	 issuing	 permits	 for	 data	 collection.	 If	 these	 collections	 were	 made	
before	 a	 precedent	 for	 depositing	 Brazilian	 vouchers	 in	 Brazilian	 herbaria	 was	
established,	the	paucity	of	Brazilian	specimens	in	our	study	with	data	could	be	because	
general	 collectors	 recording	 ethnobotany	 of	 the	 Amazon	 have	 not	 deposited	 their	
specimens	in	the	herbaria	we	have	surveyed.	In	general,	these	herbaria	include	fewer	
recent	specimens	from	the	Amazon,	because	of	the	logistical	challenges	of	conducting	
fieldwork	 in	 remote	 areas	 and	 under	 challenging	 conditions,	 including	 amongst	
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communities	less	likely	to	speak	Portuguese.	Although	the	herbarium	data	are	also	few	
in	 areas	 with	 few	 literature	 reports,	 Figure	 2-1	 shows	 that	 data	 from	 otherwise	
unstudied	sites	are	incorporated	by	including	herbarium	specimens	in	any	study.		
Beyond	filling	spatial	gaps	in	our	knowledge,	herbarium	data	might	validate	and	
augment	literature	reports.	We	considered	there	was	a	need	for	validation	of	species	
with	single	reports.	There	are	“legitimate”	reasons	a	species	might	be	cited	only	once;	
it	 might	 be	 genuinely	 rarely	 used,	 secret	 or	 specialist	 traditional	 knowledge	 or	
unshared	 uses	 (see	 Cámara-Leret	 et	 al.	 2014).	 Alternatively,	 a	 single	 citation	 might	
result	 from	 misidentification.	 A	 second	 citation	 validates	 these	 reports.	
Misidentification	 is	 reported	 to	be	widespread	 in	 herbaria;	 it	 is	 estimated	 that	more	
than	50%	of	tropical	specimens	are	incorrectly	named	(Goodwin	et	al.	2015),	although	
Goodwin	et	al.’s		study	was	based	on	a	taxonomic	group	known	for	having	species	hard	
to	identify.	In	Brazil,	continuous	research	effort	in	taxonomy,	with	updated	species	lists	
and	 floras	 being	 made	 (Flora	 do	 Brasil,	 2020),	 can	 contribute	 to	 decreased	
misidentification.	However,	there	 is	no	reason	to	suppose	that	species	 identifications	
in	ethnobotanists’	studies	are	any	more	accurate;	many	identifications	in	the	literature	
might	be	wrong	since	many	ethnobotanists	are	not	taxonomists.	Herbarium	specimens	
might	 be	 correctly	 determined	 when	 examined	 by	 experts	 at	 a	 later	 date,	 for	 this	
reason	 we	 might	 expect	 them	 to	 be	 more	 accurate.	 However,	ethnobotanists	
frequently	 collect	 sterile	material,	whereas	botanists	almost	never	do,	making	 it	 less	
likely	 that	 correct	 identification	 would	 take	 place	 as	 part	 of	 curation	 of	 herbarium	
collections.	We	 found	medicinal	 use	 of	 21	 of	 the	 128	 species	 known	 from	only	 one	
report	 in	 the	 literature	were	 substantiated	 from	 independently	 collected	 herbarium	
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specimens.	Herbaria	 are	 shown	here	 to	 add	 information	 to	what	 is	 known	 from	 the	
literature.	 “Augmenting”	 literature	 reports	 in	 this	 way	 could	 therefore	 be	 another	
important	use	of	herbaria.	As	we	demonstrate	herbaria	can	add	significant	data	over	
what	is	known	in	the	literature	by	specifying	the	use	of	plants.			
	
Studies	 synthesizing	 regional	 or	 global	 plant	 use	 data	 may	 become	 more	
common	 as	 ethnobotanical	 research	 encompasses	 large-scale	 or	 meta-analysis	
(Albuquerque	 &	 de	 Medeiros	 2012).	 Recent	 studies	 using	 data	 sets	 compiled	 from	
literature	have	tested	whether	there	are	global	patterns	of	plant	use	between	distantly	
related	 peoples	 (Saslis-Lagoudakis	 et	 al.	 2012a),	 and	 determined	 the	 relative	
importance	of	different	drivers	of	plant	selection	at	national	 levels	 (de	 la	Torre	et	al.	
2012;	 de	Medeiros	 et	 al.	 2013;	 Saslis-Lagoudakis	 et	 al.	 2014).	 Ethnopharmacological	
reviews	also	depend	on	the	synthesis	of	data	describing	 the	therapeutic	applications	
and	 modes	 of	 use	 of	 a	 taxon	 before	 interpreting	 use	 in	 the	 light	 of	 chemistry	 and	
pharmacological	activity	(Fernandes	and	Banu	2012;	Seebaluck	et	al.	2015;	Wang	et	al.	
2013).	Reviews	can	highlight	knowledge	gaps	and	prioritize	communities	and	areas	for	
field	 research	 (Uprety	et	al.	2012);	nevertheless	 the	 scope	and	 reach	of	many	meta-
analyses	 in	 ethnobotany	 demand	 more	 data	 than	 can	 be	 delivered	 by	 directed	
fieldwork	programs.	The	availability	of	data	and	its	quality	poses	a	significant	barrier	to	
further	study	(de	Medeiros	et	al	2013).	This	deficit	of	information,	for	certain	types	of	
study,	might	be	overcome	by	using	herbaria.		
Herbaria	 are	 irreplaceable	 resources;	 the	 long-term	 capital	 investment	 in	
specimen	acquisition	and	curation	that	they	represent	is	increasingly	rewarded	across	
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many	fields	(Funk	2003).	Our	study,	by	explicitly	quantifying	ethnobotanical	data	from	
herbaria	and	literature,	demonstrates	that	herbaria	contain	valuable	information	that	
can	both	 supplement	 and	 complement	 literature	 reports.	Visits	 to	herbaria	 to	 check	
specimens	 for	 associated	 data	 would	 be	 extremely	 time	 consuming;	 our	 study	 was	
facilitated	by	fast,	easy	access	to	data	from	online	herbaria.	The	ease	in	which	data	are	
accessed	 is	 set	 to	 increase	 as	 digitization	 projects	 progress	 (Haston	 et	 al.	 2012),	
generating	more	 and	more	 accurate	 data.	 Ethnobotanical	 equivalents	 of	 the	Darwin	
Core	 Biodiversity	 Data	 Standards	 (Wieczorek	 et	 al.	 2012)	 might	 be	 envisaged,	 to	
maximize	 the	 value	 of	 digitisation	 efforts.	We	 anticipate	 a	wider	 role	 for	 herbarium	
data	in	the	future.		
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Chapter	3 Ewé:	 a	 web-based	 ethnobotanical	 database	 for	
storing	and	analysing	data	
	
3.1 Introduction	
	
The	 documentation	 of	 ethnobotanical	 information	 and	 associated	 knowledge	
(i.e.	 anthropology,	 botany,	 ecology,	 chemistry	 and	 pharmacology)	 is	 essential	 for	 a	
better	 understanding	 of	 the	 relations	 between	 humans	 and	 plants	 (Balick	 and	 Cox,	
1996;	Berlin,	1992),	and	to	progress	ethnobotanical	and	ethnopharmacological	studies	
(Stepp	 and	 Thomas,	 2010).	 The	 use	 of	 databases	 in	 ethnobotanical	 research	 can	
facilitate	 data	 management,	 analysis	 and	 also	 information	 sharing	 with	 other	
researchers	 (Ningthoujam	 et	 al.	 2012).	 Nevertheless,	 database	 sustainability	 and	
collaboration	can	be	challenging	(Ningthoujam	et	al.	2012).		Ethnobotanical	databases	
found	 today	 may	 have	 an	 international	 focus	 (e.g.	 NAPRALERT	 which	 has	 a	
pharmaceutical	 focus	 (Loub	 et	 al.	 1985))	 or	 a	 regional	 one	 (e.g.	 Prelude	 database,	
which	 is	 focused	 on	 African	 medicinal	 plant	 use	 (Noe,	 2012)).	 Others	 can	 have	 a	
different	scope,	such	as	the	Medicinal	Plant	Names	Services,	from	Kew	Royal	Botanical	
Gardens	 (available	 in	 http://mpns.kew.org/)	 that	 curates	 medicinal	 plants	 names,	
enabling	 correct	 identification	 of	medicinal	 species	 in	 order	 to	 assure	 safety	 of	 use.	
The	 documentation	 and	 exploration	 of	 traditional	 knowledge	 (TK)	 are	 important	
contributors	to	bioprospecting	(Helmstädter,	2017;	Shaw,	2017).	Documentation	of	TK	
can	 also	 contribute	 to	 the	 protection	 of	 intellectual	 property	 in	 the	 context	 of	
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bioprospecting	 (Downes,	 2000),	 where	 traditional	 knowledge	 is	 identified	 as	 the	
property	 	of	communities	that	should	be	the	recipients	of	benefit-sharing	(Alexander	
et	 al.	 2004),	 and	 to	 the	preservation	of	 traditional	 knowledge.	Knowledge	erosion	 is	
caused	 by	 cultural	 change,	 modernization,	 access	 to	 western	 medicine	 (Voeks	 and	
Leony,	2004),	and	a	lack	of	interest	amongst	young	people	in	learning	about	medicinal	
use	 of	 plants	 (Brouwer	 et	 al.	 2005;	 Phillips	 and	 Gentry,	 1993;	 Ugent,	 2000).	 Finally,	
databases	 could	 highlight	 traditionally	 used	 species	 and	 direct	 research	 that	 might	
contribute	 to	 safety	 assessments	 (Calixto,	 2000;	 Ekor,	 2014;	 Jordan	 et	 al.	 2010;	
Moreira	et	al.	2014).	Here	we	present	a	web-based	ethnobotanical	database	not	only	
serving	to	store	data,	but	also	with	tools	to	conduct	simple	analyses	and	visualise	data.	
	
Ethnobotany	 can	 be	 considered	 a	 recent	 discipline,	 being	 firstly	 defined	 and	
delimited	 in	 1896	with	 the	publication	 “The	purposes	of	 Ethnobotany”	 (Harshberger	
1896).	 Since	 then,	many	 studies	 concerning	documentation	of	 traditional	 knowledge	
have	 taken	 place.	 The	 increasing	 amount	 of	 data	 produced	 by	 such	 studies	 allows	
ethnobotanical	 research	 to	address	more	comprehensive	and	comparative	questions	
in	 order	 to	 better	 understand	 plant	 use	 and	 selection,	 yet	 data	 distribution	 and	
availability	are	barriers	to	this	(Thomas	et	al.	2001).	Despite	the	advances	made	so	far	
in	 ethnobotany,	 more	 collaborative	 ethnobotanical	 research	 could	 be	 achieved	 by	
bridging	the	gap	between	ethnobotanists	and	modern	bioinformatics	(Thomas	2003).	
The	development	of	ethnobotanical	databases	 can	bridge	 this	 gap	 in	different	ways.	
For	 example,	 the	 compilation	 of	 ethnobotanical	 data,	 quite	 often	 spread	 across	
different	 institutions	 or	 sources,	 such	 as	 publications,	 herbarium	 specimen	 labels	 or	
even	 unpublished	 theses	 and	 governmental	 reports	 that	 are	 of	 hard	 access,	 in	 a	
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database,	 can	 facilitate	 large-scale	analysis	by	decreasing	 the	 time	of	data	 collection	
(Schalk	and	Oosterbroek	1996,	Souza	and	Hawkins,	2017,	Thomas	2003).		
	
	 Until	 now,	 many	 different	 ethnobotanical	 databases	 have	 been	 developed,	
many	with	online	access.	Many	of	these	databases	were	developed	for	particular	user	
groups,	 academic	 or	 non-academic,	 and	 with	 different	 foci,	 geographic	 or	 cultural	
(Thomas,	 2003).	 Without	 a	 central	 authority,	 or	 guidelines	 for	 data	 collection	 and	
storage,	 challenges	 may	 arise.	 Firstly,	 although	 the	 existence	 of	 such	 databases	
contributes	 towards	 data	 availability,	 data	 is	 not	 always	 comparable,	 and	 this	 is	 a	
barrier	 for	 collaborative	 and	 large-scale	 research	 (Thomas	 2003).	 Secondly,	 the	
sustainability	of	such	databases	is	associated	with	the	continuity	of	a	research	group	or	
project,	 long-term	data	availability	 is	not	ensured.	These	challenges	can	be	added	to	
others,	such	as	data	accuracy	and	intellectual	property	rights	(Ningthoujam	et	al.	2012;	
Heinrich	2009).	
	
Ethnobotanical	databases	can	be	 important	 tools	 to	both	preserve	 traditional	
knowledge	and	advance	 in	ethnobotanical	 research	 (Moerman,	2013,	Heinrich	et	al.,	
2009).	It	has	been	reported	that	traditional	knowledge,	available	publicly	in	databases	
can	protect	against	biopiracy	or	misappropriation	(Gupta	2004).	Traditional	knowledge	
holders	 can	 also	 benefit	 from	 ethnobotanical	 databases,	 when	 analysis	 and	 data	
generated	and	interpreted	by	the	scientific	community	is	returned	to	local	populations	
so	that	it	can	both	preserve	their	knowledge	and	also	add	new	information	or	value	to	
it.	Examples	of	 this	can	be	seen	when	 indigenous	populations	knowledge	of	 foraging	
and	phytomedicines	are	enhanced	by	scientific	corroboration	(Edwards	and	Heinrich,	
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2006).,	 Ethnopharmacological	 research	 can	 also	 add	 value,	 benefiting	 knowledge	
holders	in	the	form	of	benefit-sharing	as	defined	by	the	CBD.	The	“Access	and	Benefit	
Sharing”	(ABS)	mechanism	was	proposed	in	1992	in	the	CBD	and	implemented	in	the	
Nagoya	protocol	since	then	(United	Nations	2010).	Although	there	is	a	deficit	in	studies	
to	track	the	effectiveness	of	ABS,	a	few	case-studies	are	currently	available,	including	
one	 in	 Brazil	 that	 shows	 a	 positive	 relationship	 between	 industry	 and	 traditional	
knowledge	holders	in	supplying	raw	material	(Laird	and	Wynberg	2008).	On	the	other	
hand,	 it	 is	 argued	 that	 databases	 of	 traditional	 knowledge	 can,	 when	 knowledge	 is	
compiled	 as	 data	 or	 information,	 create	 barriers	 to	 the	 recognition	 of	 a	 proper	
heritage,	 particularly	 in	 the	 case	 of	 large	 well	 estabilished	 systems	 of	 Traditional	
Knowledge,	such	as	Ayurveda,	increasing	claims	of	ownership	(Reddy,	2006).		
		
	
Ethnobotany	 and	 ethnopharmacology	 are	 both	 interdisciplinary	 subjects,	 and	
standardizing	data	from	different	studies	is	difficult	when	research	questions	can	have	
different	 emphasis	 (Stepp	 and	 Thomas,	 2010).	 Nevertheless,	 ethnobotanical	 studies	
have	 attempted	 to	 address	 broad	 questions	 using	 published	 data,	 an	 approach	
sometimes	 termed	meta-analysis	 (de	 la	 Torre	 et	 al.	 2012;	 de	Medeiros	 et	 al.	 2013).	
Meta-analyses	will	benefit	from	tools	to	summarize	database	entries,	for	example	the	
diversity	of	species	used	for	a	certain	therapeutic	application,	or	a	map	of	showing	the	
geographical	distribution	of	a	species’	use	can	be	generated.		
	
Over	 the	 last	 30	 years	 the	 number	 of	 publications	 describing	 ethnobotanical	
studies	 in	 Brazil	 has	 increased	 (Ritter	 et	 al.	 2015).	 The	 amount	 of	 information	
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generated	and	 recorded	 in	peer-reviewed	 scientific	 publications	has	 the	potential	 to	
inform	meta-analyses,	but	the	information	should	be	made	available	in	a	useful	format.	
In	Brazil,	Plant-Database	(Manhã	et	al.	2008)	provides	an	extensive	bibliographical	data	
compilation	with	more	than	2000	papers,	many	focused	on	pharmacological	and	drug	
discovery	data.	There	is	a	need	in	Brazil	for	a	database	that	provides	easy	access	and	
visualization	 of	 species	 information.	 Open-source	 tools	 have	 been	 used	 to	 build	 the	
database,	 recognising	 that	 whilst	 funding	 for	 maintenance	 and	 development	 of	
databases	 is	 difficult	 to	 secure	 (Reiser	 et	 al.	 2016),	 a	 community	 of	 users	 may	
contribute	 if	 the	 database	 can	 be	 modified	 to	 respond	 to	 their	 changing	 research	
needs.	 	
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3.2 Methods	
3.2.1 Database	development	
	
	 A	 web-based	 app	 was	 developed	 using	 MEAN	 (MongoDB,	 ExpressJS,	
NodeJS	and	AngularJS,	available	at	http://meanjs.org/).	Information	on	the	species	was	
organized	in	a	spreadsheet	with	the	fields:	family,	genus,	species,	authority,	synonym,	
common	name,	use	category	(according	to	WHO-ICD	10)	use	category	(traditional,	as	
recorded	 in	 the	 field),	 plant	 part	 used,	 mode	 of	 application,	 country,	 city,	 biome,	
latitude,	 longitude,	reference	(paper	author	or	herbarium	name),	collector	and	origin	
(literature	 or	 herbarium).	 Subsequently	 it	was	 exported	 in	 format	 JSON	 for	 indexing	
and	searching.	The	database	homepage	is	shown	on	Figure	3-1.		
3.2.2 Data	collection	
	
	 Published	 medicinal	 use	 data,	 and	 data	 from	 Brazilian	 herbarium	 specimens	
were	 compiled	 for	 the	 Leguminosae	 of	 Brazil.	 Where	 necessary,	 geographical	
coordinates	 were	 assigned	 using	 Google	 maps	 and	 the	 Brazilian	 Geographic	 and	
Statistical	Institute	online	data	(IBGE).	Generic	and	species	names	followed	THE	PLANT	
LIST	 (The	 Plant	 List,	 2013)	 and	 Missouri	 Botanical	 Garden's	 Tropicos	 database	
(Tropicos.org,	2016),	and	were	corrected	using	the	Plantminer	R	script	(Carvalho	et	al.	
2010)	
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Figure	3-1	Homepage	of	Ewé	(top)	and	side	menu	with	search	and	visualization	options	
(bottom).	
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Publications	 citing	 medicinal	 uses	 of	 Leguminosae	 species	 in	 Brazil	 were	
identified	 using	 Google	 Scholar	 and	 searches	 of	 following	 journals:	 Acta	 Botanica	
Brasilica,	 Economic	 Botany,	 Fitoterapia,	 Flovet,	 Journal	 of	 Ethnobiology,	 Journal	 of	
Ethnobiology	and	Ethnomedicine,	Journal	of	Ethnopharmacology,	Journal	of	Medicinal	
Plants	Research,	Revista	Brasileira	de	Biociencias,	Revista	Brasileira	de	Farmacognosia,	
Revista	 Brasileira	 de	 Plantas	 Medicinais	 and	 Rodriguesia.	 Herbarium	 data	 were	
extracted	 from	 the	 online	 list	 of	 herbarium	 and	 biological	 collections	 from	 Brazil,	
Species	 Link	 (http://splink.cria.org.br/).	 The	 file	was	 exported	 to	 Excel	 format	 and	 a	
search	using	 the	keywords	 “medicinal”	and	“uses”	 (in	Portuguese)	was	 conducted	 in	
order	to	filter	only	the	specimens	with	medicinal	 information.	The	list	of	publications	
and	herbaria	sourced	here	are	in	Appendix	3	
.	
3.2.3 Data	organization	
Published	 medicinal	 use	 data,	 and	 data	 from	 Brazilian	 herbarium	 specimens	
were	compiled	for	the	Leguminosae	of	Brazil.	Using	the	1400	use	reports	from	Chapter	
2,	and	additional	collected	data,	we	generated	2	078	reports	for	databasing.	When	a	
species	 was	 reported	 in	 one	 publication	 to	 be	 used	 to	 treat	 for	 influenza	 and	
headaches,	the	two	therapeutic	applications	generated	two	different	reports,	though	
the	species	is	the	same.	
	 In	 order	 to	 standardize	 the	 traditional	 uses	 we	 adopted	 the	 World	 Health	
Organization	 international	 classification	of	diseases	10	 (WHO	 ICD-10)	as	described	 in	
table	3-1,	although	there	are	deficiencies	associated	with	standardisation	(Staub	et	al.	
2015).	 Biomes	 were	 assigned	 according	 to	 the	 geographical	 coordinates	 from	 each	
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record,	plotted	on	a	map	and	intersected	with	the	Brazilian	Biomes	shapefile	in	QGIS	
2.2.0.	Mode	of	application	data	were	classified	according	to	Table	3-2.	
	
Table	3-1.	Codes	for	WHO-ICD	10	used	to	classify	traditional	information.	
World	Health	Organization	international	classification	of	diseases	10	 CODE	
Certain	conditions	originating	in	the	perinatal	period	 CCP	
Congenital	 malformations,	 deformations	 and	 chromosomal	
abnormalities	 CMC	
Diseases	 of	 the	 blood	 and	 blood-forming	 organs	 and	 certain	 disorders	
involving	the	immune	mechanism	 DBI	
Diseases	of	the	circulatory	system	 DCS	
Diseases	of	the	digestive	system	 DDS	
Diseases	of	the	eye	and	adnexa	 DEA	
Diseases	of	the	ear	and	mastoid	process	 DEM	
Diseases	of	the	femalegenito	system	 DFS	
Diseases	of	the	genitourinary	system	 DGS	
Diseases	of	the	musculoskeletal	system	and	connective	tissue	 DMC	
Diseases	of	the	nervous	system	 DNS	
Diseases	of	the	respiratory	system	 DRS	
Diseases	of	the	skin	and	subcutaneous	tissue	 DSS	
Endocrine,	nutritional	and	metabolic	diseases	 ENM	
Certain	infectious	and	parasitic	diseases	 IPD	
Mental	and	behavioral	disorders	 MBD	
Neoplasms	 NEO	
Symptoms,	 signs	 and	 abnormal	 clinical	 and	 laboratory	 findings,	 not	
elsewhere	classified	
O THER S	Injury,	poisoning	and	certain	other	consequences	of	external	causes	External	causes	of	morbidity	and	mortality	
Factors	influencing	health	status	and	contact	with	health	services	
Codes	for	special	purposes	
Pregnancy,	childbirth	and	the	puerperium	 PCP	
	
Table	3-2.	Classification	of	different	medicinal	preparations	into	specific	modes	of	
application	categories.	
Terms	used	in	database	 Terms	used	in	publications	or	specimens	notes	
Decoction	 Decoction	
Infusion	 Tea,	infusion,	with	water,	with	milk	
Tincture	 Wine,	alcoholic	infusion,	alcoholic	extraction	
Maceration	 Maceration	
Paste	 Topic	use,	plaster	
Juice	 Drink,	juice	
Wash	 Bath,	soap,	gargle,	mouthwash	
Food	 Edible,	raw,	in	natura	
Oil	 Oil	
Syrup	 Syrup,	with	honey	
Powder	 Powder/	inhale	
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3.3 Results	
3.3.1 Database	content	
	
	 Two	 thousand	and	 seventy-eight	 records	were	 compiled	 to	date.	 These	were	
sourced	from	108	publications	(1331	records)	and	54	herbaria	(747	records).	Until	now,	
EWÉ	is	focused	on	the	Leguminosae	from	Brazil,	with	322	species	 in	117	genera	with	
medicinal	 uses.	 For	 all	 the	 databased	 records,	 1165	 (56%)	 indicate	 therapeutic	
applications	(traditional/WHO	uses),	948	(45%)	indicate	plant	parts	used	and	790	(38%)	
indicate	the	modes	of	application	(appendix	4).	All	6	Brazilian	biomes	are	indicated	in	
our	records,	with	Caatinga	and	the	Cerrado	the	best	represented.		
Literature	and	herbaria	differ	 in	 information	content.	Literature	provided	87%	
of	 therapeutic	 applications,	 95%	of	modes	of	 application	and	95%	of	parts	used.	On	
the	other	hand,	herbaria	contributed	to	86%	of	cited	geographical	localities.		
	 Senna	and	Bauhinia	were	the	most	cited	genera,	with	medicinal	use	reported	in	
all	 6	biomes.	 For	 therapeutic	applications,	Diseases	of	 the	Respiratory	System	 (DRS),	
Diseases	of	the	Digestive	System	(DDS),	Endocrine	Nutritional	and	Metabolic	Diseases	
(ENM),	were	the	categories	with	most	citations,	bark	and	 leaves	the	most	commonly	
used	plant	parts,	and	infusion	and	decoction	the	most	common	modes	of	application	
(Figure	3-2).		
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Figure	3-2.	Number	of	use	reports	for	each	category	in	Therapeutic	Applications,	Plant	
Parts	Used	and	Modes	of	Application.	
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Database	search	tools	
When	 visualized	 in	 the	 search	 tool,	 records	 are	 shown	 as	 a	 list	 that	 can	 be	
organized	according	to	any	of	the	categories	(Figure	3-3).	A	search	field	also	allows	the	
user	to	filter	the	search	by	any	term	shown	in	the	list	(Figure	3-4).		
	
Figure	3-3.	Search	tool	of	Ewé,	showing	the	number	of	records	and	data	contents	of	
each	field	of	a	chosen	sample.	
	
	
Figure	3-4.	Detail	of	the	filter	tool	from	the	search	area.		
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Clicking	on	a	 record,	 opens	 the	 full	 record,	 including	 a	map	 if	 the	 record	has	
coordinates,	below	the	records	list	(Figure	3-5).	
	
	
Figure	3-5.	Screen-shot	of	a	full	record	(Caesalpinia	echinata	Lam.)	illustrating	its	described	
uses,	the	part	used,	traditional	use,	forms	of	use	(modes	of	application)	and	the	paper	
reference	from	where	it	came.		
		
3.3.2 Database	visualization	
	 	
	 Data	 are	 visualised	 as	 a	 tree	map	with	 three	 interactive	 levels,	 family,	 genus	
and	species	(Figure	3-6	top).	For	all	levels	the	size	of	the	square	is	proportional	to	the	
number	of	records	(Figure	3-6	middle).		
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Figure	3-6.	Detail	of	the	visualization	tool	from	EWÉ	showing	the	tree	map.		
	
	 Below	the	tree	map	there	are	 four	graphs:	 therapeutic	applications	 (top	 left),	
biomes	distribution	(top	right),	plant	parts	used	(bottom	left)	and	modes	of	application	
(bottom	right).	These	four	graphs	change	according	to	the	taxonomic	scale	of	the	tree	
map.	Also	user	selection	of	one	bar	in	each	histogram	is	possible	(Figure	3-7).	
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Figure	3-7.	Detail	of	the	visualization	tool	from	EWÉ	showing	graphs	with	therapeutic	
applications,	biomes,	plant	parts	used	and	modes	of	applications.		
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3.4 Discussion	
	 	
The	internet	has	contributed	to	an	explosion	of	data	sharing	amongst	scientists,	
including	 ethnobotanists,	 thus	 contributing	 towards	 a	 better	 understanding	 of	 the	
relation	of	humans	and	plant	use	(Gaikwad	et	al.	2011;	Albuquerque	&	Medeiros	2012).	
Nevertheless,	much	ethnobotanical	data	is	still	difficult	to	access,	sometimes	the	result	
of	 inadequate	 data	 management	 (Gaikwad	 et	 al.	 2011).	 Aside	 from	 storing	 a	 large	
dataset,	 we	 presented	 a	 database	 capable	 of	 data	 visualization	 permitting	 data	
exploration.	To	the	best	of	our	knowledge,	Ewé	is	the	first	medicinal	plants	database	
to	provide	tools	for	data	storage	and	visualization	for	Brazilian	plants.	Research	can	be	
facilitated	 using	 visualization	 tools,	 since	 hypothesis	 generation	 is	 supported	 by	
examining	patterns	and	gaining	insight	into	the	data	(Keim,	2001).	Geographical	areas	
poor	 in	data	can	be	identified,	so	future	studies	can	be	directed	to	areas	of	deficient	
knowledge.		
	
Challenges	 in	 integrating	data	from	different	sources	 into	a	database,	or	even	
from	different	regional	databases	into	a	more	comprehensive	one	are	related	to	data	
standardisation	and	data	management	(Ningthoujam	et	al.	2012).	Efforts	to	provide	a	
common	 standard	 for	 ethnobotanical	 data	were	made	 by	 the	 International	Working	
Group	 on	 Taxonomic	 Databases	 for	 Plant	 Sciences	 (TDWG),	 who	 presented	 the	
Economic	 Botany	 Data	 Collection	 Standard	 (EBDCS)	 (Cook,	 1995).	 Although	 not	 all	
fields	proposed	by	EBDCS	are	present	in	Ewé,	many	such	as	source	of	information	on	
use,	 use,	 plant	 part	 used,	 organism,	 vernacular	 names,	 modes	 of	 application,	 are	
present	 here.	 Fields	 such	 as	 season	 of	 use,	 conservation	 data,	 ratings	 or	 popularity,	
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problems	 and	 potential,	 though	 important,	 can	 be	 hard	 to	 source	 from	 available	
material.	 In	 the	 future,	 Ewé	 can	 expand	 to	 include	 primary	 data,	 and	 information	
related	to	season	of	use	and	popularity	can	be	included.		
	
EBCDS	 also	 proposes	 categories	 of	 therapeutic	 applications	 and	 has	 been	
successfully	 applied	 by	 ethnobotanists	 when	 compiling	 traditional	 knowledge	 data,	
although	 it	has	also	been	argued	that	not	all	plants	and	therapeutic	applications	can	
follow	this	 standard	 (Gruca	et	al.	2014).	Categories	used	here	were	according	 to	 the	
WHO-ICD	10,	many	of	them	are	very	similar	with	the	ones	proposed	by	the	EBDCS.	The	
WHO-ICD	10	categories	were	used	to	facilitate	data	classification,	so	users	can	consult	
the	WHO	website	and	search	for	the	appropriate	term.	This	classification	also	allows	
information	 from	Ewé	to	be	compared	with	other	studies	 that	used,	at	 least	 in	part,	
the	 same	 classification	 (Baptista	 et	 al.	 2013;	 Ernst	 et	 al.	 2016;	 Leonti,	 2011;	 Saslis-
Lagoudakis	et	al.	2012a).	Nevertheless,	traditional	medicinal	use	that	were	commonly	
cited	such	as	pain,	 fever	and	 inflammation	could	not	be	associated	with	any	specific	
medical	 condition	 on	 the	 WHO	 ICD-10	 standard,	 and	 therefore	 were	 assigned	 to	
“others”.	On	the	other	hand,	the	original	terms	or	classifications	of	therapeutic	use	are	
still	provided,	in	order	to	contribute	to	the	conservation	of	traditional	knowledge.	
	
Herbarium	 vouchers	 are	 potential	 sources	 of	 ethnobotanical	 information	 to	
populate	 databases.	 As	 efforts	 in	 digitisation	 for	 herbarium	 specimens	 increase	
(Beaman	and	Cellinese,	2012;	Hill	et	al.	2012;	Tegelberg	et	al.	2014;	Thiers	et	al.	2016;	
van	Oever	and	Gofferjé,	2012),	again	standardisation	 is	needed	and	the	Darwin	Core	
standard	is	used	to	achieve	this	(Wieczorek	et	al.	2012).	However,	core	descriptors	do	
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not	include	any	ethnobotanical	fields,	so	data	describing	traditional	knowledge	present	
in	herbarium	vouchers	 is	 not	 captured.	Herbarium	vouchers	have	been	described	as	
important	 sources	 of	 ethnobotanical	 data	 (Eisenman	 et	 al.	 2012;	 Nesbitt,	 2014;	
Senchina,	 2006;	 Souza	 and	 Hawkins,	 2017).	 The	 inclusion	 of	 ethnobotanical	
information	in	the	core	descriptors	for	digitisation	could	be	beneficial.	
	
Database	sustainability	is	recognised	as	a	significant	problem	for	the	biological	
sciences	 (Attwood	 et	 al.	 2015;	 Bastow	 and	 Leonelli,	 2010;	 Merali	 and	 Giles,	 2005;	
Ningthoujam	et	al.	2012).	Being	an	open-source	scheme,	Ewé	can	be	used	on	a	private	
server	 as	 a	 research	 tool,	 and	 users	 can	 modify	 the	 code	 for	 their	 own	 needs.	
Furthermore,	 as	 an	open-source	 scheme,	 the	database	 can	evolve	 to	meet	 changing	
requirements.	Also,	Ewé	could	function	as	a	collaborative	database,	where	researchers	
can	include	their	own	data	for	private	use	but	would	be	encouraged	to	contribute	to	
the	publically	available	data.	Moreover,	when	Ewé	is	established	in	Brazil,	projects	to	
populate	 the	database	with	 information	directly	 from	the	holders	of	TK,	as	a	way	 to	
preserve	 their	 knowledge	 and	 assure	 rights	 to	 intellectual	 property,	 could	 be	
implemented.		
		
As	 an	 online	 database,	 we	 expect	 Ewé	 to	 be	 a	 source	 of	 information	 and	
knowledge	sharing	between	ethnobotanists	in	Brazil.	Although	at	the	present	moment	
Ewé	is	focused	on	the	medicinal	use	of	the	Leguminosae,	more	taxa	could	be	included,	
perhaps	 the	 entire	 medicinal	 flora	 of	 Brazil.	 Nevertheless,	 data	 quality	 should	 be	
emphasized	in	order	to	increase	the	quality	of	the	database.	
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Chapter	4 Phylogenetic	 exploration	 of	 plants	 used	 in	
ethnomedicine	 reveals	 significantly-used	 lineages	 are	 better	
characterized		
	
4.1 Introduction	
	
	The	search	for	patterns	in	plant	use	is	the	focus	of	extensive	investigation	in	the	
fields	of	ethnobotany	and	ethnopharmacology	(Albuquerque	et	al.	2007;	Bennett	and	
Husby,	2008;	de	la	Torre	et	al.	2012;	de	Medeiros	et	al.	2013;	Ladio	and	Lozada,	2004;	
Monteiro	et	al.	2006;	Saslis-Lagoudakis	et	al.	2011a;	Wayland	and	Walker,	2014;	Zhu	et	
al.	2011).	At	the	present	time,	phylogenetic	methods	are	emerging	as	powerful	tools	
to	 investigate	such	patterns	 (Cámara-Leret	et	al.	2017;	Ernst	et	al.	2016;	Grace	et	al.	
2015;	Saslis-Lagoudakis	et	al.	2015;	Saslis-Lagoudakis	et	al.	2012a;	Saslis-Lagoudakis	et	
al.	2011a;	Zhu	et	al.	2011).	It	has	long	been	known	that	plants	with	medicinal	use	are	
not	 distributed	 randomly	 in	 a	 flora,	 but	 are	 usually	 found	more	 frequently	 in	 some	
groups	 than	 in	 others	 (Bennett	 and	 Husby,	 2008;	 Moerman,	 1991;	 Moerman	 et	 al.	
1999;	Saslis-Lagoudakis	et	al.	2011a;	Weckerle	et	al.	2011).	By	identifying	lineages	rich	
in	 species	with	ethnomedicinal	use	or	metabolites	of	 interest,	phylogenetic	methods	
are	currently	being	evaluated	for	their	potential	for	predictive	bioprospecting	(Ernst	et	
al.	 2016;	 Grace	 et	 al.	 2015;	 Rønsted	 et	 al.	 2008;	 Saslis-Lagoudakis	 et	 al.	 2012a;	
Yessoufou	et	al.	2015).		
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The	 use	 of	 phylogenetic	 methods	 to	 investigate	 phylogenetic	 structure	 of	
ethnomedicinal	plants	overcomes	the	need	for	taxonomic	ranks	 (see	Moerman	et	al.	
1999,	 Bennett	 and	 Husby	 2008,	 Weckerle	 et	 al.	 2011),	 by	 measuring	 relatedness	
directly	 from	a	 phylogeny	 (Saslis-Lagoudakis	 et	 al.	 2015).	Different	 tests	 are	 used	 to	
measure	the	relatedness	of	ethnomedicinal	species,	with	the	most	common	being	the	
mean	 phylogenetic	 distance	 (MPD),	mean	 nearest	 taxon	 distance	 (MNTD)	 and	 their	
related	 indices,	 net	 related	 index	 (NRI)	 and	 nearest	 taxon	 index	 (NTI)	 described	 by	
Webb	 et	 al.	 (2008).	 Besides	 the	 identification	 of	 phylogenetic	 structure,	 it	 is	 also	
possible	 to	 identify	 lineages	 in	 the	 phylogeny	 that	 are	 contributing	 to	 the	 structure.	
These	lineages	are	called	hot	nodes	(Saslis-Lagoudakis	et	al.	2012a),	and	are	the	nodes	
in	a	phylogeny	whose	descendent	species	include	significantly	more	medicinal	species	
than	other	nodes.		
	
Closely-related	 species	 share	 similar	 secondary	 metabolites	 that	 could	 be	 of	
interest	 (Wink,	 2003)	 and	 phylogenetic	 structure	 in	 the	 distribution	 of	 secondary	
metabolites	 has	 been	 well	 documented	 for	 the	 Leguminosae	 (Wink,	 2013).	 The	
phylogenetic	 signal	 in	 phytochemistry	 has	 stimulated	 the	 development	 of	 new	
bioprospecting	 strategies	 (Halse-Gramkow	 et	 al.	 2016;	 Rønsted	 et	 al.	 2008).	 Despite	
the	 low	 number	 of	 species	 with	 ethnomedicinal	 use	 to	 have	 been	 investigated	
pharmacologically	 (Fabricant	and	Farnsworth	2001),	plant	material	has	been	of	great	
importance	 in	 bioprospecting,	 where	 ethnomedicinal	 use	 has	 guided	 investigation	
(Gurib-Fakim,	 2006).	 In	 terms	of	 phylogeny,	 describing	 lineages	with	 congruent	 uses	
across	 different	 communities	 (Saslis-Lagoudakis	 et	 al.	 2012a),	 thus	 highlighting	 such	
taxa,	 or	 identifying	 lineages	 with	 a	 strong	 phylogenetic	 signal	 in	 therapeutic	
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applications	or	properties	of	interest	(Ernst	et	al.	2016),	phylogenetic	methods	can	be	
used	to	identify	priority	taxa	for	pharmacological	study.	
	
	 The	Leguminosae	(legumes)	is	the	third	largest	plant	family	(Lewis	et	al.	2005).	
With	many	documented	uses,	the	family	is	over-utilized	for	medicine	in	some	regions	
(Korea	 and	 Ecuador)	 but	 under-utilized	 in	 others	 (North	 America)	 (Moerman	 et	 al.	
1999).		In	Brazil,	the	family	comprises	c.	2,800	species	in	more	than	200	genera	(Flora	
of	 Brazil	 2020	 in	 construction).	 The	 species	 diversity,	 widespread	 distribution	 and	
many	 reported	 uses	 (Souza	 and	 Hawkins,	 2017)	 and	 the	 availability	 of	 phylogenetic	
information	(LPWG	et	al.	2013),	combined	with	recognized	pharmacological	potential	
have	prompted	us	to	select	the	family	as	a	case	study.	Drugs	such	as	Danthron	(used	as	
a	 laxative,	derived	 from	Cassia	 sp.;	Maridass	and	De	Britto	2008)	and	Monocrotaline	
(an	 anti-tumor	 agent	 derived	 from	 Crotolaria	 sessiliflora;	 Wink,	 2013)	 are	 drugs	
derived	 from	 species	distributed	 in	Brazil	 and	used	globally.	 Two	 further	 species	 are	
found	 in	 the	 official	 Farmacopeia	 Brasileira,	 Senna	 auriculata	 and	 Stryphnodendron	
coriaceum	(Anvisa,	2010).	
	
	 Fabricant	 and	 Farnsworth's	 study	 of	 2001,	 showing	 more	 than	 90%	 of	
ethnomedicinal	 plant	 species	 are	 pharmacologically	 unscreened,	 is	 still	 frequently	
cited	to	indicate	our	poor	knowledge	of	the	properties	of	plants	used	in	ethnomedicine.	
The	first	objective	of	this	study	is	to	provide	a	contemporary	estimate,	at	least	for	one	
plant	group	in	one	area.	The	description	of	the	phylogenetic	diversity	of	medicinal	uses	
of	 the	Leguminosae	 in	Brazil	enables	 identification	of	 lineages	rich	 in	ethnomedicinal	
species.	 Whether	 “hot	 node”	 lineages	 have	 been	 the	 focus	 of	 screening	 efforts	 is	
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investigated	 in	 order	 to	 identify	 and	 explain	 patterns	 in	 ethnopharmacological	
research.	 Until	 now,	 phylogenetic	 investigations	 of	 ethnomedicinal	 plants	 have	
considered	 global	 floras	 (Halse-Gramkow	 et	 al.	 2016),	 whole	 floras	 (e.g.	 Saslis-
Lagoudakis	et	al.	2012a)	or	genera	throughout	their	range	(e.g.	Saslis-Lagoudakis	et	al.	
2011a,	Ernst	et	al.	2016),	and	have	used	data	based	on	presence/absence	of	use.	As	
well	as	being	the	first	study	focused	a	family	 level,	 this	study	also	takes	 into	account	
the	frequency	of	reported	use	per	species,	in	order	to	shed	more	light	on	patterns	of	
ethnomedicinal	plants.		 	
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4.2 Materials	and	Methods	
4.2.1 Ethnomedicinal	use	of	Legumes	in	Brazil	
Published	 ethnomedicinal	 use	 data	 were	 compiled	 for	 the	 Leguminosae	 of	
Brazil	 as	 shown	 in	 chapter	2	of	 this	 thesis.	 The	 information	gathered	was	databased	
also	as	 reported	 in	 chapter	3	of	 this	 thesis.	Generic	and	species	names	 followed	 the	
Flora	 of	 Brazil	 (Brazilian	 Flora,	 2020),	 and	 were	 corrected	 (standardized)	 using	 the	
Plantminer	R	script	(Carvalho	et	al.	2010).		
4.2.2 Pharmacology	of	species	used	in	Brazil	
Pharmacological	data	associated	with	the	Brazilian	ethnomedicinal	species,	and	
for	 all	 genera,	whether	used	or	not,	were	 sought	online	using	 “Google	 Scholar”	 and	
“Web	of	Science”	(WoS).	Search	terms	included	the	species	name	and	commonly	used	
synonyms,	together	with	“pharmacolog*”.	The	number	of	results	from	“WoS”	for	each	
species	was	recorded,	together	with	publications	related	to	pharmacological	studies.		
	
4.2.3 Phylogenetic	reconstruction	and	analysis	
	 In	order	to	understand	the	distribution	of	ethnomedicinal	species	in	the	family,	
a	 phylogenetic	 tree	 for	 the	 Leguminosae	 in	 Brazil	 was	 reconstructed	 at	 genus	 level,	
with	 one	 species	 per	 genus	 being	 sampled.	 Sequences	 from	 the	 DNA	marker	MatK	
were	 compiled	 from	 the	 Tree	 of	 Legumes	 (LPWG,	 2010)	 when	 present,	 and	 from	
publicly	 available	 sequences	 on	 Genbank	 (appendix	 5).	 In	 total	 217	 genera	 were	
sampled	(91%	of	 the	total	 flora).	Sequences	were	aligned	using	MAFT	alignment	and	
adjustments	were	made	manually.	Sequence	data	were	analyzed	under	the	maximum-
likelihood	 (ML)	 criterion,	 under	 the	 GRTGAMMA	 model	 as	 implemented	 in	 RAxML	
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7.2.8	 (Stamatakis,	 2014).	 Unsampled	 genera	 and	 species	 were	 added	 manually	 as	
polytomies	using	R,	with	the	package	PHYTOOLS	and	the	function	add.species.to.genus	
to	generate	a	species	 tree	 (Revell,	2012).	To	make	the	 tree	ultrametric,	we	used	the	
function	chronos	from	the	package	APE	(Paradis	et	al.	2004).			
	
The	phylogenetic	structure	of	ethnomedicinal	uses	was	 investigated	using	the	
Net	Relatedness	Index	(NRI)	and	Nearest	Taxon	Index	(NTI)	(Webb,	2000;	Webb	et	al.	
2002),	with	the	functions	ses.mpd	and	ses.mntd	from	the	PICANTE	package	(Kembel	et	
al.	2010).	The	chosen	null	model	was	“taxa.labels”,	which	shuffles	the	distance	matrix	
labels	across	all	taxa	included	in	distance	matrix	with	999	runs.	The	NRI	and	NTI	values	
were	 obtained	 by	 multiplying	 the	 MPD	 and	 MNTD	 values	 by	 -1.	 The	 NRI	 value	
represents	the	average	distance	between	a	species	and	all	other	species	with	the	same	
characteristic	 (in	 our	 case	 ethnomedicinal	 use,	 or	 a	 specific	 category	 of	 therapeutic	
application).	 Higher	 values	 of	 NRI	 (negative	 for	 MPD)	 indicates	 a	 phylogenetic	
clustering	 of	 a	 sample,	 while	 negative	 values	 (positive	 for	 MPD)	 show	 an	
overdispersion	 of	 the	 studied	 taxa.	 Similarly,	 NTI	 (and	 MNTD)	 values	 can	 indicate	
clustering	 or	 dispersion.	 According	 to	 Webb	 (2000),	 NRI	 values	 describe	 a	 deep	
relationship	 in	 the	 phylogeny,	 which	 here	 might	 be	 evidence	 for	 clustering	 or	
overdispersal	 at	 tribal	 or	 sub	 familial	 levels.	 On	 the	 other	 hand,	 NTI	 describes	
relatedness	 in	 terminal	clades,	 in	our	case	clustering	or	overdispersion	of	congeneric	
ethnomedicinal	 plants	 (Figure	 4-1).	 Phylogenetic	 structure	 was	 investigated	 for	 the	
ethnomedicinal	species	compared	to	the	whole	Leguminosae	flora	in	Brazil.		
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“Hot	nodes”	(as	described	on	Saslis-Lagoudakis	et	al.	2012a)	were	sought	using	
the	NODESIG	function	in	also	in	R	(R	Core	Team,	2015)	adapted	by	Abellán	et	al.	(2016).	
We	recorded	the	percentage	of	the	total	and	ethnomedicinal	flora	included	in	the	“hot	
nodes”,	as	well	as	the	“gain”	of	ethnomedicinal	species	in	a	hot	node	when	compared	
to	 random	samples,	 for	overall	ethnomedicinal	use	and	 for	each	specific	 category	of	
therapeutic	application	(classified	according	to	the	WHO	ICD-10).		
	
	
Figure	 4-1.	 	 Schematic	 representation	 of	 scenarios	 of	 relatedness.	 Clustering	 and	
overdispersion	are	inferred	from	MPD	and	MNTD	values	(and	their	related	NRI	and	NTI	
indices	respectively).	MPD	describes	relationships	that	occurred	on	deep	nodes	of	the	
phylogeny,	 while	 MNDT	 reflects	 relationships	 at	 shallower	 nodes.	 Combined	 values	
can	be	used	to	infer	different	scenarios.	Blue-	Phylogenetic	clustering,	MPD	and	MNTD	
positive.	Black-	Overdispersion	of	clustering,	MPD	negative	and	MNTD	positive.	Pink-	
Clustering	 of	 overdispersion,	 MPD	 positive	 and	 MNTD	 negative.	 Red-	 Phylogenetic	
overdispersion,	MPD	negative	and	MNTD	negative.		(adapted	from	Mazel	et	al.	2016).			
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The	 relationship	between	pharmacological	 study	and	ethnomedicinal	use	was	
investigated.	 Firstly,	we	 considered	whether	 there	 are	more	 species	 that	 have	 been	
the	 focus	 of	 pharmacological	 study	 within	 the	 lineages	 that	 are	 hot	 nodes	 for	
ethnomedicinal	 use.	We	also	 considered	whether	 intensity	of	 ethnomedicinal	 use	of	
species	for	medicine	was	greater	in	the	lineages	that	are	hot	nodes	for	ethnomedicinal	
use,	 and	 whether	 the	 intensity	 of	 research	 effort	 was	 greater	 within	 hot	 nodes.	
Intensity	of	ethnomedicinal	use	was	estimated	based	on	the	number	of	citations/use	
reports	 in	 the	 database.	 Intensity	 of	 research	 effort	 was	measured	 by	 counting	 the	
number	of	 reported	studies	 (publications)	 for	each	species.	The	 intensity	of	 research	
effort	was	 compared	 for	 the	 species	 ethnomedicinally-used	 for	medicine	 inside	 and	
outside	of	 the	hot	nodes.	A	Wilcoxon	test	was	used	to	determine	whether	there	are	
differences	 in	 the	 number	 of	 pharmacological	 studies	 and	 ethnomedicinal	 uses	
between	 species	 in	 hot	 nodes	 and	 outside	 hot	 nodes	 than	 would	 be	 expected	 if	
pharmacological	effort	and	ethnomedicinal	use	was	homogeneous.		
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4.3 Results	
4.3.1 Data	description	and	comparison		
A	total	of	286	species	(10%	of	the	total	legume	flora)	in	104	genera	(48%	of	the	
total	 legume	 flora)	 were	 reported	 to	 have	 ethnomedicinal	 use.	 The	 most	 cited	
therapeutic	 applications	 (classified	 according	 to	WHO-IDC-10),	 were	 diseases	 of	 the	
digestive	 system	 (DDS)	 (14%),	 and	 diseases	 of	 the	 respiratory	 system	 (DRS)	 (18%).	
Senna	 (245	 reports)	 and	Bauhinia	 (157	 reports)	were	 the	 two	genera	most	 cited	 for	
ethnomedicinal	use	in	Brazil.			
	
The	 pharmacological	 investigation	 shows	 143	 species	 (50%	 of	 species	 with	
ethnomedicinal	 use,	 5%	 of	 total	 flora)	 in	 77	 genera	 (72%	 of	 genera	 with	
ethnomedicinal	use,	34%	of	 total	 flora)	had	been	the	focus	of	pharmacological	study	
(appendix	6).	A	much	lower	percentage	of	genera	without	any	ethnomedicinal	use	had	
been	 studied	 (19%,	 22	 of	 the	 118	 genera).	 These	 studies	 were	 described	 in	 3047	
publications	 abstracted	by	 the	Web	of	 Science.	Senna	 and	Bauhinia	 had	 the	 highest	
number	 of	 species	 with	 pharmacological	 studies	 (14	 and	 9)	 while	 31	 genera	 with	
ethnomedicinal	use	had	not	been	the	subject	of	any	pharmacological	study	reported	in	
the	literature.		
	
4.3.2 Phylogenetic	analysis	
The	 investigation	 of	 the	 phylogenetic	 structure	 of	 ethnomedicinal	 species	 for	
medicine	shows	an	over-dispersed	structure	 for	overall	ethnomedicinal	use	 (NRI	and	
NTI	 <0,	 p<0.05)	 (Figure	 4-2).	 	 Eight	 of	 the	 ten	 therapeutic	 application	 categories	 for	
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which	more	than	10%	of	species	were	ethnomedicinal	(>30	reports)	showed	an	over-
dispersed	structure	with	statistical	significance	(Table	4-1).	
	
	 	
Figure	4-2.	Distribution	of	medicinal	uses	and	pharmacological	studies	in	the	
Leguminosae	phylogeny	and	“Hot	nodes”	for	ethnomedicinal	use.	Block	colours	at	the	
tips:	purple	=	ethnomedicinal	use	for	that	genus;	black	=	pharmacological	studies	for	
that	genus.	Branch	colours:	red	branches	=	genera	present	in	hot	nodes	for	species	
with	ethnomedicinal	use.	Clade	colours:	yellow,	grey,	green,	light	blue	and	brown	
indicate	membership	of	subfamilies.	Figure	prepared	using	iTOL	online	(Letunic	and	
Bork,	2016)	 	
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Table	 4-1.	MPD	and	MNTD	values	 for	 therapeutic	 applications,	 plant	 parts	 used	 and	
modes	 of	 application	 of	 the	 ethnomedicinal	 medicinal	 uses	 of	 the	 Leguminosae	 in	
Brazil.	DCS	-	Diseases	of	the	circulatory	system,	DDS	-	Diseases	of	the	digestive	system;	
DFS	Diseases	of	the	femalegenito	system;	DGS	-	Diseases	of	the	genitourinary	system;	
DMC	-	Diseases	of	the	musculoskeletal	system	and	connective	tissue;	DRS	-	Diseases	of	
the	 respiratory	 system;	 ENM	 -	 Endocrine,	 nutritional	 and	 metabolic	 diseases;	 IPD	 -	
Certain	infectious	and	parasitic	diseases;	OTHER-	not	classified	diseases	such	as	fever,	
pain	and	inflammation.	
	 	 	
MPD	
	 	
MNTD	
	
	 ntaxa	 mpd.obs	 NRI	 p-value	 mntd.obs	 NTI	 p-value	
DCS	 38	 1.064	 -1.886	 <0.05	 0.228	 -1.301	 ns	
DDS	 72	 1.062	 -2.065	 <0.05	 0.161	 -1.279	 ns	
DFS	 39	 0.740	 1.111	 ns	 0.115	 0.322	 ns	
DGS	 31	 1.268	 -3.342	 <0.05	 0.229	 -0.634	 ns	
DMC	 39	 1.164	 -2.756	 <0.05	 0.197	 -0.603	 ns	
DRS	 60	 1.128	 -2.412	 <0.05	 0.187	 -1.314	 ns	
ENM	 37	 1.290	 -3.235	 <0.05	 0.348	 -2.317	 <0.05	
IPD	 35	 1.039	 -1.712	 ns	 0.225	 -0.979	 ns	
OTHER	 105	 1.057	 -2.165	 <0.05	 0.142	 -1.464	 ns	
Medicinal	 276	 1.172	 -3.993	 <0.05	 0.147	 -4.202	 <0.05	
	
4.3.3 Phylogenetic	analysis:	hot	nodes	
Nodesig	 analysis	 resulted	 in	 45%	 of	 ethnomedicinal	 species	 and	 16%	 of	 the	
total	 flora	 being	 found	 arising	 from	hot	 nodes.	 The	 therapeutic	 application	 category	
with	 the	 highest	 percentage	 of	 ethnomedicinal	 species	 inside	 hot	 nodes	 was	 ENM,	
with	82%	of	ethnomedicinal	species	present,	and	the	lowest	was	DGS	where	only	56%	
was	found	inside	hot	nodes	(Table	4-2).	
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Table	4-2.	Percentage	of	total	and	medicinal	floras	inside	hot	nodes,	for	categories	of	
therapeutic	 applications	 and	 total	 medicinal	 use.	 DCS	 -	 Diseases	 of	 the	 circulatory	
system,	 DDS	 -	 Diseases	 of	 the	 digestive	 system;	 DFS	 -	 Diseases	 of	 the	 femalegenito	
system;	 DGS	 -	 Diseases	 of	 the	 genitourinary	 system;	 DMC	 -	 Diseases	 of	 the	
musculoskeletal	 system	 and	 connective	 tissue;	 DRS	 -	 Diseases	 of	 the	 respiratory	
system;	ENM	-	Endocrine,	nutritional	and	metabolic	diseases;	 IPD	-	Certain	 infectious	
and	 parasitic	 diseases;	 OTHER-	 not	 classified	 diseases	 such	 as	 fever,	 pain	 and	
inflammation.	
	
Hot	nodes	 total	flora	 Medicinal	 %	of	total	flora	 %	of	medicinal	flora	 %gain	
Medicinal	 446	 125	 16%	 45%	 320%	
DCS	 320	 26	 12%	 67%	 1021%	
DDS	 661	 48	 24%	 64%	 1119%	
DFS	 305	 23	 11%	 59%	 1282%	
DGS	 336	 18	 12%	 56%	 1512%	
DMC	 542	 33	 20%	 79%	 1268%	
DRS	 397	 41	 14%	 66%	 777%	
ENM	 316	 31	 11%	 82%	 972%	
IPD	 457	 23	 16%	 62%	 1632%	
OTHER	 614	 66	 22%	 61%	 0%	
	
	
4.3.4 Comparison	with	pharmacological	studies	
	
	 The	number	of	species	with	ethnomedicinal	use	found	inside	the	“hot	nodes”	
was	126,	representing	45.6%	of	all	ethnomedicinal	species.	Of	these	126	species	with	
ethnomedicinal	use,	74	were	the	focus	of	at	least	one	pharmacological	study.	A	lower	
number,	 64	 species,	 of	 the	150	ethnomedicinal	 species	 outside	hot	 nodes	had	been	
screened.	There	 is	a	preference	 for	 screening	ethnomedicinal	 species	 that	are	 in	hot	
nodes	 (58%	versus	42%)	and	when	compared	 to	 total	 species,	16%	of	 species	 inside	
hotnodes	were	subject	to	pharmacological	studies,	while	this	was	true	for	only	3%	of	
species	outside	hotnodes.		Species	with	ethnomedicinal	use	present	in	the	hot	nodes	
were	cited	almost	twice	as	often	as	the	ones	outside	the	hot	nodes	(p<0.05;	table	4-3)	
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but	no	significant	difference	was	found	for	the	intensity	of	screening.	Figure	4-3	shows	
on	a	phylogeny	how	intensity	of	use	and	intensity	of	study	are	distributed.		
	
Table	 4-3.	 Characterization	 of	 “hot	 nodes”	 in	 terms	 of	 absolute	 numbers	 and	
proportions	 of	 species	 and	 studies.	 Proportions	 are	 reported	 according	 to	 the	 total	
number	 of	 species	 in	 hot	 nodes	 (446	 species)	 and	 outside	 of	 hot	 nodes	 (2331),	 for	
species,	 and	 according	 to	 the	 total	 number	 of	 genera	 in	 hotnodes	 (50)	 and	 outside	
hotnodes	(152).	Citations	means	the	number	of	reports	a	species	have	in	the	database	
for	medicinal	use.	
		 Hot	nodes	 Outside	
Number	of	genera	with	ethnomedicinal	study	 37	(74%)	 65	(42%)	
Number	of	genera	with	pharmacological	study	 34	(68%)	 60	(39%)	
Number	of	species	with	ethnomedicinal	use	 126	(28%)	 150	(6%)	
Number	of	species	with	pharmacological	study	 74	(16%)	 64	(3%)	
Intensity	of	ethnomedicinal	use	(Number	of	citations)	 1192	 549	
Intensity	of	pharmacological	study	(Number	of	studies)	 1028		 1665		
Average	number	of	studies	per	species	 2.3	 0.7	
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Figure	4-3.	Comparison	between	hot	nodes	(A)	and	non-hot	nodes	(B)	in	
relation	to	number	of	citations	(blue)	and	number	of	pharmacological	studies	(orange).	
Hot	nodes	are	calculated	based	on	the	distribution	of	recorded	use	of	species.	Species	
in	hot	nodes	also	have	significantly	more	use	reports	per	species	(p<0.05).	Figure	
prepared	using	iTOL	online	(Letunic	and	Bork,	2016)	 	
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4.4 Discussion	
	
This	 study	 reveals	 that	 half	 of	 the	 species	 of	 Leguminosae	 used	 in	
ethnomedicine	 in	 Brazil	 have	 been	 the	 focus	 of	 at	 least	 one	 pharmacological	 study.	
This	 is	 a	 huge	 increase	 compared	 with	 Fabricant	 and	 Farnsworth's	 (2001)	 global	
estimate	 of	 9%	 of	 plants	 screened.	 Fabricant	 and	 Farnsworth's	 study	 has	 become	 a	
citation	 classic,	 serving	 to	 highlight	 the	 paucity	 of	 knowledge	 of	 pharmacological	
properties	 of	 ethnomedicinal	 plants.	 Our	 study	 shows	 that	 at	 least	 for	 some	 plant	
lineages	in	some	parts	of	the	world,	there	is	now	considerably	more	knowledge	of	the	
pharmacological	 properties	 of	 plants	 used	 in	 ethnomedicine.	 Investment	 in	 natural	
products	research	informed	by	traditional	knowledge	has	fluctuated	(Koehn	and	Carter,	
2005),	and	while	there	may	be	many	factors	at	play,	one	factor	sometimes	cited	is	the	
challenge	of	negotiating	benefit	sharing	with	knowledge	holders	(Harvey	et	al.	2015).	
However,	Brazil,	 like	other	BRIC	countries,	has	 invested	 in	realizing	the	value	of	 local	
and	 indigenous	 knowledge	 of	 indigenous	 plant	 resources	 through	 pharmacological	
research	 (Dutra	 et	 al.	 2016;	 Saslis-Lagoudakis	 et	 al.	 2012b).	 Given	 the	 apparent	
intensive	efforts	in	ethnopharmacology	focused	on	species	found	in	Brazil,	it	is	timely	
to	 review	 how	 this	 investment	 is	 directed.	 The	 consideration	 of	 the	 relationship	
between	pharmacological	study	and	intensity	of	ethnomedicinal	use	we	present	here	
is	 a	 first	 step	 towards	 a	 data-driven	 evaluation	 of	 how	ethnomedicine	might	 inform	
bioprospecting,	 or	 direct	 research	 into	 the	 health	 risks	 associated	with	 local	 plant-
based	healthcare.		
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	 This	 study	 goes	 far	 beyond	 counting	 the	 number	 of	 species	 used	 in	
ethnomedicine	and	recording	whether	 these	plants	are	 the	 focus	of	pharmacological	
studies.	We	use	 a	phylogenetic	 framework	 to	 identify	 evolutionary	 lineages	 that	 are	
particularly	important	in	ethnomedicine,	and	record	whether	species	in	those	lineages	
are	 more	 often	 screened	 than	 other	 ethnomedicinal	 plants.	 A	 first	 step	 was	 the	
phylogenetic	characterisation	of	ethnomedicinal	species	of	Leguminosae	in	Brazil,	and	
we	 revealed	novel	patterns	with	 significant	 implications	 for	bioprospecting.	 Previous	
phylogenetic	studies	reported	clustering	of	species	with	ethnomedicinal	use,	both	for	
whole	 floras	 (Saslis-Lagoudakis	et	al.	2012a),	and	when	species-level	phylogenies	are	
used	 to	 interrogate	 the	 patterns	 of	 plant	 use	 in	 genera	 (Ernst	 et	 al.	 2016;	 Saslis-
Lagoudakis	et	al.	2011a).	Our	study	 is	 the	 first	 focused	at	 the	 level	of	a	plant	 family,	
and	 also	 the	 first	 to	 recover	 a	 signal	 of	 phylogenetic	 overdispersal	 of	 an	
ethnomedicinal	 flora	 belonging	 to	 the	 Angiosperms.	 (Table	 4-1).	 We	 interpret	 the	
signal	 of	 overdispersion	 as	 indicative	 of	 multiple,	 independent	 lineages	 of	
ethnopharmacological	interest	and	thus	a	diversity	of	potential	leads.	Phylogenetically-
informed	 bioprospecting	 until	 now	 has	 been	 concerned	 with	 clustering,	 whether	
recovered	using	D-statistics	or	Pagel’s	lambda	(Cámara-Leret	et	al.	2017;	Rønsted	et	al.	
2008),	 or	 community	 phylogenetic	 methods	 (Saslis-Lagoudakis	 et	 al.	 2011a,	 2012a,	
2014,	 Yessoufou	 et	 al.	 2015,	 Ernst	 et	 al.	 2016,	 Halse-Gramkow	 et	 al.	 2017).		
Overdispersal	 challenges	 the	 established	 use	 of	 phylogeny	 as	 a	 predictive	 tool	 to	
inform	ethnopharmacological	screening,	but	here	we	show	that	hot	nodes	can	still	be	
identified	 and	 lineages	 of	 interest	 highlighted	 (Figure	 4-2).	 In	 the	 context	 of	 what	
might	 be	 overdispersed	 clusters	 (Figure	 4-1)	 a	 fresh	 view	 of	 priorities	 for	
pharmacological	research	effort	can	be	made.			
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Bioactivity	of	plant	species	is	related	to	the	presence	of	secondary	metabolites.	
These	 mediate	 interactions	 of	 plant	 species	 with	 pathogens	 and	 herbivores,	 other	
plants	and	pollinators	(Bourgaud	et	al.	2001,	Edris,	2007;	Heil,	2008;	Huang	et	al.	2012).	
While	some	metabolites	in	the	legumes,	such	as	flavonoids,	triterpenes	and	pinitol,	are	
of	 broad	occurrence	 and	 can	 be	 found	 in	 diverse	 groups,	 others	 are	 limited	 in	 their	
phylogenetic	 distribution	 (Wink,	 2013).	 The	 pattern	 of	 overdispersal	 we	 find	 here	
might	 result	 from	 the	 adoption	 of	 multiple	 lineages	 with	 different	 secondary	
metabolites	 for	 ethnomedicine.	 Following	 this	 interpretation,	 each	 overdispersed	
cluster	would	represent	a	different	target	for	bioprospecting.	Although	ethnomedicinal	
therapeutic	 applications	may	 not	 relate	 to	 biomedical	 conditions	 (Staub	 et	 al.	 2015)	
there	 may	 be	 phylogenetic	 patterns	 in	 application	 that	 relate	 to	 properties	 of	 the	
plants	 (Ernst	 et	 al.	 2016).	 The	 overdispersed	 phylogenetic	 structure	 of	 therapeutic	
applications	 (Table	4-1)	may	highlight	plants	with	different	 chemistries	 to	 treat	each	
condition.	With	a	huge	floristic	diversity	and	many	different	floristic	environments,	and	
also	 abiotic	 differences	 such	 as	 altitude,	 humidity,	 soil,	 a	 diversity	 of	 secondary	
metabolites	 in	 the	 Leguminosae	 in	 Brazil	 across	 species	 localities	 and	occurrences	 is	
expected.	The	 interplay	of	chemical	and	phylogenetic	diversity	also	underscores	 that	
the	hierarchical	level	of	the	study	is	important	in	devising	and	interpreting	any	study.	
Saslis-Lagoudakis	et	al.	(2012a)	indicated	in	a	study	across	all	Angiosperms	that	plants	
of	the	Leguminosae	were	included	in	cross-cultural	hot	nodes.	However,	in	this	study	
at	the	family	level,	overdispersal	reveals	phylogenetically	non-random	use,	comprising	
overdispersed	 lineages	 that	 we	 hypothesise	 here	 are	 selected	 for	 their	 diverse	
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chemistries.	Many	more	studies	are	needed	to	determine	how	general	these	emerging	
patterns	are,	and	whether	they	apply	to	less	species-rich	families.		
	
Our	 data	 show	 how	 pharmacological	 studies	 are	 distributed	 relative	 to	 hot	
nodes	(Table	4-3).	Although	hot	nodes	comprise	only	16%	of	total	species	they	include	
almost	half	of	the	ethnomedicinal	species.	As	well	as	being	evolutionary	hotspots	for	
ethnomedicinal	 species,	 overall	 the	 hot	 nodes	 encompass	 significantly	 more	 use	
reports.	 These	 same	hot	nodes	also	 include	more	 than	half	of	 the	 species	 that	have	
been	the	focus	of	pharmacological	investigation.	Therefore,	we	highlight	here	how	just	
a	 small	 part	 of	 the	 phylogeny	 concentrates	 both	 traditional	 knowledge	 and	
pharmacological	 research,	 so	 that	 lineages	outside	of	hot	nodes	are	 relatively	poorly	
known.	 Our	 study	 corroborates	 the	 view	 that	 ethnomedicinal	 use	 guides	
pharmacological	 research	 (Gurib-Fakim,	 2006),	 using	 a	 phylogenetic	 framework	 for	
Brazilian	 Leguminosae.	Whether	 emphasis	 on	 these	 lineages	 benefits	 bioprospecting	
or	 protection	of	 the	health	 of	 communities	 using	 the	plants	 is	 unclear.	We	 consider	
this	question	from	three	perspectives,	firstly	the	quality	of	the	research,	secondly	the	
phylogenetic	distribution	of	species	of	known	efficacy,	and	thirdly	the	likely	toxicity	of	
the	lineages.		
	
Firstly,	to	contribute	to	bioprospecting	or	safety	assessments,	pharmacological	
and	toxicological	survey	must	be	robust.	Although	many	pharmacological	studies	were	
found	for	the	ethnomedicinal	species,	the	quality	and	significance	of	the	studies	were	
not	easily	 assessed.	Many	 low	 impact	 studies	use	meaningless	bioassays,	 and	 report	
differences	between	in	vitro	and	 in	vivo	experiments	that	are	a	consequence	of	data	
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quality	 (Gertsch	 2009).	 Secondly,	 there	 must	 be	 the	 expectation	 that	 the	 most	
important	species	for	bioprospecting	belong	to	hot	nodes.	At	the	level	of	whole	floras,	
it	is	known	that	evolutionary	lineages	of	plants	that	are	rich	in	ethnomedicinal	species	
also	 contain	 a	 significantly	 greater	 proportion	of	 species	with	demonstrated	 efficacy	
(Saslis-Lagoudakis	 et	 al.	 2012a).	 This	 suggests	 that	 the	 focus	 on	 hot	 nodes	 is	 well	
placed.	However,	despite	the	exponential	growth	of	ethnopharmacological	studies	 in	
the	 past	 years,	 few	 significant	 discoveries	 have	 been	 made	 (Gertsch,	 2009).	 It	 is	
noteworthy	that	one	of	the	two	natural	products	derived	from	the	Leguminosae	and	
brought	 to	 market,	 monocrotaline	 originated	 from	 Crotalaria	 sessilifolia,	 is	 an	 anti-
tumor	agent	with	reported	toxicity	(Honorio	Junior	et	al.	2010;	Nogueira-Ferreira	et	al.	
2015).	Crotalaria	 species	 are	 used	 in	 Brazilian	 ethnomedicine,	 but	with	 very	 specific	
applications,	 including	 as	 abortifacients,	 and	 are	 not	 part	 of	 a	 hotnode.	 Similarly,	
Canavalia	 includes	 ethnomedicinal	 species	 with	 few	 uses	 and	 is	 known	 to	 be	 toxic	
(Dang	and	Van	Damme,	2015;	Follmer	et	al.	2001;	Oliveira	et	al.	1999),	and	is	outwith	
the	 hot	 nodes.	 We	 suggest	 that	 toxic	 species	 are	 phylogenetic	 outliers	 in	 terms	 of	
ethnomedicinal	 use,	 and	 that	 the	 heavily	 used	 lineages	 and	 species	 are	 relatively	
benign.	 Plants	 having	 a	 mild	 effect	 are	 expected	 to	 be	 dominant	 in	
ethnopharmacopoeias,	but	novelty	may	be	found	in	plants	less	closely	related	to	these	
species	which	at	least	in	Brazilian	legumes	are	already	well-known.		
	
Whether	 or	 not	 novel	 leads	 remain	 to	 be	 discovered,	 there	 are	 compelling	
reasons	to	characterise	plants	that	represent	different	lineages	in	ethnomedicine.	Lack	
of	knowledge	may	be	problematic	because	health	risks	associated	with	ethnomedicinal	
plant	use	may	be	unreported	 (Jäger	2015).	 Even	 studies	without	 significance	 for	 the	
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global	pharmaceutical	 industry	can	still	act	as	a	start	point	to	assure	safety	of	use.	 In	
the	 case	 of	 Brazilian	 Leguminosae,	 two	 commonly	 used	 plants	
Stryphnodendron	 	(Costa	et	al.	 2013)	and	Erythrina	 (Dias	et	 al.	 2013),	have	been	 the	
focus	 of	 recent	 pharmacological	 and	 toxicological	 survey	 without	 substantiating	
concerns.	However,	Crotalaria	 species	with	known	toxicity	have	been	reported	to	be	
used,	and	approximately	half	of	the	ethnomedicinal	species	appear	to	be	unscreened.	
Phylogenetic	methods	could	 to	be	used	 in	 tandem	with	ethnobotanical	databases	 to	
predict	the	health	risks	associated	with	uncharacterized	plant	species.	Here	we	show	
lineages	rich	 in	ethnomedicinal	use	are	also	rich	 in	pharmacological	studies,	showing	
effort	is	directed	towards	characterizing	closely-related,	most-used	species.	Just	as	for	
bioprospecting	 purposes,	 it	 could	 be	 argued	 that	 phylogenetically-isolated	 species	
should	be	consciously	included	in	future	research.		
	
This	 study	 shines	 a	 light	 on	 the	 phylogenetic	 distribution	 of	 ethnomedicinal	
plants	 in	 Leguminosae	 from	Brazil.	 In	highlighting	an	overdispersed	 structure	 for	 the	
first	 time	 it	 draws	 attention	 to	 the	 complex	 nature	 of	 plant	 selection	 for	
ethnomedicinal	use.	It	also	highlights	a	connection	between	lineages	of	importance	for	
ethnomedicine	 and	 those	 that	 have	 become	 the	 focus	 of	 ethnopharmacological	
research,	 raising	 questions	 about	 the	 drivers	 of	 selection	 of	 species	 for	 screening	 in	
pharmacological	studies.	Much	has	been	written	about	means	devising	rational,	data-
driven	selection	of	plants	for	screening,	for	example	by	inferring	useful	phytochemical	
composition	 from	 ethnobotanical,	 chemosystematic	 or	 ecological	 information	
(Albuquerque	et	al.	2012;	Albuquerque,	2010;	Coley	et	al.	2003;	Douwes	et	al.	2008;	
Saslis-Lagoudakis	et	al.	2011b;	Tan	et	al.	2006),	or	from	phylogeny	(Ernst	et	al.	2016;	
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Grace	et	al.	2015;	Rønsted	et	al.	2008;	Saslis-Lagoudakis	et	al.	2012a;	Yessoufou	et	al.	
2015).	 Other	 factors	 are	 important,	 for	 example	 the	 availability	 of	 plentiful	 plant	
material,	 may	 be	 a	 strong	 driver	 (Atanasov	 et	 al.	 2015).	 Widely	 distributed	 species	
might	 be	more	 likely	 to	 be	 screened.	 Existing	 protocols	 and	 emerging	 interest	 may	
create	a	snowball	effect,	so	that	many	studies	are	made	of	species	of	already	proven	
interest,	or	of	their	close	relatives.	The	species	that	are	the	most	intensively	screened	
often	 have	 food	 or	 fodder	 use	 (e.g.	 Canavalia	 species	 used	 as	 food	 for	 cattle;	
Desmodium	 species).	 Ultimately,	 our	 study	 demonstrates	 a	 method	 to	 identify	 the	
plant	 lineages	 that	 are	 most	 important	 ethnomedicinally.	 As	 research	 into	 natural	
products	grows,	this	novel	framework	provides	a	timely	insight	into	how	knowledge	of	
ethnomedicinal	plants	is	distributed.	
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Chapter	5 Spatial	 structure	 in	 the	 distribution	 of	 traditional	
knowledge	
	
5.1 Introduction	
	
	 Cultural	 diversity	 is	 characterized	 by	 the	 relationships	 between	 biological	
diversity	and	traditional	knowledge	 (Guglielmino	et	al.	1995;	Pagel	and	Mace,	2004).	
Traditional	knowledge	of	medicinal	plant	biodiversity	is	especially	significant,	because	
more	than	50	000	species	are	estimated	to	have	been	used	as	medicine	(Schippmann	
et	al.	2006,	2002),	and	plant	medicine	continues	to	contribute	to	the	health	of	millions	
of	people	(Farnsworth	et	al.	1985).	The	relationship	between	humans	and	plants,	and	
consequently	 selection	 of	 	 plants	 for	 medicine,	 can	 be	 seen	 as	 a	 complex	 set	 of	
interactions,	 depending	 on	 plant	 species	 availability	 and	 demand	 for	 treatment	 or	
prophylaxis,	leading	to	a	so	called	“herbal	landscape”	(Sõukand	and	Kalle,	2010).	How	
extensive	such	medicinal	plant	landscapes	are	can	be	difficult	to	assess.	If	plant	use	is	
the	result	of	 local	experimentation,	 rather	 than	sharing	of	 traditional	knowledge,	we	
would	expect	traditional	knowledge	to	be	very	strongly	spatially	patterned.	However,	
transmission	of	knowledge	of	medicinal	plants	is	well	documented	(Begossi	et	al.	2002;	
Ceolin	et	 al.	 2011;	 Leonti,	 2011;	 Lozada	et	 al.	 2006),	 and	migration	 is	well-known	 to	
result	in	translocation	of	knowledge	(Campos	and	Ehringhaus,	2003;	de	Medeiros	et	al.	
2011;	 Vandebroek	 and	 Pieroni,	 2007).	 Findings	 such	 as	 these	 challenge	 the	 view	 of	
medicinal	 plant	 use	 as	 strongly	 adapted	 to	 the	 local	 environment	 through	
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experimentation	in	situ	over	many	generations	(Schultes,	1960).	 If	plant	species	used	
for	medicine	 are	 readily	 adopted,	 flowing	 between	peoples	 as	 a	 result	 of	 horizontal	
transfer	of	traditional	knowledge,	and	in	space	as	a	result	of	peoples’	migrations,	then	
spatial	patterns	in	traditional	knowledge	of	medicinal	plants	might	be	limited.		
	
Understanding	the	medicinal	plant	landscape	is	complicated	by	the	distribution	
of	 plant	 species,	 and	 because	 of	 their	 relatedness.	 Plants	 comprise	 the	most	 visible	
components	 of	 biological	 communities,	 and	 turn-over	 in	 species	 between	 biomes	
characterises	 many	 of	 these	 habitats.	Medicinal	 plant	 use	 is	 shaped	 by	 the	 floristic	
environment	 (Saslis-Lagoudakis	et	al.	2014).	 In	 terms	of	 relatedness,	 it	 is	known	that	
medicinal	species	are	not	randomly	distributed	in	a	flora,	but	can	usually	be	found	in	
certain	lineages/families	(Lukhoba	et	al.	2006;	Moerman	et	al.	1999;	Saslis-Lagoudakis	
et	 al.	 2012a).	 This	 shared	 preference	 is	 usually	 attributed	 to	 independent	 discovery	
whilst	 shared	 use	 of	 closely	 related	 plants	 may	 point	 towards	 transmission	 of	
traditional	 knowledge	 (Hawkins	 and	 Teixidor-Toneu,	 2017;	 Saslis-Lagoudakis	 et	 al.	
2015;	Saslis-Lagoudakis	et	al.	2012a).		
	
Brazil	has	one	of	the	world’s	richest	floras,	estimated	to	comprise	more	than	40	
000	 species	 and	 a	 high	 level	 of	 endemism	 (around	 46.2%).	 This	 high	 biodiversity	 is	
partitioned	into	floristic	and	geographical	environments	called	biomes.	The	six	biomes	
comprise	between	19	355	and	1	240	species,	between	4	and	40%	endemism,	and	two	
are	 important	 floristic	 hotspots,	 the	 Cerrado	 and	 the	 Atlantic	 Forest	 (Forzza	 et	 al.	
2012).	 	 Brazil	 also	 has	 a	 rich	 cultural	 diversity,	 expressed	 as	 religious	 and	 ethnic	
diversity	(Araújo	et	al.	2007;	Deus,	2011;	Fleury,	1999;	Little,	2002),	but	linguistically	it	
Chapter	5	Spatial	structure	in	the	distribution	of	traditional	knowledge	
	 75	
is	quite	homogenous.	Within	Brazil,	migration	from	the	Atlantic	coast	inland	was	part	
of	 the	 colonization	 process,	 and	 since	 then	 significant	migration	 has	 been	 from	 the	
rural	 Northeast	 to	 urban	 Southeast	 (Gonçalves,	 2001).Migrations	 such	 as	 the	
settlements	of	descendants	of	African	slaved	people	(Quilombos)	in	the	Amazon	have	
resulted	in	assimilation	of	the	medicinal	plants	of	the	native	Amazonian	Indians	(Voeks	
and	 Rashford,	 2013).	 The	 widely-adopted	 dominant	 language	 and	mobility	 presents	
opportunity	for	knowledge	exchange.		
	
In	this	study	the	relationship	between	human	culture	and	resource	use,	shaped	
by	 the	 floristic	 environment,	 is	 explored	 in	 the	 context	 of	 evolutionary	 ethnobotany	
(Albuquerque	 and	 Ferreira	 Júnior,	 2017;	 Saslis-Lagoudakis	 et	 al.	 2015).	 The	 main	
objective	 is	 to	 test	 the	 null	 hypothesis	 that	 medicinal	 plant	 use	 in	 Brazil	 is	
homogeneous,	aside	from	constraints	of	availability	in	local	floras.	The	approach	taken	
exploits	 1.	 existing	 data	 describing	 the	 spatial	 distribution	 of	 plants	 2.	 a	 modified	
hypothesis	of	plant	phylogenetic	relationships	from	published	DNA	sequence	data	and	
3.	 a	 newly	 compiled	 traditional	 knowledge	 database,	 derived	 from	 herbarium	
specimen	 records.	 This	 attempt	 to	 critically	 evaluate	 the	 extent	 to	 which	 there	 is	
heterogeneity	in	medicinal	plant	use	at	a	landscape	scale	depends	on	the	application	
of	 methods	 from	 biogeography	 to	 traditional	 knowledge.	 These	 utility	 of	 these	
methods,	 including	 phylogenetic	 assessments	 of	 beta	 diversity,	 and	 Principal	
Components	of	Phylogenetic	Structure	(PCPS	Duarte,	2011),	is	determined	here,	asking	
whether	 they	 could	 be	 used	 more	 widely	 to	 document	 turn-over	 in	 traditional	
knowledge	of	biodiversity.	
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5.2 Methodology	
5.2.1 Data	collection	and	standardization		
	
Herbarium	 vouchers	 containing	 information	 on	medicinal	 use	 were	 collected	
from	online	herbarium	data	available	from	CRIA	Species	Link	(http://splink.cria.org.br/).	
A	 list	of	all	angiosperms	was	downloaded	from	the	website	as	a	CSV	file	and	species	
with	medicinal	 use	were	 identified	 by	 filtering	 and	 searching	 the	 field	 “description”	
with	 the	 key	 words	 “medicin*”	 and	 “uses”.	 Species	 names	 were	 standardized	 with	
Plantminer	(Carvalho	et	al.	2010)	to	names	in	THE	PLANT	LIST	(The	Plant	List	2013)	and	
Missouri	Botanical	Garden's	Tropicos	database	(Tropicos.org	2016).	Records	were	then	
filtered	 and	 only	 records	 with	 identification	 to	 species	 level	 and	 geographical	
coordinates	were	selected	for	further	analysis.	The	floristic	composition	of	each	biome	
was	extracted	from	the	Brazilian	flora	(Brazilian	Flora,	2020)	and	these	species	names	
also	were	standardized	with	Plantminer	as	described	above.	The	information	gathered	
was	 databased	 so	 that	 for	 every	 species/therapeutic	 application	 combination	 found	
there	 was	 a	 single	 entry	 in	 the	 database,	 which	 we	 call	 a	 species	 use	 report.	 The	
database	had	 the	 following	 fields:	 genus	 and	 species	 as	 recorded	 in	 the	publication,	
currently	 accepted	 name,	 therapeutic	 application	 as	 recorded	 in	 the	 publication,	
therapeutic	application	categorized	according	to	the	World	Health	Organization	(WHO)	
International	Classification	of	Diseases	10	(http://www.who.int/classifications/icd/en/),	
parts	used	and	mode	of	application.		
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Species	were	plotted	on	a	map	using	QGIS	 (Quantum	GIS	development	team,	
2017)	with	boundaries	of	Brazil	and	each	of	the	six	Brazilian	biomes,	and	a	matrix	was	
extracted	with	each	record	being	allocated	to	a	biome.		
	
5.2.2 Data	analysis	
	
	 A	suite	of	analyses,	from	taxonomic	and	phylogenetic	methods	for	investigating	
species	 composition	were	adopted	here.	 The	 range	of	 approaches	and	how	possible	
outcomes	could	be	interpreted	in	a	phylogenetic	context	is	presented	in	appendix	7.	
	
5.2.2.1 Taxonomic	Beta	diversity	
	
Taxonomic	 beta	 diversity	 and	 phylogenetic	 beta	 diversity	 were	 calculated	 to	
compare	medicinal	plant	use	between	biomes.	For	 the	 taxonomic	beta	diversity,	 the	
chosen	dissimilarity	index	was	beta-similarity	due	to	its	better	fitness	against	a	dataset	
of	presence	and	absence,	where:	
	!"#$ = 1 − ( )*+, -,/ 0))	
Other	dissimilarity	metrics	are	also	used	for	similar	analysis,	but	can	be	strongly	
influenced	 by	 differences	 in	 species	 richness	 (see	 Kreft	 and	 Jetz,	 2010).	 The	
dissimilarity	 between	 biomes	was	 investigated	 in	 terms	 of	medicinal	 plant	 use,	 and	
according	to	species	composition	at	both	species	and	generic	level.	Here,	four	different	
matrices	 were	 made,	 two	 for	 medicinal	 plant	 use	 containing	 only	 medicinal	
species/genera	 and	 two	 containing	 all	 species/genera	 in	 the	 Brazilian	 flora.	 To	
investigate	the	correlation	between	total	flora	and	medicinal	flora,	a	Mantel	test	based	
on	 “Pearson”	 distance	was	 conducted	 between	 the	 dissimilarity	matrices	 (medicinal	
Chapter	5	Spatial	structure	in	the	distribution	of	traditional	knowledge	
	 78	
species	vs	 total	 species	and	medicinal	genera	vs	 total	genera)	using	R	 (R	Core	Team,	
2015).	A	cluster	analysis	for	the	four	different	matrices	was	done	also	using	R	(R	Core	
Team,	2015).	
	
5.2.2.2	Phylogenetic	structure	and	beta	diversity	
	
A	 phylogenetic	 tree	 at	 generic	 level	was	 reconstructed	 for	 the	 Brazilian	 flora	
using	 the	 S.Phylomaker	 tool,	 (Qian	 and	 Jin,	 2016),	 with	 one	 species	 per	 genus.	
S.Phylomaker	 uses	 PhytoPhylo	 megaphylogeny	 (an	 updated	 version	 of	 Zanne	 et	 al.	
(2014))	as	a	backbone,	and	matches	a	provided	species	list	by	the	user	to	the	species	
present	in	the	phylogeny.	When	present,	the	species	is	selected	for	pruning,	and	when	
not	available	in	the	phylogeny,	the	species	is	added	to	the	backbone	within	the	genus	
of	 family.	 To	 get	 the	 final	 tree,	 all	 selected	 and	 added	 species	 are	 pruned	 from	 the	
megaphylogeny,	 and	 the	 phylogenetic	 tree	 is	 reconstructed	 according	 to	 three	
different	 scenarios.	 The	 selected	 phylogenetic	 scenario	 from	 S.Phylomaker	 was	 the	
third	 one,	 where	 genera	 not	 present	 in	 the	 megaphylogeny	 were	 added	 to	 their	
families	using	 the	same	approach	 implemented	 in	Phylomatic	 (Webb	and	Donoghue,	
2005)	and	BLADJ	(Webb	et	al.	2008)	(Figure	5.1).	
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Figure	5-1.	Graphic	explanation	of	S.Phylomaker	steps.	A	shows	the	first	steps,	where	
taxa	provided	by	the	user	is	matched	to	the	taxa	present	in	the	megaphylogeny.	Taxa	
present	 in	both	datasets	are	 selected	and	marked	 for	pruning	 (red	 clades).	 Taxa	not	
present	 in	 the	 megaphylogeny	 but	 provided	 by	 the	 user	 is	 added	 to	 the	 backbone	
within	the	genus	or	the	family	(blue	clade).	Finally,	the	selected	taxa	(red	and	blue)	are	
pruned,	and	 the	phylogeny	 is	 reconstructed,	 in	 this	case	 following	scenario	3,	where	
the	branch	lengths	are	calculated	according	to	information	available	from	some	nodes	
that	were	 previously	 present	 in	 the	 phylogeny	 (stars)	 (following	 BLADJ-(Webb	 et	 al.	
2008)).		
	
The	phylogenetic	 structure	of	 traditional	 uses	was	 investigated	using	 the	Net	
Relatedness	Index	(NRI)	and	Nearest	Taxon	Index	(NTI)	(Webb,	2000;	Webb	et	al.	2002),	
with	 the	 functions	 ses.mpd	 and	 ses.mntd	 from	 the	 PICANTE	 package	 (Kembel	 et	 al.	
2010),	 by	multiplying	 the	MPD	 and	MNTD	 values	 by	 -1.	 The	 chosen	 null	model	was	
“taxa.labels”,	 which	 shuffles	 the	 distance	 matrix	 labels	 across	 all	 taxa	 included	 in	
distance	 matrix	 with	 999	 runs.	 Phylogenetic	 structure	 of	 medicinal	 plant	 use	 was	
A B 
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investigated	for	each	biome	in	relation	to	the	total	Brazilian	flora.	Possible	outcomes	
and	the	relationships	of	NRI	and	NTI	values	were	shown	in	chapter	4,	figure	4.1.		 	
	
Three	different	measures	 of	 phylogenetic	 beta	 diversity	were	used	here.	 The	
first	 incorporates	 the	 bNRI	 and	 bNTI	 obtained	 from	 the	 functions	 “comdist”	 	 and	
“comdistnt”	 in	Phylocom	 (Webb	et	al.	2008).	 “Comdist”	measures	 the	MPD	 for	each	
taxon	in	a	sample	and	measures	the	mean	value	to	the	average	distance	to	all	taxa	in	
the	other	 sample.	 “Comdistnt”	does	 the	 same	but	 for	 the	MNTD	values.	Adding	 the	
abundance	 data	 (here	 abundance	 was	 the	 number	 of	 times	 a	 taxon	 was	 cited	 as	
medicinal	 in	 a	 biome),	 the	 average	 distance	 changes	 to	 be	 among	 two	 random	
individuals	drawn	from	each	of	two	samples	(Webb	et	al.	2008).		
	
The	 second	 phylogenetic	 index	 of	 beta	 diversity	 was	 calculated	 using	 the	
function	“phyloSor”	(Bryant	et	al.	2008)	from	the	package	Picante	(Kembel	et	al.	2010)	
in	R.	This	 index	 ranges	 from	0	 to	1,	where	0	 indicates	a	 that	 two	communities	 (here	
biomes)	 share	 no	 taxa,	 and	 1	 indicates	 that	 both	 biomes	 have	 the	 same	 taxa.	 This	
second	 index	 allows	 a	 comparison	 of	 the	 phylogenetic	 beta	 diversity	 and	 the	
taxonomic	 beta	 diversity	 to	 be	 made	 using	 a	 phylogenetic	 dissimilarity	 index,	
calculated	as	1-	phyloSor	index	(Souza-Neto	et	al.	2016).	The	taxonomic	beta	diversity	
was	measured	 here	 using	 the	 function	 “betadiver”	 in	 R,	 and	 the	 chosen	 index	 was	
“Sorensen”	 due	 to	 its	 relation	 to	 phyloSor	 (Bryant	 et	 al.	 2008;	 Feng	 et	 al.	 2012;	
Swenson	et	al.	2011).	This	comparison	is	important	because	while	the	taxonomic	beta	
diversity	 might	 indicate	 a	 high	 dissimilarity	 between	 biomes,	 the	 phylogenetic	 beta	
diversity	 dissimilarity	might	 indicate	 some	 degree	 of	 relatedness	 between	medicinal	
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plants	used	in	both	biomes	(Figure	5-2).		To	test	whether	a	species/generic	turnover	is	
dominant	between	two	biomes,	in	other	words	whether	beta-diversity	is	mostly	due	to	
different	species/genera	being	used/present	in	different	communities,	the	partitioning	
of	 betadiversity	 into	 nestedness	 and	 turnover	 components	 were	 calculated	 the	
function	“beta.pair”	from	the	package	“Betapart”,	following	Leprieur	et	al.	(2012).			
	
The	third	measure	of	phylogenetic	beta	diversity	is	based	on	the	PCPS	method	
(Pillar	 and	 Duarte,	 2010).	 This	 method	 is	 based	 on	 decomposing	 the	 phylogenetic	
information	 for	 each	 community	 (here	 biome)	 using	 phylogenetic	 fuzzy	 weighting	
(Pillar	 and	 Duarte,	 2010)	 into	 several	 orthogonal	 eigenvectors	 that	 can	 be	 then	
analysed	as	a	PCA.	 	Each	eigenvector	 is	a	phylogenetic	gradient	 for	 the	communities	
studied	 and	 shows	 the	 variation	 across	 the	whole	 phylogeny.	 Eigenvectors	with	 the	
highest	values	describe	deep	relationships	in	the	phylogenetic	tree,	while	eigenvectors	
with	 low	 values	 describe	 shallower	 relationships	 in	 the	 phylogeny	 as	 changes	 in	
families	 or	 genera	 (Duarte	 et	 al.	 2012).	 This	 method	 allows	 lineages	 influencing	
phylogenetic	beta	diversity	differences	when	medicinal	use	is	associated	with	specific	
biomes	to	be	identified	(Duarte	et	al.	2012).		
	
5.2.2.3	Therapeutic	applications	
	
Brazilian	 biomes	 were	 analysed	 pair-wise	 with	 a	 Spearman	 rank-order	
correlation	to	test	whether	the	proportion	of	therapeutic	applications	is	homogeneous	
throughout	Brazil.			
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Figure	5-2.	Comparison	between	taxonomic	and	phylogenetic	beta	diversity.	A,	B	and	C	
are	different	communities	with	different	plant	species,	but	sharing	only	one	species.	A	
taxonomic	beta	diversity	analysis	with	such	communities	would	result	 in	a	high	value	
of	dissimilarity,	and	distance	between	communities	would	be	the	same.	On	the	other	
hand,	 a	 phylogenetic	 beta	 diversity	 analysis	 would	 result	 in	 a	 lower	 value	 of	
dissimilarity,	 since	 some	 of	 the	 species	 present	 	 are	 closely-related	 species,	 for	
example	 species	 coloured	 in	 green	 form	 a	 group	 of	 closely	 related	 species,	 and	 the	
same	 for	 species	 coloured	 in	 yellow.	 Considering	 the	 phylogenetic	 similarity,	
communities	A	and	C	would	be	more	similar,	than	either	are	to	B.		
	
	 	
A B C 
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5.3	 Results	
5.3.1	 Data	collection	
Of	5.38	million	 records	online,	 7	122	 records	 referring	 to	medicinal	use	were	
selected.	 These	 records	 included	 a	 total	 of	 1	 994	 species	 in	 880	 genera	 and	 209	
families.	 Of	 these,	 1	 579	 species	 in	 733	 genera	 and	 199	 families	 had	 geographical	
coordinates	 that	 allowed	 to	match	 their	occurrence	 to	a	 specific	biome.	The	biomes	
most	 represented	 here	 according	 to	 the	 number	 of	 records	 were	 the	 Atlantic	
Rainforest	 and	 the	 Cerrado,	 while	 the	 Pampas	 had	 the	 lowest	 number	 of	 records.	
Figure	5.3	shows	the	distribution	of	records	and	compare	the	number	of	species	with	
medicinal	use	to	the	total	number	of	species.	Pantanal	was	the	biome	with	the	higher	
percentage	of	medicinal	species	when	compared	to	the	total	flora	(12%),	followed	by	
the	Caatinga	(8%),	Cerrado	(5%),	Atlantic	Forest	(4%),	Pampas	(3%)	and	Amazon	(2%).		
	
	
Figure	5-3.	Distribution	and	number	of	species	with	ethnomedicinal	use	and	records	
for	each	biome	in	Brazil.			
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5.3.2.1	 Taxonomic	 beta	 diversity	 (or	 the	 relationship	 between	medicinal	 flora	 and	
overall	flora)	
	 Taxonomic	 beta	 diversity	 analysis	 shows	 that	 changes	 in	 the	 species	
composition	 of	 medicinal	 floras	 between	 different	 biomes	 is	 overall	 more	 different	
than	expected	when	compared	to	floristic	changes.	Analyses	at	generic	level	(appendix	
8)	 show	 the	 same	pattern,	with	 the	 composition	 of	medicinal	 floras	 at	 generic	 level	
more	different	than	the	composition	of	floras.	When	endemic	species	for	each	biome	
are	excluded	 this	 result	 is	 still	present,	but	 the	 relation	between	medicinal	 flora	and	
total	flora	changes	between	some	pairs	of	biomes	(Table	5-1).		
	
	
Table	5-1	Dissimilarity	matrices	at	species	level	for	medicinal	plant	use	(lower	diagonal)	
and	 total	 flora	 (upper	 diagonal)	 in	 the	 Brazilian	 Biomes.	 Green	 colour	 indicates	 a	
smaller	difference	in	the	medicinal	flora	than	in	the	total	flora.	Red	colour	indicates	a	
larger	difference.	
A	 Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	 Pantanal	
Amazon	 	 0.77	 0.64	 0.73	 0.82	 0.46	
Atlantic	 0.59	
	
0.48	 0.59	 0.31	 0.38	
Caatinga	 0.72	 0.61	
	
0.33	 0.80	 0.56	
Cerrado	 0.65	 0.60	 0.63	
	
0.62	 0.28	
Pampa	 0.84	 0.46	 0.81	 0.58	
	
0.74	
Pantanal	 0.82	 0.65	 0.74	 0.42	 0.89	 	
	 	 	 	 	 	 		
The	Mantel	 test	 revealed	a	 significant	 similarity	between	medicinal	 plant	use	
and	total	flora	at	species	level,	for	the	Brazilian	biomes	(r=0.7101,	p<0.05)	and	also	at	a	
generic	level	(r=0.7101,	p<0.05)	(Figure	5.4).		
	
Chapter	5	Spatial	structure	in	the	distribution	of	traditional	knowledge	
	 85	
	
Figure	5-4.	Clusters	based	on	beta	similarity	for	medicinal	plant	use	and	total	flora	in	
the	Brazilian	Biomes.	A-	medicinal	plant	use	at	 species	 level.	B-	 total	 flora	at	 species	
level.	C-	medicinal	plant	use	at	generic	level.	D-	total	flora	at	generic	level.	
	
	
5.3.2.2	Phylogenetic	structure	and	beta	diversity	
	
	 Overall,	medicinal	plants	are	phylogenetically	clustered	in	Brazil,	meaning	that	
medicinal	 genera	 are	more	 related	 to	 each	 other	 than	 expected	 by	 chance	 at	 both	
deep	and	shallow	phylogenetic	nodes	 (NRI	and	NTI).	Considering	 the	whole	Brazilian	
flora,	 the	 five	biomes	Amazon	Forest,	Atlantic	Forest,	Caatinga,	Cerrado	and	Pampas	
also	showed	significant	phylogenetic	clustering,	but	the	Pantanal	did	not	(Table	5-2).		
	 	
A B 
C D 
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Table	5-2.	Phylogenetic	structure	for	the	Brazilian	flora	overall,	according	to	medicinal	
plant	use,	and	for	each	Brazilian	biome.	
		 		 		 MPD	 		 		 MNTD	 		
		 ntaxa	 mpd.obs	 NRI	 p-value	 mntd.obs	 NTI	 p-value	
Brazil	 710	 261.7496	 13.0461	 0.001	 58.7713	 7.2529	 0.001	
Amazon	 200	 258.8319	 8.2827	 0.001	 79.2895	 3.5733	 0.001	
Atlantic	 430	 261.13	 10.554	 0.001	 63.0911	 6.3334	 0.001	
Caatinga	 247	 243.9496	 11.9223	 0.001	 73.3218	 4.5516	 0.001	
Cerrado	 374	 257.1855	 10.5437	 0.001	 65.4044	 5.77	 0.001	
Pampas	 53	 235.1347	 5.619	 0.001	 94.9478	 3.21	 0.001	
Pantanal	 107	 279.9804	 1.9211	 0.001	 108.258	 0.4272	 0.217	
	
	Significant	phylogenetic	relatedness	was	observed	between	all	pairs	of	biomes	
for	medicinal	plant	use	according	to	the	bNRI	index	(both	with	and	without	abundance	
data).	According	to	the	bNTI	index,	with	and	without	abundance,	the	Amazon	Forest-
Cerrado,	 Amazon	 Forest-Pampas,	 Atlantic	 Forest-Pampas	 and	 Caatinga-Pampas	 pairs	
were	 significantly	 related.	 One	 additional	 pair	 Cerrado-Pampas,	 was	 significantly	
clustered	when	only	when	abundance	data	is	considered.	(Table	5-3).	Overall,	there	is	
an	indication	of	medicinal	families	and	genera	used	in	Pantanal	to	be	more	distant	to	
the	ones	used	in	other	biomes	(table	5-3A).	Notably,	the	values	for	bNTI	suggest	some	
genera	 used	 in	 Pantanal	 find	 no	 close	 relatives	 in	 other	 biomes,	 but	 considering	
abundance	data,	there	may	be	few	records	of	such	genera	being	used.	
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Table	 5-3.	 Phylogenetic	 beta	 diversity	 indices	 from	 the	 “comdist”	 and	 “comdistnt”	
analysis	in	Phylocom.	Upper	diagonal=	bNTI	index.	Lower	diagonal=	bNRI	index.	Values	
in	bold	have	p>0.05.	A-	without	abundance	data.	B-	with	abundance	data		
	A	 Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	 Pantanal	
Amazon	 	 2.98	 2.62	 2.59	 1.64	 -0.50	
Atlantic	 10.71	 	 3.51	 3.94	 1.49	 -2.20	
Caatinga	 11.83	 12.58	 	 3.65	 2.59	 -1.29	
Cerrado	 10.61	 11.58	 12.56	 	 0.66	 -2.04	
Pampa	 8.29	 8.12	 8.99	 7.98	 	 0.23	
Pantanal	 5.41	 5.36	 6.32	 5.33	 5.01	 	
	
B	 Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	 Pantanal	
Amazon	 	 5.23	 2.17	 4.23	 4.35	 1.33	
Atlantic	 8.32	 	 4.74	 3.53	 7.60	 5.69	
Caatinga	 8.06	 9.14	 	 3.16	 5.03	 1.84	
Cerrado	 7.73	 9.10	 8.92	 	 7.14	 5.35	
Pampa	 7.46	 8.43	 7.85	 7.56	 	 0.72	
Pantanal	 4.12	 5.15	 5.09	 4.49	 4.70	 	
	
Taxonomic	beta	diversity	 is	higher	than	phylogenetic	beta	diversity,	 indicating	
turnover	between	biomes	within	lineages	(table	5-4).	
	
Table	5-4.	Beta	diversity	values	for	each	pair	of	biomes,	according	to	medicinal	plant	use	at	
generic	level.	Upper	diagonal-	taxonomic	beta	diversity.	Lower	diagonal-	Phylogenetic	beta	
diversity.		
	
Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	 Pantanal	
Amazon	 	 0.60	 0.59	 0.56	 0.83	 0.67	
Atlantic	 0.44	 	 0.54	 0.44	 0.84	 0.72	
Caatinga	 0.42	 0.40	 	 0.49	 0.84	 0.65	
Cerrado	 0.40	 0.32	 0.34	 	 0.82	 0.64	
Pampa	 0.64	 0.72	 0.65	 0.69	 	 0.78	
Pantanal	 0.48	 0.55	 0.48	 0.48	 0.60	 	
	
	 Turnover	 component	 with	 a	 higher	 value	 at	 the	 taxonomic	 beta	 diversity	
suggests	that	close	relatives	are	selected	when	species	turn	over	between	all	pairs	of	
biomes	(Table	5-5).		
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Table	5-5.	Turnover	component	of	beta	diversity	indices	for	each	pair	of	biomes,	
according	to	medicinal	plant	use	at	generic	level.	Upper	diagonal-	taxonomic	beta	
diversity.	Lower	diagonal-	Phylogenetic	beta	diversity.		
	
Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	 Pantanal	
Amazon	 	 0.37	 0.54	 0.37	 0.58	 0.53	
Atlantic	 0.24	 	 0.37	 0.40	 0.26	 0.31	
Caatinga	 0.38	 0.24	 	 0.36	 0.55	 0.42	
Cerrado	 0.23	 0.29	 0.21	 	 0.26	 0.20	
Pampa	 0.27	 0.11	 0.22	 0.10	 	 0.66	
Pantanal	 0.38	 0.23	 0.33	 0.16	 0.37	 	
	
The	 Principal	 Components	 of	 Phylogenetic	 Structure	 found	with	 the	 first	 two	
being	 responsible	 for	72%	of	 total	variation	 (appendix	9).	There	 is	a	higher	 similarity	
between	Caatinga	and	Pampas	and	the	Amazon-Atlantic-Cerrado,	having	the	Pantanal	
as	an	outlier	(Figure	5-5,	appendix	10).		
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Figure	5-5.	Heatmap	showing	the	distances	for	each	genera	to	a	specific	biome,	
obtained	 from	 the	pcps	 analysis.	A-Pantanal.	 B-	 Pampas.	C-	Cerrado.	D-	Caatinga.	 E-	
Atlantic	Forest.	F-	Amazon	Forest.	Distances	are	shown	as	blue	for	smaller	distances	to	
red	for	higher	distances.	Figure	prepared	using	 iTOL	online	(Letunic	and	Bork,	2016).
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5.3.2.3	Therapeutic	applications	
	
	 A	total	of	864	records	with	514	species	and	318	genera	 (15%	of	 records)	had	
information	 on	 therapeutic	 application.	 The	 most	 cited	 categories	 were	 Others,	
followed	 by	 DDS	 and	 DRS.	 The	 total	 number	 of	 records	 for	 each	 therapeutic	
application	category	for	each	biome	is	presented	on	table	5-6.	A	Spearman	rank	order	
correlation	test	showed	there	was	no	significant	difference	between	almost	all	biomes	
in	 terms	of	 the	relative	proportions	of	 therapeutic	applications,	but	 the	Amazon	and	
the	Pampas,	and	Caatinga	and	the	Pampas	(appendix	11).		
	
Table	5-6.	Distribution	of	therapeutic	applications	in	each	biome	in	Brazil,	according	to	
data	collected	from	herbarium	vouchers.	
Therapeutic	
Application	
Categories	 Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	 Pantanal	
	DBI	 8	 9	 7	 7	 1	 3	
	DCS	 2	 24	 6	 19	 2	 0	
	DDS	 24	 104	 25	 53	 3	 6	
	DEA	 2	 4	 1	 5	 0	 1	
	DFS	 4	 19	 11	 21	 0	 1	
	DGS	 6	 41	 12	 25	 1	 6	
	DMC	 4	 15	 12	 16	 1	 1	
	DNS	 0	 4	 7	 0	 0	 0	
	DRS	 12	 75	 36	 49	 0	 1	
	DSS	 3	 21	 4	 11	 1	 1	
	ENM	 8	 16	 11	 8	 0	 0	
	IPD	 4	 20	 11	 14	 0	 2	
	Neo	 0	 5	 0	 4	 0	 0	
	OTHERS	 124	 123	 43	 45	 3	 5	
	PCP	 1	 1	 1	 2	 0	 0	
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5.4	 Discussion	
5.4.1	 Data	 mining	 from	 herbarium	 specimens:	 how	 many	 plant	 species	 used	 in	
medicine?	
	
Meta-analyses	 have	 the	 potential	 to	 contribute	 to	 deeper	 understanding	 of	
patterns	in	plant	use	(de	la	Torre	et	al.	2012;	de	Medeiros	et	al.	2013;	Saslis-Lagoudakis	
et	al.	2012a;	Weckerle	et	al.	2011).	Existing	meta-analyses	have	used	data	synthesized	
from	the	literature.	Here,	instead	of	using	published	sources,	data	were	compiled	from	
online	 herbarium	 vouchers,	 an	 approach	 validated	 through	 research	 carried	 out	 for	
this	PhD	study	(Chapter	2;	Souza	and	Hawkins,	2017)	and	provisioning	a	rich	dataset,	
not	only	in	terms	of	the	high	number	of	species	with	medicinal	use,	but	also	in	terms	
of	 the	 spatial	 distribution	 of	 uses.	 The	 use	 of	 almost	 2	 000	 species	 has	 been	
documented.	Previously	 there	have	been	medicinal	plant	checklists	 for	 regions	 (Agra	
et	 al.	 2008,	 2007;	Guarim-Neto	 and	Morais,	 2003),	 but	 this	 is	 the	 first	 country-wide	
estimate	 of	 the	 number	 of	 medicinal	 plants	 in	 Brazil.	 Proportionally,	 2	 000	 species	
represent	only	6%	of	the	Brazilian	flora.	Schippmann	et	al.	(2006)	estimated	17.1%	of	
species	 used	 in	medicine,	 based	 on	 figures	 for	 15	 countries,	 including	Malaysia,	 the	
country	 with	 the	 lowest	 proportion	 of	 plant	 species	 used	 in	medicine	 with	 7.7%	 of	
species	used.	The	State	of	the	World’s	Plants	report	2017	(Alkin	et	al.	2017)	reported	
8.3%	of	plant	species	used	in	medicine	based	on	the	number	of	names	in	the	Medicinal	
Plants	Names	service	database.	Our	data	supposes	Brazil	has	the	lowest	proportion	of	
medicinal	plants	yet	reported.	Whether	this	might	be	due	to	poor	data	availability,	or	
to	a	real	deficit	of	medicinal	plant	use	can	be	considered.	All	our	data	are	drawn	from	
digitized	 herbarium	 specimens,	 and	 this	 probably	 contributes	 to	 underestimation	 of	
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the	 number	 of	 medicinal	 plant	 species.	 A	 comparison	 of	 reports	 from	 digitized	
herbarium	 and	 literature	 sources	 showed	 154	 and	 264	 species	 respectively	 for	
Leguminosae	used	for	medicine	in	Brazil	(Souza	and	Hawkins,	2017;	Chapter	2).	If	the	
same	proportion	(42%)	of	all	plant	species	are	not	captured	by	herbarium	survey,	we	
might	expect	literature	survey	to	identify	as	many	as	3,400	species	used	in	medicine.	
Though	still	less	than	10%	of	the	total	flora,	in	this	case	our	estimate	for	Brazil	would	
fall	within	the	range	reported	by	Schippman	et	al.	(2006).		
	
Neither	herbarium	nor	literature	survey	would	be	expected	to	record	all	uses,	
since	 there	 is	a	need	 for	more	 fieldwork	 in	ethnobotany	 (Cámara-Leret	et	al.	2014a;	
Souza	and	Hawkins,	2017).	For	the	study	of	spatial	heterogeneity	in	plant	use,	 it	may	
be	more	 important	that	there	are	no	biases,	where	under	recording	 is	one	source	of	
bias.	Research	using	 literature	 reports	can	 infer	 spatial	distribution	 from	studies,	but	
overall	 few	 study	 sites	 can	 be	 included.	 In	 chapter	 3,	 86%	 of	 total	 localities	 in	 our	
database	 of	 medicinal	 Leguminosae	 were	 from	 herbarium	 data,	 showing	 more	
complete	distribution	data	from	herbarium	specimens.		
		
5.4.2	 An	overview	of	the	spatial	distribution	of	uses:	how	good	is	the	spatial	data?		
	
	 Data	were	assigned	to	the	six	Brazilian	biomes,	permitting	spatial	analysis	at	a	
regional	scale.	There	is	variation	in	the	number	of	records	between	biomes,	with	the	
Atlantic	 Forest	 and	 the	 Cerrado	with	 the	 highest	 number,	 and	 the	 Pampas	 and	 the	
Pantanal	the	lowest	(Figure	5-3).	This	reflects	the	availability	of	digitized	data	in	online	
sources,	 and	 could	 be	 related	 the	 activity	 of	 research	 groups	 in	 these	 areas.	 More	
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reports	are	 from	 localities	 in	 the	Caatinga,	Cerrado	and	Atlantic	Forest,	where	active	
ethnobotanical	 research	 programmes	 are	 associated	 with	 the	 largest	 universities	 in	
Brazil.	 Fewer	 are	 from	 the	 Amazon,	 which	 is	 well-known	 to	 be	 relatively	 under-
documented	 (Cámara-Leret	et	al.	2014;	Ritter	et	al.	2015;	Souza	and	Hawkins,	2017;	
Chapter	 2).	 However,	 it	 has	 also	 been	 suggested	 that	 people	 with	 relatively	 low	
acculturation	may	use	fewer	plant	species	for	medicine	(Vandebroek	et	al.	2004),	and	
this	 might	 also	 contribute	 to	 real	 relatively	 low	 counts	 for	 medicinal	 plants	 in	 the	
Amazon.	 The	 relatively	 species-poor	 Pantanal	 and	 Pampas	 have	 a	 low	 number	 of	
records,	 though	 at	 12%	 the	 Pantanal	 has	 the	 highest	 proportion	 of	 species	 with	
recorded	medicinal	use.	Ultimately,	 the	significant	 similarity	between	 taxonomic	and	
medicinal	 beta-diversity	 suggests	 that	 data	 are	 not	 spatially	 biased.	 However,	 the	
impact	of	 removing	endemic	 species	points	 towards	a	bias	 in	our	data	 for	 recording	
“interesting”	endemic	species.	
	
5.4.3	 Taxonomic	beta	diversity:	greater	than	expected	
	
Beta	 diversity	 measures	 the	 similarity	 or	 dissimilarity	 in	 species	 composition	
amongst	 sites	 (Whittaker,	 1972).	We	 calculated	 taxonomic	 beta	 diversity,	 at	 species	
and	genus	level,	recording	beta	diversity	for	both	floristic	compositions	overall,	and	for	
the	 medicinal	 floras	 of	 biomes.	 Overall,	 floristic	 similarity	 predicted	 similarity	 of	
medicinal	plants	use	 (p<0.05),	meaning	 the	more	similar	 the	 floras,	 the	more	similar	
the	medicinal	 plants.	However,	 although	 floristically	 similar	 biomes	 are	more	 similar	
medicinally,	the	plants	used	are	very	different,	with	at	least	42%	and	as	many	as	89%	
of	species	used	differing	between	biomes.	This	difference	is	nearly	always	greater	than	
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expected,	given	 floristic	differences	between	biomes.	Cultivated	species	are	 included	
in	 this	 calculation	 (10%	of	medicinal	plants).	Nevertheless,	 significantly	more	 (12/15;	
p<0.05	 pairwise)	 comparisons	 showed	 greater	 difference.	 However,	 Brazil	
encompasses	culturally	diverse	indigenous	and	rural	communities	(Araújo	et	al.	2007;	
Deus,	 2011;	 Fleury,	 1999;	 Little,	 2002).	 That	 the	 medicinal	 plants	 are	 more	
heterogeneous	 than	 expected	 under	 our	 null	 model	 suggests	 interaction	 of	 culture	
with	 environment	 increases	 spatial	 heterogeneity	 in	 plant	 use.	 However,	 differing	
demand	 for	 treatment	 does	 not	 appear	 to	 be	 a	 driver	 of	 this	 differentiation,	 since	
therapeutic	 applications	 showed	 no	 difference	 between	 biomes	 according	 to	 a	
Spearman	rank-order	correlation	test	(p<0.05).	
	
5.4.4	 Phylogenetic	structure:	significant	structure	at	deep	and	shallow	levels		
	
Phylogenetic	 analyses	 show	 that	 medicinal	 plant	 use	 in	 Brazil	 is	 significantly	
phylogenetically	 clustered	 at	 deep	 (MPD)	 and	 at	 tip	 (MNTD)	 levels,	 in	 other	 words	
medicinal	plants	are	more	closely-related	to	each	other	than	expected	by	chance.	This	
overall	 clustering	 was	 expected,	 since	 medicinal	 plant	 use	 is	 often	 reported	 as	
phylogenetically	 structured	 in	 other	 floras	 and	 taxa	 (Ernst	 et	 al.	 2016;	 Forest	 et	 al.	
2007;	Grace	et	al.	2015;	Lukhoba	et	al.	2006;	Rønsted	et	al.	2008;	Saslis-Lagoudakis	et	
al.	 2015;	 Saslis-Lagoudakis	 et	 al.	 2012a).	 Only	 the	 Pantanal	 showed	 non-significant	
clustering	 of	 medicinal	 plant	 use,	 at	 tip	 (MNTD)	 level.	 Although	 one	 possible	
explanation	 could	 be	 because	 of	 the	medicinal	 use	 in	 the	 Pantanal	 of	 a	waterlily,	 a	
single	species	that	is	phylogenetically	very	distinctive,	further	tests	that	excluded	this	
species	 still	 presented	 the	 same	 result.	 These	 tests	 indicate	 that,	 although	 the	
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medicinal	 use	 of	 a	waterlily	may	 contribute	towards	 the	 overdispersion,	 it	 is	 not	 its	
sole	 cause,	 and	 that,	 the	 remaining	 medicinally	 used	 species	 in	 Pantanal	 are	 more	
distantly	related	than	expected.	
The	tests	for	clustering	are	interpreted	further	in	the	light	of	the	turn-over,	or	
beta	 diversity,	 of	 species	 across	 biomes.	 Saslis-Lagoudakis	 et	 al.	 (2015),	 referred	 to	
“phylogenetic	replacement”,	specifically	 in	the	context	of	migrant	communities.	They	
noted	that	many	authors	had	observed	that	when	there	is	a	preference	for	a	plant	not	
available	 to	 a	migrant	 community,	 a	 close	 relative	 is	 used	 in	 its	 place.	 Phylogenetic	
replacement,	 at	 the	 level	 of	 whole	 medicinal	 floras	 under	 comparison,	 can	 be	
identified	using	tests	of	phylogenetic	beta	diversity.	
		
5.4.5	 Phylogenetic	beta	diversity	
	
Phylogenetic	distances	between	species	used	in	different	biomes:	whether	or	
not	abundance	is	considered,	phylogenetic	measures	show	medicinal	plant	use	is	more	
similar	 than	 expected	 for	 all	 deep	 node	 comparisons.	 Relatedness	 at	 deep	 nodes	 is	
attributed	to	shared	preference	 for	some	of	 the	 lineages	common	across	all	biomes.	
Cross-cultural	 studies	 comparing	 floras	 from	 different	 floristic	 kingdoms	 using	 the	
same	 methodology	 have	 shown	 similar	 results	 (Saslis-Lagoudakis	 et	 al.	 2012a).	 The	
regions	compared	here	are	 in	closer	geographical	proximity	with	greater	opportunity	
for	 knowledge	 transfer.	Nevertheless,	 only	 four	 of	 15	 comparisons	 are	 significant	 at	
shallow	 phylogenetic	 level	 though	 they	 all	 indicate	 clustering	 when	 abundance	 is	
considered.	 The	measure	 used	 to	 assess	 shallow	 relationship	 is	 very	 stringent,	 only	
considering	closely	related	species,	and	this	study	is	at	generic	level,	that	could	reduce	
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the	signal	of	phylogenetic	replacement.	Yet	still	there	is	evidence	of	this	phenomenon.	
When	 abundance	 is	 not	 considered,	 the	medicinal	 plants	 of	 the	 Pantanal	 are	more	
different	 than	 expected	 at	 tip	 nodes.	 We	 attribute	 this	 to	 the	 use	 of	 abundant	
phylogenetically	 isolated	 species	 adapted	 to	 this	 wetland	 biome,	 such	 as	 waterlilies	
used	medicinally	only	in	the	Pantanal.		
	
	 Phylogenetic	beta	diversity	compared	to	taxonomic	beta	diversity:	taxonomic	
beta	 diversity	 indices	 measure	 how	 species	 composition	 changes	 in	 space,	 and	
phylogenetic	 beta	 diversity	 shows	 how	 phylogenetic	 relatedness	 changes	 in	 space	
(Graham	 and	 Fine,	 2008).	 The	 comparison	 of	 taxonomic	 and	 phylogenetic	 beta	
diversity,	 especially	 the	 turnover	 components	 of	 such	 indices,	 indicate	 whether	 the	
species	differences	are	attributed	to	alternative	species	 from	closely-related	 lineages	
being	represented	in	samples	(Souza-Neto	et	al.	2016).	Here,	indices	for	phylogenetic	
beta	diversity	are	lower	than	the	ones	for	taxonomic	beta	diversity,	providing	evidence	
for	phylogenetic	replacement.	Unlike	the	taxonomic	beta	diversity,	phylogenetic	beta	
diversity	shows	that	the	medicinal	plants	are	more	similar	to	each	other	than	would	be	
expected	given	phylogenetic	measures	of	 floristic	differences.	Despite	 the	taxonomic	
heterogeneity	 of	 the	 medicinal	 plant	 landscape,	 phylogenetic	 replacement	 is	 a	
homogenizing	force.		Heterogeneity	because	of	different	species	use	is	contrasted	with	
phylogenetic	 continuity	 suggestive	 of	 relative	 uniformity	 of	 traditional	 knowledge	
across	Brazil.		The	geographical	extent	of	vernacular	names	in	Portuguese	to	describe	
related	 Brazilian	 medicinal	 plants	 supports	 the	 view	 that	 traditional	 knowledge	 of	
related	 plants	 extends	 beyond	 the	 limits	 of	 individual	 species	 (Souza,	 unpublished).	
Generic	 complexes	 are	 a	well-known	 phenomenon	 to	 ethnobotanists	 (Berlin,	 1973),	
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but	 formal	 comparative	 studies	 of	 the	 spatial	 extent	 of	 names	 beyond	 species	
distributions	are	lacking.		
	
Principal	Component	of	Phylogenetic	Structure	(PCPS):	PCPS	has	been	used	in	
ecology	 to	 identify	 lineages	 contributing	 to	 the	 phylogenetic	 differences	 between	
communities	(Brum	et	al.	2012;	Carlucci	et	al.	2017;	Duarte	et	al.	2014,	2012;	Gianuca	
et	al.	2014;	Pillar	and	Duarte,	2010).	Applied	here	for	the	first	time	to	medicinal	floras,	
it	is	used	to	identify	lineages	contributing	the	differences	between	medicinal	floras	of	
the	different	biomes.	The	first	two	principal	components	in	our	study	are	responsible	
for	 72%	 of	 the	 variation	 found	 between	 biomes,	 and	 correspond	 to	 deep	 lineage	
differences	 (appendices	 8	 and	 9).	 Although	 significantly	 clustered	 at	 deep	 lineages,	
there	are	preferences	for	medicinal	plants	that	differ	between	biomes.	PCPS	identifies	
the	 lineages	 which	 account	 for	 the	 relatively	 high	 phylogenetic	 distances	 between	
medicinal	 plants	 of	 Caatinga,	 Pampas	 and	 Pantanal	 biomes.	 Cerrado,	 Amazon	 and	
Atlantic	medicinal	 plants	 are	 relatively	 similar	 at	 deep	 phylogenetic	 levels	 -	 Pampas	
and	 Caatinga	 differ	 from	 these	 because	 of	 the	 relatively	 few	 monocots+magnoliids	
used,	 whereas	 Pantanal	 medicinal	 floras	 differ	 from	 the	 Cerrado/Amazon/Atlantic	
cluster	 because	 of	 the	 over-use	 of	 monocots+magnoliids.	 These	 data,	 focused	 on	
deeper	phylogenetic	levels	are	not	indicative	of	phylogenetic	replacement	but	indicate	
deep	lineages	where	phylogenetic	replacement	is	more	likely.		
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5.4.6	 Conclusions	
	
	 Medicinal	plant	knowledge	has	been	characterized	both	as	deep,	the	result	of	
generations	of	experimentation	in-situ,	and	as	readily	transmitted.	The	two	processes	
exert	 opposite	 influences,	 the	 former	 driving	 towards	 strong	 spatial	 structure	 in	
knowledge,	and	the	latter	towards	a	more	homogeneous	landscape	of	medicinal	plant	
use.	This	study	shows	that	medicinal	plant	use	is	not	homogeneous	across	Brazil.	It	is	
well-known	 that	plant	use	 can	vary	at	 small	 spatial	 scales	where	cultural	differences	
are	 strong,	 and	 this	 has	 been	 documented	 for	 traditional	 knowledge	 of	 medicinal	
plants	in	Brazil	(Shepard,	2004).	At	a	landscape	scale,	our	data	also	point	towards	local	
knowledge.	Plant	use	in	Brazil	is	more	different	than	predicted	by	floristic	differences	
at	 species	 level.	 This	 difference	 is	 despite	 a	 preference	 for	 some	 plant	 groups,	
significant	migration	and	homogeneity	in	terms	of	language	–	three	potential	drivers	of	
uniformity	 in	plant	use.	 In	Brazil,	 the	 influence	of	 the	 local	environment	 in	medicinal	
plant	selection	has	been	documented	(Albuquerque	et	al.	2005;	de	Albuquerque	and	
de	 Oliveira,	 2007),	 through	 analysis	 of	 local,	 species	 level	 data.	 Using	 methods	
borrowed	 from	 ecological	 studies	 to	 understanding	 changes	 in	 plant	 composition	 in	
different	environments,	we	shed	light	on	distribution	of	medicinal	plant	knowledge	in	
relation	to	floristic	environment,	but	on	a	much	larger	scale.	These	Brazilian	data	might	
serve	as	benchmarks	 for	 future,	more	global	studies	of	 the	distribution	of	 traditional	
knowledge.		
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Chapter	6 General	discussion	and	conclusions	
	
6.1	 Novel	contributions	
	
This	thesis	describes	my	exploration	of	ethnobotanical	documentation	together	
with	phylogenetic	and	spatial	patterns	in	species	with	medicinal	use	in	Brazil.	Brazil	has	
one	 of	 the	 world’s	 richest	 floras	 (Forzza	 et	 al.	 2012),	 distributed	 in	 six	 different	
environments	 called	 biomes.	 The	 association	 of	 floristic	 environments	with	 different	
cultural	 expressions	 is	 reflected	 in	 the	 rich,	 though	 not	 homogeneous,	 traditional	
knowledge	present	 in	Brazil.	With	 a	 history	 of	migration	 and	 colonization,	medicinal	
plant	 use	 in	 Brazil	 that	 once	 was	 part	 of	 local	 indigenous	 knowledge,	 adapted	 and	
evolved	 to	 encompass	 traditional	 knowledge	 from	 other	 populations	 that	moved	 to	
Brazil	 (Voeks,	 2013).	 Plant	 knowledge	 began	 to	 be	 described	 and	 compiled	 in	 the	
1800’s	 (Brandão	 et	 al.	 2012),	 and	 since	 then,	 the	 number	 of	 ethnobotanical	
investigations	 has	 increased	 significantly	 (Ritter	 et	 al.	 2015).	 From	 its	 origins	
documenting	 traditional	 knowledge,	 ethnobotanical	 research	 has	 begun	 to	 address	
broader	 questions	 searching	 for	 patterns,	 such	 as	 similarities	 or	 differences	 in	
medicinal	plant	use,	and	seeking	to	explain	them.	Often	research	of	this	kind	is	based	
on	published	data	(de	Medeiros	et	al.	2013).	
	
In	 this	 study,	 chapter	 2	 investigated	 the	 role	 of	 herbarium	 specimens	 in	
providing	 information	 for	 ethnobotanical	 research.	 By	 comparing	 information	 from	
Chapter	6	General	discussion	and	conclusions	
	 100	
published	 sources	 and	 herbarium	 data	 I	 showed	 that	 herbaria	 are	 underutilized	
sources	of	ethnobotanical	information.	Despite	the	potential	of	herbaria	to	contribute	
to	 new	 species	 to	 lists,	 and	new	 information	 for	 species	 already	documented	 in	 the	
literature,	 the	 comparison	 I	 made	 here	 draws	 attention	 to	 arguments	 for	 better	
documentation	of	data	associated	with	herbarium	collections,	especially	in	the	light	of	
increasing	digitisation	(Blagoderov	et	al.	2012;	Thiers	et	al.	2016).	
	
To	manage	the	data	compiled	for	species	of	Leguminosae	with	use	medicinally,	
I	 developed	 a	 database,	 described	 in	 chapter	 3.	 Besides	 storing	 data,	 Ewé	 also	
provided	 tools	 that	 supported	 some	 of	 the	 analyses	 that	 were	 used	 in	 my	 thesis	
research,	 such	as	 identifying	 the	most	 reported	genera	and	 their	uses,	 and	mapping	
the	distribution	of	medicinal	use	of	plant	species.	Although	data	present	in	Ewé	to	date	
relates	 to	medicinal	 uses	 of	 Leguminosae	 in	 Brazil,	 there	 is	 potential	 to	 expand	 the	
database	to	include	the	whole	medicinal	flora	of	Brazil,	and	develop	co-participation	in	
populating	and	maintaining	the	database.	
	
Medicinal	plants	are	important	not	only	in	traditional	health	systems,	but	also	
as	sources	of	biomedical	drugs	 (Fabricant	and	Farnsworth,	2001;	Gurib-Fakim,	2006).	
Bioprospecting	could	be	informed	by	phylogeny	(Saslis-Lagoudakis	et	al.	2012a),	but	in	
Brazil	 such	methodology	 has	 never	 been	 applied.	 Using	 the	 data	 I	 compiled,	 it	 was	
possible	 to	 investigate	 patterns	 in	 the	 phylogenetic	 distribution	 of	 species	 with	
medicinal	use,	 in	order	 to	 identify	 lineages	 that	could	be	 targeted	 in	bioprospecting.	
This	 work	 is	 described	 in	 chapter	 4.	 By	 relating	 pharmacological	 study	 for	 the	
Leguminosae	to	use	data,	I	found	50%	of	species	used	medicinally	had	been	screened.	
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In	a	phylogenetic	framework	I	showed	lineages	rich	in	species	with	medicinal	use	were	
better	 characterised.	 Although	 phylogenetic	 studies	 had	 not	 been	 used	 in	 Brazil	 to	
guide	 investment	 in	 pharmacological	 study,	 research	effort	was	 greater	 in	 groups	of	
closely-related	species	that	included	significantly	more	plants	used	in	medicine.		
	
Chapter	5	explored	the	spatial	distribution	of	traditional	knowledge,	also	using	
data	compiled	from	herbaria,	but	for	all	Angiosperms	in	Brazil.	With	more	than	7	000	
records	distributed	amongst	the	six	Brazilian	biomes,	it	was	possible	to	identify	spatial	
heterogeneity	 in	 plant	 use,	 characterised	 by	 a	 greater	 turn-over	 in	 plants	 with	
medicinal	 use	 than	 the	 floristic	 turn	over.	 In	 this	 chapter,	 I	 used	methods	borrowed	
from	 ecology	 and	 biogeography	 to	 investigate	 species	 composition	 change	 between	
regions,	anticipating	that	future	research	could	be	based	on	similar	methodology	to	be	
able	to	compare	results.		
	
6.2	 Data	mining		
	
	 Three	sources	of	data	were	used	for	this	thesis	work.	All	were	compiled	from	
existing	 available	 data.	 Firstly,	 traditional	 knowledge	 related	 to	 medicinal	 plant	 use	
was	sourced	from	the	scientific	literature	and	from	herbarium	vouchers.	The	intensity	
of	 research	effort	 relating	 to	pharmacological	 studies	of	 the	 Leguminosae	 species	of	
Brazil	 was	 estimated	 by	 searching	 the	 scientific	 literature.	 Thirdly,	 the	 phylogenetic	
frameworks	 used	 to	 interpret	 the	 pharmacological	 and	 the	 spatial	 data	 were	
reconstructed	 using	 DNA	 sequences	 from	 public	 databases,	 existing	 phylogenetic	
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hypotheses	 and	 inferences	 about	 relationship	 from	 existing	 taxonomies.	 Although	
much	 research	 is	 based	on	primary	data	 collected	 in	 the	 field	or	 laboratory,	 science	
today	 is	 frequently	 based	 on	 data	 mining	 as	 research	 in	 biology	 and	 health	 care	
becomes	increasingly	data	intensive	(Aronova	et	al.	2010;	Birney,	2012;	Liu	et	al.	2012;	
Thessen	 and	 Patterson,	 2011).	 Data	 mining	 can	 be	 challenging,	 particularly	 when	
information	is	scattered	in	different	places	and	data	is	presented	in	a	complex,	weakly-
structured	way,	as	is	often	the	case	in	ethnobotany	(Albuquerque	and	Medeiros,	2012).	
There	 is	 likely	a	reciprocity	between	research	using	primary	and	secondary	data.	The	
work	presented	here,	based	on	secondary	data,	might	influence	what	data	is	collected	
and	where	it	is	collected	in	the	future.		
	
	 The	 first	 task	 I	 took	 on	 in	 this	 project	 was	 data	 mining	 from	 literature	 and	
herbaria.	Ethnobotanical	literature	is	increasing	in	Brazil,	remarkably	since	2010	(Ritter	
et	 al.	 2015).	 Although	 access	 to	 these	 papers	 was	 easy	 through	 tools	 like	 Google	
Scholar	 and	Web	 of	 Knowledge,	 data	 collection	 and	 information	 quality	 assessment	
from	 each	 paper	 was	 time	 consuming.	 Despite	 increasing	 efforts	 to	 develop	 and	
benefit	from	text	mining	tools	(Fan	et	al.	2006),	there	is	a	lack	of	a	proper	ontology	in	
ethnobotanical	data,	and	species	names,	therapeutic	applications	and	preparations	are	
presented	 in	 a	 diversity	 of	 ways	 (Christie,	 2006;	 Daly	 et	 al.	 2016;	 Ellen,	 2016).	
Therefore,	 traditional	 knowledge	data	 generally	 needs	 to	 be	manually	 compiled	 and	
standardised	prior	to	further	comparison.	Compilation	of	herbarium	data	is	influenced	
by	access	to	herbarium	vouchers	and	availability	of	information	on	the	vouchers	labels.	
The	 digitisation	 of	 herbarium	 vouchers	 greatly	 benefited	 this	 thesis	 research,	 which	
used	 voucher	 information	 from	 CRIA-Species	 link,	 a	 Brazilian	 online	 biological	
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collection.	Not	all	herbaria	are	yet	digitised,	and	 lack	of	uniformity	 in	 compilation	of	
information	from	labels	can	be	a	barrier.	CRIA-Species	link	transcribed	label	data,	so	I	
could	search	for	key	words.	Generally	labels	are	not	transcribed	in	full,	and	a	system	of	
core	 descriptors	 are	 used	 by	 most	 major	 herbaria	 (Wieczorek	 et	 al.	 2012).	 Most	
digitised	 herbarium	 collections	 cannot	 therefore	 be	 used	 to	 provision	 data	 for	
ethnobotanical	 meta-analysis.	 Also,	 as	 found	 in	 this	 study	 many	 times,	 information	
from	herbarium	vouchers	can	be	 incomplete	 if	 label	text	 is	only	partially	transcribed.	
This	was	true	for	both	traditional	use	information	and	geographical	coordinates,	which	
were	missing	or	gave	a	wrong	point	locality	when	plotted	on	a	map.		
	
My	study	draws	attention	to	the	need	to	establish	a	set	of	parameters	and	an	
ontology	 capable	 of	 assuring	 a	 better	 use	 of	 digitization	 efforts	 to	 extract	 as	 much	
information	 as	 possible	 (Beaman	 and	 Cellinese,	 2012).	 Ontologies	 to	 describe	
traditional	 knowledge	 for	 all	 data	 collections,	 literature	 and	herbaria,	 are	 needed	 to	
improve	 comparison	power	and	address	 comprehensive	questions	or	meta-analyses.	
Nevertheless,	 it	 is	 argued	 that	 such	 etic	 (scientific/outsider)	 standardisation	 distorts	
the	emic	 (local)	perception	of	 local	TK,	discarding	 information	 (Staub	et	al.	 2015).	 In	
this	sense,	I	documented	both	standardised	and	traditional	knowledge	as	presented	in	
the	 literature,	 though	 the	 literature	 may	 already	 present	 an	 etic	 view.	 The	 use	 of	
secondary	 sources	presents	a	 risk	of	bias	 related	 to	 species	 identification,	or	 sample	
reliability	if	used	in	meta-analyses	(de	Medeiros	et	al.	2013).	Misleading	interpretation	
of	the	emic	view	presents	a	further	risk.		For	herbarium	vouchers	citing	medicinal	use,	
where	there	is	no	description	of	the	source	of	such	information	or	the	methodologies	
used,	it	is	harder	to	estimate	whether	these	errors	have	been	introduced.		
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6.3	 The	phylogenetic	framework	
	
To	 date,	 the	 phylogenetic	 framework	 applied	 to	 the	 interpretation	 of	 plants	
used	in	medicine,	or	potentially	used	in	medicine,	has	been	used	in	two	ways.	The	first	
relates	to	describe	hot	nodes	in	traditional	use	and	to	identify	closely-related	lineages	
from	different	medicinal	floras	(Saslis-Lagoudakis	et	al.	2012a).	This	first	framework	is	
based	 on	 community	 phylogenetic	 metrics.	 The	 second	 framework	 is	 based	 on	
evolutionary	 metrics	 (Pagel’s	 lambda),	 and	 relates	 to	 the	 identification	 of	 a	
phylogenetic	 signal	 in	 traits	 or	medicinal	 chemistries	 of	 interest	 (Cámara-Leret	 et	 al.	
2017;	Ernst	et	al.	2016;	Halse-Gramkow	et	al.	2016;	Rønsted	et	al.	2008).	Novelty	 in	
this	 study	 is	 two-fold.	 Phylogenetic	 frameworks	 are	 used,	 first	 to	 better	 understand	
research	 effort	 for	 the	 first	 time	 and	 secondly	 to	 characterise	 spatial	 distribution	 of	
traditional	knowledge,	again	for	the	first	time.		
	
	 Phylogenetic	 frameworks	 have	 been	used	 to	 inform	 the	 potential	 of	 lineages	
rich	 in	medicinally	used	species	as	targets	 for	bioprospecting	(Saslis-Lagoudakis	et	al.	
2012a).	Nevertheless,	 this	hypothesis	 is	 relatively	new,	and	extensive	evaluation	and	
corroboration	 is	needed.	 In	chapter	4,	although	the	phylogenetic	 framework	was	the	
same	as	the	one	used	by	Saslis-Lagoudakis	et	al.	(2012a),	by	comparing	lineages	rich	in	
medicinally	 used	 species	 and	 which	 species	 had	 been	 screened,	 it	 was	 possible	 to	
identify	gaps	in	knowledge	and	lineages	that	could	be	targeted	for	future	studies.	It	is	
not	possible	to	affirm	that	pharmacological	studies	have	been	guided	explicitly	by	the	
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search	 or	 closely-related	 species.	 Nevertheless,	 results	 shown	 in	 chapter	 4	 evidence	
the	extent	of	pharmacological	 investigation	for	the	Leguminosae,	where	lineages	rich	
in	 medicinally	 used	 species	 are	 better	 characterised.	 At	 the	 same	 time,	 it	 draws	
attention	to	the	need	for	further	investigation	of	less	characterised	plant	species,	that	
still	comprise	an	important	part	of	traditional	knowledge	systems.	The	combination	of	
methods	 used	 here	 might	 help	 on	 a	 better	 identification	 of	 new	 targets	 for	
bioprospecting.	
	
The	 second	 novel	 phylogenetic	 framework	 presented	 here	 was	 the	 use	 of	
community	 ecology	 and	 biogeography	 to	 test	 turnover	 in	 medicinal	 species	
composition	between	biomes,	 in	chapter	5.	While	many	ethnobotanical	studies	have	
been	 concerned	with	 listing	 plant	 species	 (an	 important	 task	 to	 preserve	 traditional	
knowledge),	the	use	of	more	robust	and	comparable	methodologies	is	of	great	interest	
for	the	theoretical	 foundations	of	ethnobotany	(Albuquerque	et	al.	2016).	Therefore,	
methodologies	to	investigate	the	relationships	between	humans	and	plant	species	are	
being	 “developed”	 or	 borrowed	 from	 other	 areas	 in	 science	 in	 order	 to	 address	
hypothesis-driven	questions	(Albuquerque	and	Hanazaki,	2009).	In	chapter	5,	by	using	
methods	borrowed	from	biogeography	and	community	phylogenetics,	 it	was	possible	
not	only	to	visualise	the	spatial	structure	of	traditional	knowledge	in	different	biomes,	
but	 also	 to	quantify	 turnover	 in	 species	 composition.	 These	methods	have	not	been	
used	 in	 ethnobotanical	 research	 before,	 and	 I	 expect	 that	 future	 studies	might	 use	
similar	methods	facilitating	comparisons.		
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6.4	 Phylogenies	and	evolutionary	ethnobotany	
	
	 Evolutionary	 ethnobotany	 is	 a	 relative	 new	 area	 being	 explored	 by	
ethnobotanists,	and	is	reliant	on	phylogenetic	frameworks.	Phylogenetic	investigations	
can	 test	 whether	 there	 are	 evolutionary	 relationships	 underlying	 traditional	 use,	
guiding	drug	discoveries	(Saslis-Lagoudakis	et	al.	2015),	or	investigate	trait	similarities	
(Cámara-Leret	 et	 al.	 2017;	 Ernst	 et	 al.	 2016;	 Halse-Gramkow	 et	 al.	 2016).	 As	 shown	
here	in	chapter	5,	phylogenetic	turnover	can	also	be	accounted	for	when	investigating	
spatial	 distribution	 of	 traditional	 knowledge.	 Although	 studies	 to	 date	 revealed	
significant	 patterns	 in	 medicinal	 plant	 use,	 many	 were	 based	 on	 taxonomic	 scales	
ranging	 from	 floras	 (with	 generic	 level	 trees	 (Saslis-Lagoudakis	 et	 al.	 2012a;	 Saslis-
Lagoudakis	et	al.	2014;	Yessoufou	et	al.	2015)	to	genus	level	(Ernst	et	al.	2016;	Saslis-
Lagoudakis	 et	 al.	 2011a).	 Phylogenies	 in	 this	 thesis	 were	 reconstructed	 based	 on	
available	 sequences,	 and	 at	 generic	 level.	 A	 species-level	 tree	 for	 the	 Leguminosae,	
despite	having	almost	all	species	could	only	be	reconstructed	if	species	were	included	
as	 polytomies.	 Although	 community	 phylogenetics	 is	 often	 focused	 on	 deep	 nodes,	
with	 unaccounted	 or	 non-significant	 relationships	 at	 shallow	 nodes,	 better	 species-
level	trees	are	needed.		
	
	 The	selection	of	medicinal	plant	species	has	been	investigated,	and	the	idea	of	
the	 presence	 of	 similar	 characteristics	 underlying	 species	 selection	 is	 explored	 in	
diverse	ways.	Casagrande	(2000)	explores	the	idea	of	medicinal	prototypes,	or	groups	
of	plant	 species	with	basic	 characteristics	 that	 identify	 species	 as	medicinal.	 Ferreira	
Júnior	and	Albuquerque	(2015)	go	further,	and	explore	the	existence	of	a	“consensus	
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within	a	diversity”,	where	species	with	great	consensus	represent	an	important	core	of	
a	 traditional	medicine	 system,	 and	 are	 less	 likely	 to	 be	 replaced	over	 time.	Hawkins	
and	 Teixidor-Toneu	 (2017)	 and	 Garnatje	 et	 al.	 (2017)	 discuss	 concepts	 phylogenetic	
convergence,	homology	and	shared	traits	medicinal	species	selection,	and	concepts	of	
core,	consensus	species	would	benefit	enormously	from	a	well-resolved	species	 level	
phylogeny.	 Species	 trees	 compared	 to	 a	 rich	 trait	 matrix,	 would	 permit	 the	
identification	of	generic	complexes	(Martin,	2004),	and	turnover	and	core	lineages	and	
phylogenetic	replacement	could	be	better	characterised.		
	
6.5	 Future	work	
All	analyses	presented	here	were	based	on	large-scale	data	distribution,	related	
to	 the	 whole	 of	 Brazil	 (whether	 one	 family	 or	 the	 whole	 of	 the	 Angiosperms).	
Nevertheless,	I	believe	future	work	on	smaller	scales,	comparing	local	communities	or	
investigating	 genera	 can	 benefit	 from	 the	 framework	 presented	 here.	 Much	 of	 the	
ethnobotanical	 information	 collected	 for	 this	 thesis	 had	 its	 origin	 in	 herbarium	
specimen	 labels	 (part	of	 the	 Leguminosae	 in	 chapters	2,	3	and	4,	 and	all	 of	data	 for	
chapter	5).	Although	this	work	was	facilitated	by	online	availability	of	the	data,	not	all	
herbaria	in	Brazil	are	digitised,	and	efforts	to	collect	more	data	from	this	source	could	
yield	 a	 more	 comprehensive	 picture	 of	 the	 ethnomedicinal	 flora.	 Nevertheless,	 for	
some	herbarium	this	would	be	a	huge	task,	for	example	in	the	herbarium	UB,	the	27%	
of	 specimens	not	 yet	 digitised	 comprise	 80000	 specimens	 to	be	 looked	 at	 (Proença-	
personal	communication).	Another	challenge	here	would	be	to	collect	all	 information	
present	in	literature	for	Brazil.		
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Ewé	database	was	designed	not	only	 to	be	used	 to	 support	data	 storage	and	
analysis	 for	 this	 thesis,	 but	 to	 be	 populated	with	 ethnobotanical	 data	 for	 the	whole	
Brazilian	 flora,	 and	 ideally,	 to	 be	 used	 by	 other	 ethnobotanists	 and	
ethnopharmacologists	 in	 Brazil.	 Ewe	 database	 development	 tools,	 being	 an	 open	
source	 scheme,	 can	 be	 useful	 in	 this	 expansion	 by	 allowing	 a	 collaborative	
development	of	the	database	by	the	users,	allied	to	data	being	provided	by	other	users,	
in	 order	 to	 expand	 and	 adequate	 to	 all	 research	 group’s	 needs.	 Nevertheless,	
challenges	here	include	funding	and	maintenance	of	the	database	system	to	assure	its	
sustainability,	 that	 could	 be	 sought	 with	 Brazilian	 universities	 and	 science	 and	
technology	 agencies,	 and	 agreements	 on	 an	 ontology	 to	 guide	 classification	 of	
therapeutic	applications,	and	taxonomic	identifiers.		
	
Another	 challenge	 encountered	 in	 this	 thesis	 is	 related	 to	 species	 names	
reported	as	currently	accepted.	In	some	chapters,	species	names	followed	the	Brazilian	
flora	while	in	others	followed	the	Plant	List	and	Trópicos.	Although	the	latest	version	of	
the	Brazilian	Flora	 is	 still	 being	worked	on,	many	 species	 from	herbarium	specimens	
were	 not	 reported	 in	 the	 Flora,	 but	were	 reported	 as	 accepted	 names	 in	 the	 other	
species	 lists.	 A	 final	 list	 with	 all	 accepted	 species	 name	 in	 the	 future	 will	 help	 in	
overcoming	issues	like	this	one,	and	facilitate	in	the	database	organisation.		
	
Finally,	 the	 phylogenetic	 framework	 reported	 in	 this	 thesis	 could	 be	
significantly	improved,	by	addition	of	more	species-level	sequence	data.	Phylogenetic	
reconstruction,	perhaps	using	Next	Generation	Sequencing,	would	benefit	enormously	
Chapter	6	General	discussion	and	conclusions	
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from	 cloud	 computing	 and	 computer	 clusters.	 Cloud	 computing	 would	 decrease	
analysis	time	and	allow	the	possibility	of	working	with	larger	and	more	comprehensive	
datasets,	 that	 could	 lead	 to	 better	 resolved	 phylogenies	 and	 an	 enhanced	
understanding	of	evolutionary	relationships	between	humans	and	plant	use.		
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Appendices	
Appendices	1	to	6	are	provided	in	digital	format,	and	appendices	7	to	11	are	provided	
here.	
	
Appendix	1.	Comparison	of	herbarium	label	and	published	medicinal	use:	herbaria	as	
an	underutilized	source	of	ethnobotanical	use	(publication).		
	
Appendix	2.	Species,	therapeutic	applications,	plants	parts	used,	modes	of	application	
and	source	for	reports	of	medicinal	use	of	Legumes	in	Brazil.	
Appendix	3.	List	of	references	and	herbaria	sourced	for	Ewé.	
Appendix	4.	Ewé	data	to	date.	
Appendix	5.	Accession	numbers	for	the	Brazilian	Leguminosae	phylogeny.	
Appendix	 6.	 List	 of	 medicinally	 used	 Brazilian	 Leguminosae	 with	 pharmacological	
studies.	
Appendix	 7.	 Table	 of	 possible	 outcomes	 of	 results	 from	phylogenetic	 frameworks	 in	
ethnobotanical	investigation.	
Appendix	8.	Generic	level	taxonomic	beta	diversity	
Appendix	9.	PCPS	values	and	eigenvectors	
Appendix	10.	PCPS	scatterplot	of	the	medicinal	floras	of	the	Brazilian	Biomes,	showing	
the	relation	of	biomes	according	to	the	first	two	principal	components	
Appendix	 11.	 Spearman	 rank	 order	 correlation	 for	 therapeutic	 application	 between	
each	pair	of	biomes	in	Brazil.	Numbers	in	bold	=p<0.05.	
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Appendix	7.	Table	of	possible	outcomes	of	results	from	phylogenetic	frameworks	in	ethnobotanical	investigation	
	
	
Comparison	
	
	
Finding		
	
Interpretation		
Taxonomic	beta	diversity	of	medicinal	plants	at	species	level	
(TaxβMEDsp)	v.	
Taxonomic	beta	diversity	of	the	whole	flora	at	species	level	
(TaxβFLORsp)	
TaxβMEDsp	>	
TaxβFLORsp	
Different	species	are	used	in	different	places,	with	more	turnover	than	
expected,	given	floristic	turn-over;	suggests	high	local	adaptation/low	
transmission	of	knowledge	in	space	
Taxonomic	beta	diversity	of	medicinal	plants	at	species	level	
(TaxβMEDsp)	v.	
Taxonomic	beta	diversity	of	the	whole	flora	at	species	level	
(TaxβFLORsp)	
TaxβMEDsp	<	
TaxβFLORsp	
There	is	more	shared	use	of	species	than	would	be	expected	given	turn-
over	in	species	availability;	suggests	high	transmission	of	knowledge,	or	
preferential	use	of	widespread	species		
Taxonomic	beta	diversity	of	medicinal	plants	at	generic	level	
(TaxβMEDgen)	v.	
Taxonomic	beta	diversity	of	the	whole	flora	at	generic	level	
(TaxβFLORgen)	
TaxβMEDgen	>	
TaxβFLORgen	
Different	genera	are	used	in	different	places,	with	more	turnover	than	
expected,	given	floristic	turn-over;	suggests	low	transmission	of	knowledge	
in	space	
Taxonomic	beta	diversity	of	medicinal	plants	at	generic	level	
(TaxβMEDgen)	v.	
Taxonomic	beta	diversity	of	the	whole	flora	at	generic	level	
(TaxβFLORgen)	
TaxβMEDgen	<	
TaxβFLORgen	
There	is	more	shared	use	of	genera	than	would	be	expected	given	turn-
over	in	species	availability;	suggests	high	transmission	of	knowledge,	or	
preferential	use	of	widespread	genera	
Taxonomic	beta	diversity	-	Species	level	comparison	v.	
Generic	level	comparison		
(TaxβMEDsp	>	
TaxβFLORsp)	AND		
(TaxβMEDgen	>	
TaxβFLORgen)	
Diversity	of	genera	and	species	high;	suggests	signal	of	species	
replacement	within	genera	is	not	strong		
Taxonomic	beta	diversity	-	Species	level	comparison	v.	
Generic	level	comparison		
(TaxβMEDsp	>	
TaxβFLORsp)	AND		
(TaxβMEDgen	<	
TaxβFLORgen)	
Diversity	of	genera	low	despite	diversity	of	species;	suggests	species	
replacement	within	genera		
Taxonomic	beta	diversity	-	Species	level	comparison	v.	
Generic	level	comparison		
(TaxβMEDsp	<	
TaxβFLORsp)	AND		
(TaxβMEDgen	>	
TaxβFLORgen)	
Not	expected	–	high	retention	of	species	but	turnover	in	genera		
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Taxonomic	beta	diversity	-	Species	level	comparison	v.	
Generic	level	comparison		
(TaxβMEDsp	<	
TaxβFLORsp)	AND		
(TaxβMEDgen	<	
TaxβFLORgen)	
Conservation	of	species	use	and	use	of	genera;	suggests	use	of	widespread	
species	and	genera,	and	low	local	adaptation			
Taxonomic	beta	diversity	of	medicinal	plants	at	species	level	
(TaxβMEDsp)	v.	
Phylogenetic	beta	diversity	of	medicinal	plants	at	species	level	
(PhyloβMEDsp)	
(TaxβMEDsp	>	
PhyloβMEDsp)	
Turn-over	in	use	of	species	is	high,	but	the	species	used	are	in	shared	
lineages;	suggests	phylogenetic	replacement		
Taxonomic	beta	diversity	of	medicinal	plants	at	species	level	
(TaxβMEDsp)	v.	
Phylogenetic	beta	diversity	of	the	whole	flora	at	species	level	
(PhyloβMEDsp)	
(TaxβMEDsp	<	
PhyloβMEDsp)	
Not	expected	–	high	retention	of	species	but	turnover	in	lineages	
Taxonomic	beta	diversity	of	medicinal	plants	at	generic	level	
(TaxβMEDgeneric)	v.	
Phylogenetic	beta	diversity	of	the	whole	flora	at	generic	level	
(PhyloβMEDgen)	
(TaxβMEDgen	>	
PhyloβMEDgen)	
Turn-over	in	use	of	genera	is	high,	but	the	genera	used	as	in	shared	
lineages;	suggests	preferences	of	lineages	above	generic	level,	e.g.	
preferences	for	families		
Taxonomic	beta	diversity	of	medicinal	plants	at	generic	level	
(TaxβMEDgeneric)	v.	
Phylogenetic	beta	diversity	of	the	whole	flora	at	generic	level	
(PhyloβMEDgen)	
(TaxβMEDgen	<	
PhyloβMEDgen)	
Not	expected	–	high	retention	of	genera	but	turnover	in	lineages	
Interpretation	of	statistics	for	ethnobotanical	data	
Statistic	 Finding	 Interpretation		
Phylogenetic	structure	of	medicinal	plants	at	shallow	phylogenetic	
nodes	using	species/generic-level		phylogeny	
(MED_NTIsp/MED_NTIgen)	
+ve	significant		 Use	of	species/genera	more	closely-related	to	each	other	than	expected	
from	a	random	sample	
Phylogenetic	structure	of	medicinal	plants	at	shallow	phylogenetic	
nodes	using	species/generic-level	phylogeny	
(MED_NTIsp/MED_NTIgen)	
-ve	significant		 Use	of	species/genera	more	distantly	related	to	each	other	than	expected	
from	a	random	sample		
Phylogenetic	structure	of	medicinal	plants	at	deep	phylogenetic	
nodes	using	species/generic-level		phylogeny	
(MED_NRIsp/MED_NRIgen)	
+ve	significant		 Use	of	species/genera	belonging	to	the	same	deep	lineages	is	greater	than	
expected	from	a	random	sample	
Phylogenetic	structure	of	medicinal	plants	at	deep	phylogenetic	 -ve	significant		 Use	of	species/genera	belonging	to	different	deep	lineages	is	greater	than	
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nodes	using	species/generic-level		phylogeny	
(MED_NRIsp/MED_NRIgen)	
expected	from	a	random	sample	
Phylogenetic	beta	diversity	of	medicinal	plants	using	NTI	statistic	and	
species/generic-level		phylogeny	(βMED_NTIsp/βMED_NTIgen)	
+ve	significant		 Turn-over	in	species/genera	is	between	closely-related	species/genera;	
suggests	“phylogenetic	replacement”	
Phylogenetic	beta	diversity	of	medicinal	plants	using	NTI	statistic	and	
species/generic-level		phylogeny	(βMED_NTIsp/βMED_NTIgen)	
-ve	significant		 Turn-over	in	species/genera	is	between	distantly-related	species/genera;	
suggestive	of	a	driver	to	differentiate		
Phylogenetic	beta	diversity	of	medicinal	plants	using	NTI	statistic	and	
species/generic-level		phylogeny	(βMED_NRIsp/βMED_NRIgen)	
+ve	significant		 Turn-over	in	species/genera	is	between	species/genera	in	the	same	deep	
lineages;	suggests	preference	of	use	for	the	same	deep	lineages		
Phylogenetic	beta	diversity	of	medicinal	plants	using	NTI	statistic	and	
species/generic-level		phylogeny	(βMED_NRIsp/βMED_NRIgen)	
-ve	significant		 Turn-over	in	species/genera	is	between	lineages;	suggestive	of	a	driver	to	
differentiate	
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Appendix	8.	Dissimilarity	matrices	at	generic	level	for	medicinal	plant	use	(lower	
diagonal)	and	total	flora	(upper	diagonal)	in	the	Brazilian	Biomes.	in	the	Brazilian	
Biomes.	Green	color	indicates	a	smaller	difference	in	the	medicinal	flora	than	in	the	
total	flora.	Red	color	indicates	a	larger	difference.	
B	 Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	 Pantanal	
Amazon	 		 0.33	 0.23	 0.28	 0.44	 0.15	
Atlantic	 0.37	 		 0.13	 0.15	 0.08	 0.09	
Caatinga	 0.54	 0.37	 		 0.13	 0.39	 0.20	
Cerrado	 0.37	 0.40	 0.37	 		 0.27	 0.10	
Pampa	 0.58	 0.26	 0.55	 0.26	 		 0.54	
Pantanal	 0.54	 0.31	 0.43	 0.20	 0.66	 		
	
Appendix	9.	PCPS	values	and	eigenvectors	for	the	PCPS	analysis	of	the	medicinally-
used	species	of	the	Brazilian	flora	
	
A. Principal	components	for	Brazilian	Biomes	as	resulted	from	the	PCPS	analysis.	
	
	
pcps.1	 pcps.2	 pcps.3	 pcps.4	 pcps.5	
Amazon	 -0.013242374	 0.04135311	 0.001479729	 -0.02800117	 3.13E-02	
Atlantic	 0.009668027	 0.04360697	 0.044060126	 0.04287837	 -4.28E-05	
Caatinga	 -0.062669653	 -0.01937558	 -0.068328543	 0.02326362	 2.61E-03	
Cerrado	 -0.01584214	 0.04526533	 -0.007304452	 -0.0253052	 -3.14E-02	
Pampas	 -0.057178105	 -0.07669566	 0.045790136	 -0.01048259	 -2.18E-03	
Pantanal	 0.139264245	 -0.03415416	 -0.015696997	 -0.00235302	 -3.11E-04	
	
B. Eigenvalues	for	the	PCPS	analysis	on	the	medicinal	flora	of	Brazilian	Biomes	
	
PCPS	 Eigenvalues	 Relative_eig	 Cumulative_eig	
1	 0.027111156	 0.49203888	 0.4920389	
2	 0.013084742	 0.23747427	 0.7295131	
3	 0.009008761	 0.16349952	 0.8930127	
4	 0.003919591	 0.07113643	 0.9641491	
5	 0.001975371	 0.03585091	 1	
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Appendix	10.	Principal	components	of	phylogenetic	structure	for	the	medicinal	floras	
of	the	Brazilian	Biomes,	showing	the	relation	of	biomes	according	to	the	first	two	
principal	components	
	
	
	
Appendix	11.	Spearman	rank	order	correlation	for	therapeutic	application	between	
each	pair	of	biomes	in	Brazil.	Numbers	in	bold	=p<0.05.	
	
Biomes	 Amazon	 Atlantic	 Caatinga	 Cerrado	 Pampa	
Atlantic	 0.73	
	 	 	 	Caatinga	 0.84	 0.84	
	 	 	Cerrado	 0.77	 0.92	 0.81	
	 	Pampas	 0.47	 0.63	 0.40	 0.56	
	Pantanal	 0.73	 0.60	 0.62	 0.64	 0.55	
	
	
	
